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This thesis reports on the use of amino acids and peptides as chiral ligands/catalysts in two 
asymmetric processes: Meso-desymmetrization of an epoxide and the kinetic resolution of 
secondary alcohols. Chapter 1 comprises a literature review, which gives a general overview 
of methods of asymmetric synthesis, followed by an overview on the existing classes of 
asymmetric DMAP-type acyl-transfer catalysis as the major topic of the thesis. Chapter 2 
describes the synthesis and evaluation of four peptide ligands used in combination with 
scandium(III) triflate for the meso-desymmetrization of cyclohexene oxide. 
Enantioselectivities were determined by chiral HPLC, and gave results of up to 41% ee. 
Chapter 3 discusses the synthesis and characterisation of three classes of nucleophilic 
DMAP-type catalysts, in which various amino acid/peptide auxiliaries were attached either α, 
β, or γ- to the pyridine nitrogen. The peptides contained tryptophan, chosen to exploit a 
potential π–π stacking interaction with the acyl-pyridinium cation. Catalysts substituted at the 
α and γ positions gave no kinetic resolution for 1-(2-naphthyl)ethanol 121; however, a 
dipeptide (Leu-Trp)-containing catalyst 128 substituted at the β-position gave an s-value of 
5.3. In order to improve the selectivity, 128 was derivatised at the C-terminal to form two 
tripeptide-containing catalysts, and acylated at the NH group of the indole ring (141). A range 
of secondary alcohols were tested and selectivity factors increased to up to 10.7. A series of 
second-generation catalysts were synthesised, but s-values did not improve. 
An NMR study was performed to reveal a possible conformational change during the 
stereoselective step. Computational modelling was performed using molecular mechanics 
(MMFF94) and quantum mechanics (B3LYP/6-31G, M06/6-31G*, ωB97X-D/6-31G) to 
determine a possible transition-state model, which indicated a π–cation interaction of the 
electron-rich indole ring of a tryptophan moiety with the electron-deficient pyridinium cation 
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APT    Attached proton test 
aq. Aqueous 
Ar Aromatic 
BnBr Benzyl Bromide 
Boc di-tert-butyl dicarbonate 
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br. s Broad singlet 
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HCl  Hydrochloric acid 
HOBt 1-Hydroxybenzotriazole 
HPLC High-performance liquid chromatography 
hr. Hour 
HRMS High-resolution mass spectrometry 
HSQC Heteronuclear single quantum coherence 
Hz Hertz 
IR Infrared spectrometry 
J Coupling constant 
krel Selectivity factor 











MMFF94 Merck molecular force field 
m.p. Melting point 
m/z Mass to charge ratio 
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p  Para 
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PT Proton transfer 
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s Singlet 
SN1 Unimolecular nucleophilic substitution 
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Chapter 1: Literature Review 
1.1 Asymmetric Synthesis 
Asymmetric synthesis – the production of chiral compounds from prochiral substrates or 
racemic molecules – is one of the main areas of research in organic chemistry and has 
widespread industrial uses.1 The production and sale of chiral molecules in enantiomerically 
pure form is a multibillion dollar industry that includes pharmaceuticals (e.g. 1 and 2), 
agrochemicals (e.g. 3 and 4), polymers, and starting material/intermediates for total synthesis 
(Fig. 1.1). 
 
Figure 1.1. Examples of chiral pharmaceuticals and pesticides. 
One of the main reasons for producing enantiopure compounds is that opposite enantiomers 
can have drastically different chemical reactivity;2 this is especially true in the 
pharmaceutical and agrochemical industry. Since biological macromolecules in living 
systems are made up exclusively of one enantiomer, biologically active compounds like 
drugs can show different behaviours for opposite enantiomers. Other reasons for producing 
enantiopure compounds include the following: 1) Biological activity is usually only 
associated with one enantiomer. For example, deltamethrin (4) (Fig. 1.1) exists as eight 
stereoisomers, but only the isomer shown is biologically active;2 2) The presence of the 
inactive enantiomer may inhibit the active one; 3) Stereoisomers that may appear harmless in 
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the short-term could have long-term side effects; 4) Producing pharmaceutical drugs in 
enantiopure form is required by law.3 
1.2 Methods for Asymmetric Synthesis 
There are four general methodologies in asymmetric synthesis, namely:2 1) Substrate-
controlled methodology in which stereocontrol is directed intramolecularly by a chiral entity 
present in the molecule from a chiral pool substrate such as an amino acid, carbohydrate, 
terperne etc.; 2) Auxiliary-controlled methods, in which stereocontrol is also directed 
intramolecularly but by a chiral auxiliary (attached to the substrate) that is removed after the 
reaction is complete;4 3) Reagent-controlled methods, in which stereocontrol is directed 
intermolecularly by a stoichiometric amount of a chiral reagent; and 4) Catalyst-controlled 
methods, in which stereocontrol is directed intermolecularly or intramolecularly (see 
organocatalysis) by a chiral catalyst in conjunction with a reagent (see section 1.3).5 
Additionally, racemic mixtures can be resolved in a classical resolution6 by adding a 
stoichiometric amount of a chiral resolving agent and then separating the diastereomers, or by 
a kinetic resolution7 in which the fast reacting enantiomer produces a product and the slow 
reacting enantiomer is resolved (discussed further in section 1.6). Ideally, if there is some 
way for the racemic starting material to racemize,8 all of the substrate can be resolved into a 
single enantiomer, a process known as dynamic kinetic resolution.6 
Of all the methods listed above, asymmetric catalysis (4) is the most favourable, since 
enantiomerically pure compounds can be formed using a small amount of recoverable 
catalyst at a lower cost, higher yield, and greater atom economy than with the other methods. 
In view of the research carried out in this thesis, only the latter type will be discussed. 
1.3 Asymmetric Catalysis 
In a chemical reaction, a catalyst speeds up a reaction by providing a lower activation-energy 
reaction path towards the product. Figure 1.2 shows a typical reaction-coordinate diagram for 
the conversion of substrate A into product B, for both the uncatalysed (i) and catalysed (ii) 
reactions in which transition-state free-energy changes (ΔG‡) for the catalysed reaction are 
given for the two steps overall. The difference between the free energies of the reactants and 
products is given by ΔG°. 
	  
	  




Figure 1.2. Reaction-coordinate diagram for (i) an uncatalysed and (ii) a catalysed reaction. 
A catalytic asymmetric process (Fig. 1.3) relies on a kinetic phenomenon in which one 
enantiomer reacts faster than the other. Here it is assumed that the R-enantiomer is faster 
formed. Therefore, the transition states that lead to the two products, R and S, should have 
different activation energies by virtue of diastereomeric complex formation between the 
substrate and the catalyst. 
 
Figure 1.3. Reaction-coordinate diagram for a catalytic reaction. 
Asymmetric catalysis has traditionally fallen into two general categories as involving either 
transition-metal complexes or enzymes. However, over the last decade a third category, 
coined organocatalysis, has emerged from a few interesting reactions to being a thriving area 
of research that include a wide range of reactions.9-11  




Organocatalysis is asymmetric catalysis involving an organic catalyst consisting of the main 
elements of organic chemistry,10 namely: carbon, hydrogen, oxygen, nitrogen, sulfur, and 
phosphorus. Figure 1.4 shows some examples of asymmetric organocatalysts. 
 
Figure 1.4. Examples of asymmetric organocatalysts (5–10).  
There are certain advantages to using an organic catalyst over traditional asymmetric 
catalysts such as transition-metal catalysts and enzymes, since they are inexpensive, easily 
synthesised, stable in air or aqueous media, and do not result in undesirable by-products such 
as heavy metals.10 Moreover, organic molecules such as amino acids, carbohydrates, and 
terpenes are available from the chiral pool as single enantiomers. 
The earliest example of an asymmetric reaction catalysed by an organic molecule was 
reported by Bredig and Fiske in 1913 involving the addition of HCN to benzaldehyde in the 
presence of quinine (6).12 Unfortunately, an ee of only 10% was obtained. Over the following 
90 years there were sporadic reports of organic molecules catalysing asymmetric reactions. In 
1998 MacMillan introduced iminium-ion activation – a mode of catalysis involving the use of 
a chiral amine – to catalyse the asymmetric Diels Alder reaction. Since then the field has 
grown to the extent that organic catalysts are used in a wide range of reactions, e.g. 
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oxidations,13, 14 reductions,15, 16 aminations, Strecker reaction (for amino acid synthesis),17,18 
halogenation,19-21 Michael additions,22,23 and others.24-26 
Organocatalysis can be classified based on their mechanism of action into four types: Lewis 
acid, Lewis base, Brønsted acid, and Brønsted base.27 This thesis focuses on the use of Lewis 
bases as catalysts, specifically the use of chiral 4-dimethylaminopyridine (DMAP)-type 
derivatives for the kinetic resolution of secondary alcohols, which will be discussed in the 
next section. 
1.5. Review of DMAP Chemistry 
1.5.1 Introduction 
DMAP (11, Fig. 1.5) is a versatile, mild, and inexpensive nucleophilic catalyst used in a wide 
range of useful chemical transformations,28-31 such as the acylation of alcohols, amines, and 
enolates, the Baylis-Hillmann reaction, the Dakin-West reaction, the protection of amines, C-
acylations, silylations, and many others.  
 
Figure 1.5. Structure of 4-dimethylaminopyridine (DMAP). 
Its catalytic activity was first detailed in 1967 by Litvinenko and Kirichenko when they 
discovered that replacing pyridine with 11 caused a rate increase of 104 for the benzoylation 
of m-chloroaniline.32 Independently, Steglich and Höfle showed in 1969 that 11 accelerates 
the acylation of the sterically hindered alcohol, 1-methylcyclohexanol.33 
Since its discovery as a nucleophilic acyl transfer catalyst, a range of more reactive 
nucleophilic DMAP-derived catalysts have been reported. For example, 4-
pyrrolidinopyridine (PPY, 12) and the pyridonaphthyridine 13, react 2.4 and 6 times faster 
than 11 respectively in the acylation of tertiary alcohols.34 Han et al.35 has also shown that the 
tricyclic triaminopyridines based on 14 – also called “super DMAP”36 – are also more 
reactive than 11. 




Figure 1.6. Nucleophilic acyl-transfer catalysts based on the DMAP concept. 
Despite the availability of more efficient variants of 11, it is still the reagent of choice for 
acyl transfer reactions. The availability of 11 in commercial quantities, its wide range of 
reported applications, and its low cost, have continued to stimulate great interest in its use as 
a catalyst, some examples of which are given in the following: 
1.5.1.2 Steglich Esterification28 
The esterification of carboxylic acids is a popular reaction employing 11 as a catalyst. 
Steglich et al. first described the reaction in 1978 using dicyclohexylcarbodiimide (DCC) and 
a catalytic amount of 11 as carboxylic acid activating agent (Scheme 1.1). 
 
Scheme 1.1. Steglich Esterification using DMAP 
1.5.1.3 Total Synthesis 
In the synthesis of the CP molecule, Nicolaou included a report of a successful model study 
for the one-carbon homologation of an aldehyde into a nitrile by cyanohydrin formation and 
deoxygenation. One of the hydroxyl groups was acylated using DMAP and 
thiocarbonyldiiimidazole to form the thiocarbamate, while deoxygenation of the cyanohydrin 
was achieved via a radical reduction (Scheme 1.2).37 
 
Scheme 1.2. One-carbon homologation of an aldehyde into a nitrile 
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1.5.1.4 Reagents Supported on DMAP 
The ionic liquid [bmim]PF6 has been employed as solvent for OsO4 immobilised on DMAP 
as a catalyst in a simple and practical approach for olefin dihydroxylation (Scheme 1.3).38 
Isolated yields varied between 73 and 99 % for various substrates. 
 
Scheme 1.3. Reagents Supported on DMAP 
Similarly, chiral variants of 11 that promote a wide range of enantioselective transformations 
is an important topic in asymmetric catalysis, and has matured to the extent that developing 
effective chiral 11 analogues has become an active area of research.39,40 The kinetic 
resolution of secondary alcohols provides a testing ground for applying new design principles 
for chiral catalysts of 11, since optically active secondary alcohols are important starting 
materials and intermediates in the synthesis of natural products, bioactive non-natural 
products, and chiral ligands. This has led to a renewed interest in understanding the 
mechanism of DMAP catalysis and the factors that influence its reactivity. Thus, the next 
three sections will highlight the mechanism of DMAP catalysis, the general concept of 
kinetic resolution, and the use of chiral DMAP derivatives. 
1.5.2 Mechanism of DMAP Catalysis 
Scheme 1.4 shows the currently accepted mechanism of catalysed acylation using 11. In the 
first step the pyridine nitrogen attacks the acylating agent (e.g. anhydride or acid chloride) to 
form an acyl-pyridinium cation A.35  




Scheme 1.4. Mechanism of DMAP Catalysis34 
The next step, which is the rate-determining step k2, involves nucleophilic attack of the 
hydroxyl group of the alcohol on the N-acyl-pyridinium ion A to form intermediate B. This is 
followed by rapid deprotonation of B to form the ester, with regeneration of the catalyst.35 
The HX is usually removed by an auxiliary base like triethylamine that does not participate in 
acyl-transfer. That way the DMAP can achieve turnover as a catalyst. 
The development of chiral derivatives of 11 in order to achieve an asymmetric transformation 
has prompted researchers to pay closer attention to this seemingly straightforward process. 34 
A recent review on the mechanism of acylation reactions of 11 has revealed interesting 
aspects about the factors that increase the catalyst efficiency, the deprotonation step, and 
solvent effects, which are now discussed. 
The efficiency of the catalysis depends on the stability of the acyl-pyridinium salt.28 
Therefore, factors that lead to a more stable acyl-pyridinium salt such as electron-donation 
will enhance its concentration and accelerate the reaction. Similarly, factors that destabilize 
the acyl-pyridinium cation will decrease its concentration. The presence of an electron-
donating group in the 4-position, greatly enhances the catalytic activity of 11 and other 
related pyridine compounds.28 This can be rationalised using resonance theory, in which the 
lone pair on the exocyclic nitrogen overlaps with the π orbitals of the pyridine ring producing 
a number of canonical forms, four of which are shown in Scheme 1.5.  
 
Scheme 1.5. Resonance structures of N-acyl-pyridinium cation 
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Thus the increased electronic communication between the exocyclic nitrogen and the 
carbonyl group, through the pyridine ring, increases the stability of the acyl-pyridinium 
cation;34 this accounts for the improved nucleophilicity of DMAP derivatives such as 12, 13 
and 14.  
Inductively donating groups attached to nitrogen at the 4-position (e.g. alkyl groups), and 
directly to the pyridine ring in the 3- and 5-positions also stabilize the acyl-pyridinium cation, 
while any groups attached to the 2- and 6-positions destabilize the acyl-pyridinium cation due 
to steric interactions with the acyl group. Table 1.1 shows some acylation enthalpies for 
various pyridine catalysts calculated by Zipse et al.41 As can be expected, extra substitution 
(4-substitution is there in each) at the 3- and 5-positions results in the highest exothermic 
acylation enthalpy, and the compounds are efficient catalysts; while introduction of 
substitution to the 2- and 6-positions results in a reduced exothermic acylation enthalpy and 
the resultant compounds are inefficient as acylation catalysts.41 
Table 1.1. Acylation enthalpies for various catalysts. 
 
The concentration of the acyl-pyridinium ion also depends on the nature of the acylating 
agent. When acetyl chloride is used the equilibrium of the reaction (Scheme 1.4, k1) is shifted 
completely to the right, but when acetic anhydride is used only 5–10% (relative to DMAP) of 
an acyl-pyridinium cation is formed at any one time.42 However, the rate of the reaction 
overall is faster when an acetate anion is present than when a chloride anion is present. This is 
due to a looser degree of binding between the pyridinium cation and the anion: “Loose 
binding” between mesomerically stabilized anion (e.g. acetates) and cation leads to faster 





   
substitution 
position 
 4 4 3, 4, 5 2, 3, 4 2, 4 
ΔHrxn 
kJ/kmol 
0.00 −82.2 −93.1 −108.9 −60.4 −66.2 
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binding”, due to high ionicity between the anion (e.g. chloride) and the cation, leads to a 
decrease in the rate because access to the carbonyl is restricted (Fig. 1.7) probably due to 
steric hindrance by the bigger chloride group.43 
 
Figure 1.7. Loose binding and tight binding between acyl-pyridinium cation and anion. 
In order to shed more light on the mechanism, Zipse et al.44 used theoretical and kinetic 
methods to investigate the deprotonation step since three bases are present in the reaction, 
namely: 11 (DMAP), the anion (X- of the acylating agent), and the auxiliary base. For this, 
they studied the acylation of tert-butanol with acetic anhydride in the presence of catalytic 




Their theoretical results support the mechanism described in Scheme 1.4 in which there is no 
base catalysis on the hydroxyl hydrogen, and in which the acetate counterion is the most 
likely base in the “deprotonating step”. Kinetic studies have shown that neither the auxiliary 
base nor catalytic DMAP removes the proton in intermediate B (Scheme 1.4), due to lack of 
correlation between the catalytic reactivity and their pKa.44 The choice of solvent also plays 
an important role in the rate of the reaction, which increases in non-polar solvents, while 
polar solvents result in lower rates.43  
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1.6 Kinetic Resolution using Chiral DMAP Catalysts 
A kinetic resolution involves the use of a chiral agent (reagent, catalyst, solvent, etc.) to 
achieve partial or complete resolution due to the selective reaction of one enantiomer over the 
other, giving an enantioenriched staring material that can then be isolated (Scheme 1.7).6,45 
The kinetic resolution operates when kS ≠ kR, and the reaction is stopped at some time so as 
to achieve about 50% conversion. 
	  
Scheme 1.7 
Figure 1.8 shows a graphical representation of a general case for a kinetic resolution, 
highlighting the three relevant processes: the uncatalysed reaction; the catalysed reaction of 
the R-starting material; and the catalysed reaction of the S-starting material. In this idealized 
situation, the fast-reacting enantiomer (in this example, R) will have a lower energy barrier 
than the slow-reacting enantiomer (S) – i.e. kR >> kS – and will react until it is consumed, 
yielding a higher percentage of the R-product.  
 
Figure 1.8. Kinetic Resolution5 
The free energies of these competing transition states define the rate constants for the 




controls the product distribution.15 This is an important factor in kinetic resolution termed the 
selectivity factor (s) (i.e. krel = s).  
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Figure 1.9 shows a general reaction profile for a typical kinetic resolution reaction, for two 
enantiomers, SS and SR that cannot racemize (i.e., krac = 0, or kR, kS>> krac). In this example 
kR>>ks, so the R enantiomer of the substrate (SR) will react faster than the S enantiomer (SS), 
leaving SS enriched. The selectivity factor (s) can be determined using the conversion (C) and 
the ee of the starting material and product.46 At the start of the reaction SS = SR = 0.5 for time 
t0. At time t 
SR + SS + C  = 1                                                              (1) 
Rearranging gives,     SR = 1- C - SS  and  SS = 1 - C - SR                                                     (2) 
For reactions that are first order or pseudo-first order in [S], with kR >> kS 
d SR
dt
=  kR SR ,                                                  (3) 
       and            d SS
dt
=  kS SS                                                         (4) 
 
Figure 1.9. Relative rate constants in kinetic resolutions.6,46 
Kagan45 derived the expression for the selectivity factor using these equations, plus the 
definition of ee, to show that the selectivity factor (or s-value) is related to C and ee by 
1	  Literature	  Review	  
13	  
	  
s = ln 1  - C 1  - ee
ln 1  - C 1 + ee
                     where ee = SS      -­‐  SR  (5) 
Figure 1.10 shows how the ee of the starting material (initially as a racemate) increases as the 
reaction progresses. High substrate enantiomeric excesses can be obtained by running the 
reaction to higher conversion to consume all of the fast-reacting enantiomer. Selectivity 
factors with s > 10 are generally considered useful for obtaining the product in an 
enantioenriched form (> 90 % ee) at 50% conversion. 
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1.7 Chiral DMAP Derivatives 
In 1996 Vedejs and Chen introduced the first chiral DMAP derivative 15 (Fig 1.11) for the 
kinetic resolution of secondary alcohols using stoichiometric quantities of 15.47  
 
Figure 1.11. Structure of Vedejs and Chen’s first chiral DMAP derivative. 
They obtained s-values up to 53 for a range of benzylic alcohols and an s-value of 14 for an 
allylic alcohol. However, Vedjes and Chen were unable to use 15 in catalytic amounts, 
presumably due to steric congestion at the α-position, since Litvinenko and Kirichenko’s 
initial report (section 1.5.1) showed that any steric bulk near the 2- or 6-position (even a 
methyl group) greatly diminishes DMAP’s catalytic activity, referred to in future as its 





relative rates 1 0.047 3.7 x 104 
 
Scheme 1.839 
An effective chiral DMAP catalyst therefore requires the chirality-directing group to get as 
close to the catalyst’s active site (N-acyl-pyridinium) as possible without inhibiting its 
reactivity. Another aspect is to introduce steric effects to shield one face of the molecule, 
thereby controlling the approach of the nucleophile. Since too much steric bulk can inhibit 
the catalyst’s reactivity, an alternative strategy would be to use a stereogenic group to 
desymmetrize DMAP through stacking interactions (π–π or π–cation) between the pyridine 
ring and the chiral side chain attached to either the β- or γ-positions. Scheme 1.9 shows how 
stacking interactions with a chiral stacking group (electron-rich) can result in 
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desymmetrization of one face of the pyridine ring, close to the active site following reaction 
of catalyst A with an acylating agent, R–X, to form intermediate B. This derivatisation brings 
about a conformational change in which an electron-rich functional group in the side chain 
interacts with the electron-deficient pyridine ring, thereby also stabilizing the acyl-pyridinium 
cation. The nucleophile (NuH) then attacks B in a chiral environment, resulting in the 
regeneration of A and the production of the product. 
 
Scheme 1.9. Stacking interactions between the pyridinium ion and an electron-rich side 
chain41 
Asymmetric DMAP catalysts can be classified according to the type of stereogenic unit 
present promoting the enantio-discrimination: axial (atropisomers), central, and planar. 
Another class of asymmetric acyl-transfer catalysis involves using achiral DMAP in the 
presence of a chiral H-bond donor; all the strategies will be discussed in the next four 
sections. The use of amino acids/peptides – which also contain central chirality, and is the 
focus of this thesis – will be discussed separately in section 1.8.  
1.7.1 Central Chirality 
4-Substituted DMAP Catalysis 
In 1997, Kawabata  et.al produced PPY-derived catalyst 16 that acts through an “induced fit” 
mechanism similar to the concept just introduced above in Scheme 1.9. In his case the 4-
pyrrolidino substituent was annulated at its 2,3-positions with a chiral cyclopentanol ring 
bearing a 2-naphthylmethyl substituent. In the neutral state, the catalyst exists in an open 
conformation A, while in the acylated state the catalyst flips to a closed conformation B in 
which the naphthalene ring stacks over the active site, Figure 1.12.49 
 




Figure 1.12. Open and closed conformations of Fuji’s catalyst. 
Mechanistic detail on the reaction was obtained from a 1H NMR study of 16 and its N-
acyliminion ion 16a (Fig.1.12) – formed by mixing 16 and iso-butyryl chloride in CDCl3. 
NOe measurements indicated the preferred conformation of A to be the “open conformation” 
in which the naphthyl ring and the pyridine ring lie apart from each other. Protons Ha and Hb 
are indistinguishable and appear at δH 8.01 ppm, while Hc and Hd appear at δH 6.37 ppm, 
suggesting that there is free rotation around the N(2)–C(1’) bond. By comparison, in the N-
acyliminium ion B, protons Ha, Hb, Hc, and Hd all appeared independently at δH 7.45 ppm, 
8.73 ppm, 5.69 ppm, and 6.87 ppm respectively; Ha and Hc were shifed upfield (0.50–0.68 
ppm), while Hb and Hd were shifted downfield (0.50–0.72 ppm), indicating a π–π interaction 
between the naphthalene ring and the acyl-pyridinium moiety predominantly on one side of 
the pyridine ring. Therefore, upon acylation the naphthyl ring transfers asymmetry from the 
chiral centres at C(1) and C(8) to the catalysts’ active site via π–stacking to the pyridine ring. 
This intramolecular interaction shields one face of the catalyst and exposes the other to the 
attacking nucleophile, thus allowing a stereoselective process to occur. 
The catalyst was tested in the kinetic resolution of a range of mono-acylated 1,2-diols and 
produced s-values in the range of 4.7 up to 12.3 (Scheme 1.10).49 
 
Scheme 1.10. 
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In 2000, Spivey et al. introduced a series of chiral, non-racemic trans-2,5-disubstituted C2-
symmetric PPY catalysts (Fig. 1.13).50 
 
Figure 1.13. Spivey’s trans-2,5-disubstituted C2-symmetric PPY catalysts. 
Their catalyst design was based on molecular modelling studies that suggested that a π–π 
interaction would occur between the acyl-pyridinium ion and the aryl ether groups (in a 
similar way to Fuji’s induced fit mechanism), attached to the pyrrolidine ring. They also 
rationalised that a C2-symmetric catalyst would result in a lower number of diastereomeric 
transition-states in the stereodifferentiating step. The catalysts were tested in the kinetic 
resolution of 1-phenylethanol with acetic anhydride as the acyl donor in THF (Table 1.2), but 
s-values were low (< 2).  
Table 1.2. Kinetic resolution of 1-phenylethanol using different catalysts. 
catalyst C ee(alcohol)  s-value 
17 72.2 18.7 1.3 
18 48.2 19.1 1.8 
19 38.1 2.5 1.1 
20 14.1 2.6 1.4 
21 31.5 6.3 1.5 
22 27.2 6.6 1.5 
23 28.2 5.1 1.4 
 
Spivey suggested that possible reasons could be that the desired π–π interaction did not take 
place, or that the chiral groups were ineffective in transferring chirality to the acyl-pyridinium 
ion. The authors also noted that two of the catalysts (22 and 23) had low THF solubility, 
which could have hampered the formation of the acyl-pyridinium ion. Thereafter, Spivey 
turned his attention to using axial chirality (see section 1.7.2) 
Díez synthesised a C2-symmetric catalyst 24 and two non C2-symmetric sulfone-containing 
PPY catalysts, also incorporating the chirality into the pyrrolidine ring (Fig. 1.14).51 
Compounds 24 and 25 were not expected to produce much asymmetric induction, since the 
stereogenic centres are not near the active site. Therefore, a benzyl group was introduced 
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using the reactivity of the sulfone (of catalyst 25) to form compound 26. The catalysts were 
tested in the kinetic resolution of 1-phenylethanol 27 but s-values were also low (Table 1.3). 
 
Figure 1.14. Díez’ C2-symmetric catalyst 22 and two sulfone-containing PPY catalysts 23, 
24. 
Table 1.3. Kinetic resolution of 1-phenylethanol using catalysts 22-24. 
 
catalyst C ee(alcohol) s-value 
(+)-24 28 0.8 1.8 
(+)-24 40 1.8 2.1 
(+)-25 8.6 6.9 1.6 
(+)-25 21 4.1 1.4 
(+)-26 57 1.2 1.5 
(+)-26 62 2.5 1.4 
 
Molecular modelling of the lowest-energy conformation of catalyst 26 (Fig. 1.15) revealed 
the reason for the low s-values.51 Although the benzyloxy group’s phenyl ring is positioned in 
the vicinity of the reactive centre, it is too far away to effectively shield one face of the 
catalyst.	  




Figure 1.15. Lowest energy conformation for compound 26.51 
3-Substituted DMAP Catalysis 
Other groups used a different approach and attached the chirality directing group to the β- 
position, closer to the pyridine nitrogen. In 2002, Jeong designed an interesting chiral DMAP 
catalyst containing Kemp’s triacid as a linker (attached to the β-position to minimize steric 
repulsion), and a binaphthyl framework as the chiral atropisomeric subunit (Fig. 1.19).52  
 
Figure 1.16. Jeong’s β-substituted DMAP catalyst. 
Molecular modelling revealed that in the energy-minimum structure the dimethylamino group 
points away from the binaphthyl group in order to minimize steric repulsion, while the 
pyridine nitrogen atom is close to the naphthyl ring of the chiral ligand. Presumably, the role 
of the linker is to allow the binapthyl group to reach the active site where it can provide 
shielding of one face of the catalyst. Catalyst 28 gave modest to excellent s-values (4–21) for 
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70 79 4.4 
 
67 85 6.3 
 
77 99 8.1 
 
59 90 13.3 
 
72 84 4.7 
 
72 98 8.3 
 
63 95 12.4 
 
62 99 21.0 
 
As Table 1.4 shows, the s-value increased with increasing steric bulk of the alkyl group of the 
alcohol, in which the best result was obtained for the acylation of racemic trans-2-
phenylcyclohexanol, which proceeded with s = 21. 
Other groups pursued this concept of remote asymmetric induction via conformational 
control. Yamada introduced a thiazolidine-2-thione (attached β to the pyridine nitrogen) 
catalyst 28 that functioned via a “conformational switch” system similar to Fuji’s “induced 
fit” mechanism. On acylation, the thiocarbonyl (π-bond) is postulated to interact with the 
pyridine ring (cation), resulting in a conformational change in the molecule (Fig. 1.17).53 




Figure 1.17. Yamada’s catalysts upon acylation. 
1H NMR studies revealed that when the thiocarbonyl interacts with the pyridine ring it 
selectively shields one face of the molecule, transferring asymmetry to the catalyst’s active 
site. This was determined by comparing the spectra of 29 and its N-methyl-pyridinium ion 
29a to corresponding reference compounds lacking the thiocarbonyl moiety (Fig. 1.18). 
	  
Figure 1.18. Structural studies of catalyst 29, its reference (30), and their corresponding 
methyl salts (29a and 30a). 
Table 1.5 shows the results of the 1H NMR study, which indicated much greater shifts for the 
pyridine hydrogens going from catalyst 29 to its pyridinium salt 29a compared to those for 
going from 30 to 30a as monitored by Δδ and Δδa – the differences in chemical shifts 
between 29 and 30, and chemical shift differences in the reference compounds 29a and 30a 
respectively. These results reflect the effect of the thiocarbonyl moiety on the chemical shifts 
of the pyridinium protons implying a proximity effect.  
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Table 1.5. Selected 1H NMR chemical shifts (ppm) for 29, 30 and methylated analogues.53 
Proton δ29 δ30 Δδ c δ29a δ30a Δδac 
H-2 a,b 8.22 8.14 0.08 9.55 8.46 1.09 
H-5 a,b 6.56 6.57 −0.01 6.87 7.11 −0.24 
H-6 a,b 8.18 8.22 −0.04 8.08 8.52 −0.44 
a. Measured using CDCl3 as solvent. b. All pyridine protons where unambiguously assigned by NMR 
spectroscopy (1H, 13C, HSQC, and COSY). c. The Δδ values were calculated using the equations, Δδ = 
δ29 − δ30, and Δδa = δ29a − δ30a. 
These observations are consistent with Yamada’s previously reported π–cation complex,54 
and indicate that 29a has a fixed conformation in which there is close proximity of the C=S 
group with one face of pyridine ring. This interaction is absent in 29. Therefore, the π–cation 
interaction allows the incoming alcohol to only approach the acyl-pyridinium ion from the 
opposite, exposed face. The catalysts produced s-values up to 13 for a range of secondary 
alcohols (Table 1.6).53 
Table 1.6. Kinetic resolution of various alcohols catalysed by 29. 
 
substrate C ee(alcohol) s-value 
R1 = Me, R2 = H 65 89 7.3 
R1 = Me, R2 = OMe 68 97 10 
R1 = Me, R2 = NO2 72 98 8.9 
R1 = t-Bu, R2 = H 62 88 9.6 
 
65 97 13 
 
66 92 8.1 
 
65 94 9.8 
 
61 78 6.6 
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The Connon group synthesised the 3-substituted PPY derived catalysts, 31, 32, and 33 (Fig. 
1.19) also with Fuji’s “induced fit” concept in mind, but based on an amide without an extra 
(thio)carbonyl appendage. They rationalised that their catalyst would also undergo a 
conformational change upon acylation, causing the sterically demanding aromatic rings to 
shield one face of the catalyst.55 Catalysts 30–32 were tested in the kinetic resolution of 
mono-acylated diols, but produced variable s-values (1.4–9.4). 
 
Figure 1.19 Connon’s 3-substituted PPY derived catalysts. 
NMR studies and molecular modelling by Connon revealed two important factors responsible 
for the stereoselectivity. These were π–π stacking between the pyridine ring and the aromatic 
groups in the side chain attached to the 3-position, as well as H-bonding interactions between 
the substrate and the hydroxyl group of the catalyst. 
The most efficient catalyst 32 (of three) was tested in the kinetic resolution of various 
secondary alcohols (Table 1.7). Results were varied, but they did obtain an s-value of 30 for 
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Table 1.7. Kinetic resolution of various alcohols catalysed by 32.55 
	  
substrate C  ee(alcohol)  s-value 
 
27.5 25 6.3 
 
17 17 6.0 
 
14.6 1 1.1 
 
19 19 13.5 
 
19 22 30.0 
  
Levacher et al. created a DMAP catalyst bearing a chiral sulfoxide 33 at the 3-position via 
bromine-magnesium exchange on a 3-bromo-DMAP derivative followed by substitution with 
a chiral sulfinate via Anderson chemistry.	  Sulfoxide, 33, was obtained as a pure enantiomer 
in a 60% yield (Scheme 1.10).56 	  
 
Scheme 1.10. Synthesis of Levacher’s sulfoxide-containing DMAP catalyst 
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They rationalised that the proximity of the dimethylamino group to the sulfoxide would 
prevent free rotation around the C(3)-S bond. Molecular modelling showed that in the lowest 
energy conformation, the lone pair of the sulfoxide and the pyridine ring are in a co-planar 
arrangement. This constraint suggested sterodifferentiation between the two faces of the 
catalyst. The initial control reaction with DMAP took 2 hours (Scheme 1.11), but the reaction 
with 33 took 24 hours. 
	  
Scheme 1.11. 
The authors suggested that the decrease in rate was due to the electron-withdrawing sulfoxide 
dipole, hampering the formation of the acyl-pyridinium salt. The sulfoxide presumably also 
did not provide good enough shielding of the face because only modest levels of selectivity 
(s-values up to 4.5) in the resolution of various secondary alcohols were obtained. Table 1.8 
shows the results of the kinetic resolution of various secondary benzylic alcohols using 33 as 
a chiral catalyst. 










15.5 9.4 3.4 
 
18.3 10.4 3.0 
 
16.7 12.0 4.5 
 
22.4 12.8 2.9 
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In 2007 the Richards group synthesised a C2-symmetric organometallic DMAP catalyst with 
a chiral pyrrolidino group at C-4 incorporating two extra ferrocene groups attached to the β-
positions.57,58 
 
Figure 1.20. Richards’ C2-symmetric organometallic DMAP catalyst. 
The iron-containing groups do not participate in the reaction, but provide steric bulk to the 
two faces. Catalyst 35 was tested in the kinetic resolution of the normal library of secondary 
alcohols that had become standard for catalyst evaluation (Table 1.9), but s-values were 
relatively modest, once again suggesting that proximity between chiral element and the active 
site was not optimal.  










R = Et 52 32 2.5 
R = Et 22 16 4.5 
R = Et 12 9 5.3 
R = Et 8 6 5.8 
R = i-Pr 23 20 6.1 
R = i-Pr 32 25 4.1 
  
Recently (2014) the Sibi group introduced a DMAP catalyst with fluxional chirality59 – in 
which an achiral moiety is used to relay and amplify stereochemical information from 
existing chiral centres to a different site in the molecule60 – for the kinetic resolution of 
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secondary alcohols and biaryl compounds. The catalyst design consisted of three main 
components: a DMAP moiety; a pyrazolidinone group (the chiral element developed by the 
group in 2003)61 attached β to the pyridine nitrogen; and a fluxional substituent, which can be 
varied and functions as a blocking group (Figure 1.21).  
 
Figure 1.21. Catalyst design for the novel fluxionally chiral DMAP catalyst. 
The results of a catalyst screening (varying R1, R2, and R3) revealed 36, with R1 as tert-butyl, 
R2 as 1-naphthyl, and R3 as dimethylamino to be the best catalyst (Fig. 1.22). Catalyst 36 was 
tested in the kinetic resolution of a range of sec-alcohol; 1-(2-naphthyl)ethanol and 4-phenyl-
3-butyn-2-ol gave the highest s-values of 17 and 37 respectively. 
	  
Figure 1.22 
Next, they tested catalyst 36 in the kinetic resolution of axially chiral biaryl compounds, 
which had previously been tested only with biaryl-derived catalysts,59 and only once using a 
chiral DMAP catalyst (s = 1.4).62 A range of mono-protected bis-2-naphthols were evaluated 
and returned excellent results. Scheme 1.12 shows three of the highest s-values obtained.  




Scheme 1.12. Selected examples of the kinetic resolution of biaryls using catalyst 3659 
The origin of the stereoselectivity was determined by X-ray crystallography, which indicated 
that the tert-butyl group and the naphthyl ring are on opposite sides of the five-membered 
ring due to steric interactions. According to the researchers, the naphthyl substituent blocks 
the bottom face of the catalyst, as well as the back side – away from the pyridine nitrogen, 
and close to the dimethylamino nitrogen (Fig. 1.23). 
	  
Figure 1.23. X-ray crystal structure of catalyst 36.59 
Therefore, in the stereoselective step the hydroxyl group of the biaryl substrate approaches 
the catalyst from the top face, while the other protected hydroxyl group (R’) approaches from 
the backside (to minimize steric interactions between the naphthyl ring and the biaryl ring). 
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This approach is favoured in the S-enantiomer, resulting in a kinetic resolution of the R-
enantiomer. 
1.7.2 Axial Chirality 
In 1998, Spivey introduced the first atropisomeric acyl-transfer catalysts, which consisted of 
a DMAP molecule attached to a hindered biaryl at the 3-position, with restricted rotation 
about the aryl-pyridine bond (Fig. 1.24).63,64  
 
Figure 1.24. Spivey’s axially chiral acyl-transfer catalyst. 
Initial tests showed that while the catalytic reactivity was comparable to that of DMAP (for 
the acylation of methyl cyclohexanol), the catalysts gave disappointing selectivities for the 
kinetic resolution of secondary benzylic alcohols (Table 1.10). 
Table 1.10. Kinetic resolution of secondary benzylic alcohols with catalytic atropisomeric 
DMAP derivatives 37–39. 
 
substrate catalyst C  ee(alcohol) s-value 
Ar = Ph 37 35.0 9.1 1.5 
Ar = Ph 38 26.0 11.6 2.2 
Ar = 1-Nap 38 18.3 9.0 2.5 
Ar = 1-Nap 39 17.6 13.1 4.7 
 
To improve the selectivities, they synthesised compound 43 (R = Ph) in a short three-step 
synthesis from 3,5-dibromo-4-chloropyridine on a gram-scale (Scheme 1.13). Catalyst 43 
(resolved by semi-preparative chiral HPLC) gave vastly improved results for the kinetic 
resolution for the same substrates (Table 1.11).65 




Scheme 1.13. Synthesis of Spivey’s atropisomeric DMAP catalyst. 
Table 1.11. Kinetic resolution of secondary benzylic alcohols with catalytic atropisomeric 
DMAP (-)-43. 
 
substrate C e.e(alcohol) s-value 
Ar = 1-Nap , R =  Me 17.2 18.6 21 
Ar = 1-Nap , R =  Me 22.3 26.3 29 
Ar = Ph, R =  Me 39.0 49.9 13 
Ar = 2-Tol , R =  Me 41.4 60.7 25 
Ar = Ph, R =  t-Bu 17.5 18.8 20 
 
They also reported that the nature of the N-alkyl group has an effect on the s-values (Table 
1.12)66 with the 4-dibutyl-substituted catalyst giving optimal reactivity and selectivity. 
However, possible reasons for the improved selectivities are not yet known. 
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Table 1.12. Kinetic resolution of 1-(1-naphthyl)ethanol catalysed by atropisomeric DMAP 
derivatives. 
catalyst R s-value 
43a Me 10 
43b Et 16 
43c (CH2)4 3.5 
43d Bu 31 
43e Pent 30 
43f Hex 39a 
a. T = 93 °C, time = 14.3 hrs 
Spivey then tried to improve the selectivity of 43 even further by adding a methyl group to 
the pyridine ring α-position to form 44.67 They rationalised that the presence of a methyl 
group α to the pyridine nitrogen would influence the conformation of the carbonyl group of 
the acyl-pyridinium intermediate.  
 
Even though α-substitution is known to strongly attenuate the nucleophilicity of pyridine 
catalysts, they hoped that the effect on the carbonyl would enhance enantiodiscrimination. 
Sammakia and Hurley showed that α-substituted 4-PPY catalysts can catalyse the 
methanolysis of α-hydroxy esters – though the mechanism is not nucleophilic.68 
Unfortunately, 44 gave a low selectivity in the kinetic resolution of 1-(1-naphthyl)ethanol (s 
= 2.0). 
To explain the high s-values with catalyst 43 Spivey proposed a transition-state model based 
on the minimization of steric interactions:65 The alcohol attacks the acyl-pyridinium ion – in 
an orientation that minimizes steric repulsion with both the naphthalene ring system (of the 
catalyst) and the isopropyl groups (of the acyl-pyridinium ion) – from the opposite face to the 
phenyl substituent (on the naphthalene). Importantly, the hydroxyl group adopts a 
stereoelectronically favoured colinear approach on the carbonyl. The groups at the 
stereogenic centre adopt a minimized steric trajectory in which the larger ligand points away 
from the pyridinium vicinity (Fig. 1.26). 




Figure 1.26. A transition-state representation of a kinetic resolution using Spivey’s catalyst, 
isobutyric anhydride, and a secondary alcohol (NEt2 group omitted for clarity). 
In 2013, Spivey and Zipse69 reported on using computational methods to predict that 45, 
containing a 4-Bu2N group and a 3,5-(CH3)2C6H3 “blocking group” (attached to the 
binaphthyl group) would exhibit high levels of selectivity for the kinetic resolution of 1-(1-
naphthyl)ethanol. Here, they obtained an s-value of 44 with a 44% conversion. 
Computational modelling showed that the improved selectivity was most likely due to steric 
repulsion between the naphthyl ring of the S-alcohol and one of the methyl groups (ortho or 
meta) of the blocking group (blocking groups that were para-substituted did not improve the 
selectivity). Comparing the levels of enantioselecitvity that were predicted computationally 
with results obtained experimentally allowed the method to be validated. 
 
1.7.3 Planar-Chiral DMAP Catalysts 
In 1996 Fu and Ruble introduced the first planar-chiral DMAP catalysts.70 They based their 
design on desymmetrizing DMAP by incorporating the pyridine ring of the DMAP as a 
replacement for one of the rings of ferrocene, as well as adding a group to the pyridine 2-
position (Fig. 1.27).70 In such a way, as with previously described motifs in this review, facial 
discrimination on the pyridine faces would be achieved as well as sides. 




Figure 1.27. Fu’s planar-chiral catalyst design. 
Fu’s catalysts consist of either a pentamethyl or pentaphenylcyclopentadienyl ligand 
complexed to the iron metal centre. The R group was varied from being a single substituent 
to an annulated ring. Iron is the preferred metal since it promotes electron-release into the 
pyridine ring, increasing the negative charge on the nitrogen atom.40,71-76 Figure 1.28 
illustrates the genesis of the catalyst design. 
 
Figure 1.28. Fu’s planar-chiral catalysts.39 
Fu’s initial tests yielded moderate selectivities (s-values up to 6.5) for the kinetic resolution 
of racemic 1-(1-naphthyl)ethanol with 46 as catalyst.70 Optimization studies revealed the best 
catalyst to be 50,77 solvent (t-amyl alcohol),78 and a temperature of 0 °C;78 The kinetic 
resolution of the customary aryl alkyl carbinols produced some impressive s-values (Table 
1.13). Catalyst 50 also showed activity in the kinetic resolution of chiral allylic alcohols (s-
values up to 80),79 as well as propargylic alcohols (s-values up to 20).80 Fu noted that the high 
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stereoselectivity displayed by 50 is attributable to the η5-C5Ph5 group, which effectively 
desymmetrizes one face of the catalyst.77  
Table 1.13. Kinetic resolution of benzylic secondary alcohols with 50. 
 
substrate C ee(alcohol) s-value 
R1 = Me; R2 = H 55 99 43 
R1 = t-Bu; R2 = H 51 96 95 
R1 = CH2Cl; R2 = H 56 98 32 
R1 = Me; R2 = F 54 99 68 
 
53 99 71 
 
52 95 65 
 
To demonstrate the potential of their catalysts in actual synthesis, the Fu group resolved two 
key intermediates in high ee,79 as 54 from Brenna’s total synthesis of (–)-baclofen,81 and 55 
from Sinha-Lerner’s total synthesis of epothilone A (Fig. 1.29).82  
 
Figure 1.29. Structure of (–)-baclofen (54) and epothilone A (55). 
In another example of the selectivity of 50, Ley performed a kinetic resolution of 57 from 
racemic 56 (Fig. 1.30) in his total synthesis of iso- and bongkrekic acid.83 




Figure 1.30. Kinetic resolution of 50 in the total synthesis of iso- and bongkrekic acid. 
The concept of planar DMAP catalysis generated great interest in other research groups. In 
2005 Johannsen et al. synthesised chiral DMAP derivatives with a planar-chiral ferroence 
substituent at the pyridine C-2 position 58 and at the C-3 position 59 (Fig. 1.31). Although 59 
was more reactive than 58 (due to steric congestion at the 2-position in 58), neither of the two 
catalysts showed any selectivity in the kinetic resolution of 1-phenylethanol, probably 
because, unlike Fu’s catalyst, they are not able to provide effective discrimination of the two 
pyridine faces.84,85 
 
Figure 1.31. Johannsen’s planar-chiral ferroence catalysts. 
1.7.4 Helicenoidal DMAP 
In 2011 Carbery and co-workers presented the first asymmetric DMAP organocatalyst 60 
consisting of a DMAP moiety embedded into a helicenoidal framework.86  
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Catalyst 60 resulted in excellent selectivities at a low catalyst loading of 0.5 mol % for the 
kinetic resolution of secondary aryl alkyl alcohols (Table 1.14).86 
Table 1.14. Kinetic resolution of benzylic secondary alcohols with 60. 
 
Substrate C  s-value 
R1 = Me, R2 = F, R3 = H, R4 = H 47 18 
R1 = Et, R2,R3 = H, R4 = H 43 23 
R1 = t-Bu, R2,R3 = H, R4 = H 46 26 
R1 = Me, R2 = H, R3 = Br, R4 = H 42 23 
R1 = Me, R2 = H, R3 = Me, R4 = H 40 32 
R1 = Me, R2 = H,R3 = OMe, R4 = H 47 43 
R1 = Me, R2 = H, R3 = Ph, R4 = H 55 27 








Molecular modelling revealed two factors responsible for the observed selectivity as: i) π–
stacking between the substrate aryl group and the pyridinium ring of the catalyst – as in 
previous cases this discriminates the two pyridine faces; ii) minimization of steric clash 
between the methyl group (as “Rs”) and the i-Pr group of the acyl group – this assumes that 
the phenyl group of the alcohol (as RL) points “away” towards the less hindered side away 
from the helix, while the methyl group (as RS) points away from the isopropyl group of the 
acyl group being transferred, (Fig. 1.33).  




Figure 1.33. Proposed transition-state model for catalyst 60.86 
Catalyst 60 was demonstrated to be catalytically active at loadings as low as 0.05 mol % as 
shown in the preparative kinetic resolution of 1-(1-naphthyl)ethanol (Scheme 1.14). 
 
Scheme 1.14 
Carbery’s catalysts gave impressive selectivities, but the synthesis of 60 had two 
limitations:87 1) the catalyst was synthesised as a racemate and had to be resolved by chiral 
HPLC; 2) some of the intermediates in the synthesis were sensitive, which limited scalability; 
However, the researchers succeeded in synthesizing derivatives of 60 in the hope of 
improving the selectivity. Thus 62 was synthesised via a rhodium-catalysed [2+2+2] triyne 
cycloisomerization in a 95:5 dr (Scheme 1.15), with the major product being easily obtained 
following column chromatography. Catalyst 62 was obtained in a low yield of 33%, but the 
larger scale of the reaction enabled 62 to be formed in over 1 g. In a kinetic resolution of 1-
(2-naphthyl)ethanol, 62 gave an s-value of 33 (similar to 60).87 





1.7.5 Combination of Thiourea Derivatives with DMAP 
During the previous decade the use of chiral ion-pairs has become a useful tool in 
organocatalysis.88 The use of chiral ion-paring is well established in the field of phase-
transfer catalysis, in which anionic intermediates form supramolecular interactions with 
chiral cations. List and co-workers expanded on this concept and introduced asymmetric 
counter-ion-directed catalysis (ACDC),89, 90 in which enantioselectivity is achieved by ion 
pairing of a cationic intermediate with a chiral, enantiomerically-pure anion to form an 
asymmetric catalyst. Thiourea derivatives in particular have emerged as an important class of 
compounds for the development of new organocatalytic reactions, since they are especially 
valuable for their ability to recognize anions and negative charges.91-93	   
The Seidel group took a different and interesting approach in their design of a chiral acylation 
catalyst, in that they decided to introduce the chiral environment via the leaving group of the 
acylating agent. In this they combined achiral DMAP with a chiral thiourea anion binder in 
the expectation of H-bonding between the chiral thiourea and the anion leaving group from 
the acylating agent occurring to create a chiral ion-pair with the acyl-pyridinium cation, thus 
creating a local chiral environment for discrimination of the alcohol enantiomers, (Scheme 
1.16). 
 




Scheme 1.16. In situ generation of chiral acyl pyridinium salt 
Of the chiral H-bond donor ligands tested, bis-thiourea 63 gave good selectivities (s-values 
up to 24) in the kinetic resolution of racemic secondary amines (Table 1.15).94,95 The kinetic 
resolution of amines poses challenges to small-molecule catalysts (e.g. the amine is usually 
just as nucleophilic as the catalyst) that the Seidel group hoped to address using their dual-
catalysis strategy.95,96  
 
Figure 1.34. Chiral H-bond donor ligands. 
The mixed amide-thiourea 64 gave even better results and was applied to the kinetic 
resolution of racemic propargylic amines,96 allylic amines (with 4-PPY),97 as well as the 
meso-desymmetrization of meso-diamines,98 and other reactions.99 Some results for aryl/alkyl 
secondary amines are shown in Table 1.15. More recently (2012), the Seidel group have used 
64 in combination with 4-dipropylamino pyridine in the kinetic resolution of secondary 
amines to achieve s-values up to 65,100 as well as 1,2-diaryl-1,2-diaminoethanes with s-values 
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Table 1.15. The kinetic resolution of secondary amines with 64. 
 
Substrate C s-value 
R1 = Me, R2,R3 = H 41 13 
R1, R3 = Me, R2 = H 44 17 
R1 = Me, R2 =Cl, R3 = H 48 38 




1.8 Amino Acids and Peptides as Asymmetric Catalysts 
Amino acids are chiral pool molecules that are widely used in asymmetric synthesis as 
starting materials, auxiliaries, reagents, and catalysts. The range of structural and functional 
diversity in the amino acid side chains can exert a high degree of stereocontrol through steric 
effects (amino acids with bulky side chains have proven to be particularly useful), H-bonding 
effects, chelation, π–stacking, etc; these properties are also incorporated into peptides by 
easily coupling amino acids together.2  
The use of amino acids and short peptides – or peptide-like molecules – as asymmetric 
catalysts is currently a subject of great interest in organic synthesis.102-104 They provide 
several advantages over other catalysts such as enzymes and transition-metal catalysts, since 
they are inexpensive, readily available in high enantiomeric purity, and are available as both 
enantionmers. Peptides are also usually more stable than enzymes or other bioorganic 
molecules, and are more easily attached to a solid support than organometallic compounds or 
bioorganic compounds. Their smaller size, compared to enzymes, make mechanistic 
investigations much easier.105 
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Amino acids have been used as asymmetric catalysts in C-C bond formation, oxidation, 
brominations and many other reactions.102 Some of the earliest examples of the use of 
peptides and amino acids in asymmetric catalysis date back to the early 1970’s: Inoue and 
Oku showed that polyamino acids catalyse the conjugate addition of thiols to enones;106,107 
Juliá and Colonna demonstrated that poly-alanines and poly-leucines catalyse the oxidation 
of chalcones;108,109 and Hajos, Parrish, Eder, Sauer, and Wiechert showed that proline 
catalyses the asymmetric Aldol reaction.110,111 Despite these early examples of peptide 
catalysis, the field has only started to flourish in the last decade following the work of Miller 
(peptides),112 and various researchers in the field of organocatalysis (List, Barbas, McMillan, 
Jørgensen,25 and others).  
1.8.1 Peptides as Acyl-Transfer Catalysts in Kinetic Resolution Reactions 
1.8.1.1 N-Alkylimidazoles 
Inspired by nature’s acyl-transfer enzymes, in 1998 Miller and co-workers introduced a series 
of acyl-transfer catalysts, which were shown to catalyse reactions with high efficiency and 
specificity. Miller’s catalysts contained an N-substituted imidazole 65 or an N-alkylated 
histidine (substituent at C-5) 66 (Fig. 1.35) residue embedded in a peptide chain.112 These 
residues were chosen because of their ease of synthesis and the nucleophilicity of imidazole 
moieties. 
 
Figure 1.35. Miller’s imidazole 65 and N-alkylated histidine 66 amino acid fragments. 
The catalysts function in a similar way to DMAP, with the imidazole ring participating as the 
nucleophile in the acyl-transfer reaction. Scheme 1.17 shows the resonance structure of the 
imidazole group of histidine (substituent at C-4), indicating the nucleophilic nitrogen 
available for formation of an acyl-imidazolium ion intermediate for transfer. 




Scheme 1.17 Resonance structures of histidine	  




Catalyst 67, which adopted a secondary structure through a β-turn – a region of a peptide 
involving four consecutive amino acid residues in which the polypeptide chain folds back on 
itself by almost 180 degrees113 – gave a good s-value of 17, while the control, catalyst 68, 
gave no selectivity, since the molecule can not form a secondary β-turn structure. 
Miller’s second set of β-turn catalysts, diastereomers 69 and 70 (Fig. 1.37), which differ only 
in the stereochemistry at the proline residue, both incorporated fragment 66 into the peptide 
backbone.114 These two catalysts displayed dramatically different conformations and 
reactivities. Catalyst 69, which forms one H-bond in its secondary structure, gave an s-value 
of 3, while catalyst 70, which forms two H-bonds in its secondary structure, gave an s-value 
1	  Literature	  Review	  
43	  
	  
of 28 for the same substrate. They rationalised that the extra H-bond in 70 promotes 
formation of a more rigid molecule, which promotes the enantioselectivity.  
 
Figure 1.37 
This hypothesis was tested with larger peptide catalyst 71, which forms four intramolecular 
H-bonds (according to NMR studies) versus its diastereomer, catalyst 72, which only forms 
one intramolecular H-bond. Catalyst 71 gave an s-value of 51, while catalyst 72 gave an s-
value of 7.115 
Figure 1.38 
Compound 74 – an analogue of 71, which was synthesised via a Ru-catalysed cross-coupling 
metathesis (Scheme 1.18)115 – was then tested and the results compared to its analogue 71. 
Although 74 was designed to be more rigid than previous catalysts tested, s-values dropped to 
12, suggesting that a subtle balance between flexibility and rigidity is important for attaining 
the preferred conformation in the stereoselective step. 





Figure 1.39 shows the mechanistic model proposed by Miller, using NMR and IR techniques, 
to explain the enantioselectivity induced by peptide catalyst 70.114 In this model, one of the 
substrate enantiomers can preferentially H-bond to the catalyst, resulting in promotion of a 
faster acylation by the acylimidazolium moiety.  
 
Figure 1.39 
The acylation with catalyst 75, which lacks the H-bond donor amide gave a low s-value of 
less than 1.5, consistent with Miller’s model.116a 





Miller then set out to screen a library of compounds in order to find a more reactive and 
selective peptide catalyst. The screening involved using a fluorescently labelled assay in 
which a resin-bound proton-activated fluorophore was used as a sensor during the acylation 
of racemic alcohols (Fig. 1.41).117116b The brightest beads under the fluorescence microscope 
allowed identification of the most active catalysts, based on the conjugate acid formed by 
scavenging the acetic acid by-product being fluorescent. 
 
Figure 1.41 
This screening (of approximately 105 proteins) led to identification of octapeptide 76 
containing an alkylated histidine residue. Catalyst 76 proved to be an effective asymmetric 
acylation catalyst in the kinetic resolution of a variety of racemic secondary alcohol 
substrates, producing excellent (> 10) s-values for aromatic secondary alcohols (except for 1-
phenyl-1-propanol), but much lower values for certain non-aromatic secondary alcohols (Fig. 
1.42). 





Miller tested the efficiency of another peptide catalyst 77 (found in the fluorescent screen and 
shown in Figure 1.43) in the kinetic resolution of substrate 78, to form 79, which was 









In 2008, Schreiner et al. synthesised and evaluated an N-methyl histidine peptide 80. Unlike 
other groups, whose design concept focus on forming a catalytically active secondary 
structure via hydrogen bonding, 80 contained a γ-aminoadamantane carboxylic acid as well 
as natural and non-natural amino acids in the chain.118a The lipophilic character of the catalyst 
favoured the formation of the acyl-pyridinium ion in non-polar solvents like toluene. 
 
Figure 1.45 
The catalyst was tested in the kinetic resolution of trans-cyclohexan-1,2-diol to produce 
excellent results (Table 1.16). 
 




Table 1.16. Kinetic resolution of secondary alcohols using catalyst 80. 
 
N ee (S,S)-81 yield s-value 
1 > 85 37 > 8 
2 > 99 37 > 50 
3 > 99 41 > 50 
4 > 99 41 > 50 
 
The origin of the stereoselective step was determined by molecular modelling (Fig. 1.46), 
which revealed two C=O groups to likely provide the hydrogen-bonding contacts needed for 
chiral recognition of the diols. The model also showed that the adamantane building block 
provides a scaffold that holds the catalytic site and the centres governing recognition and 
stereochemistry into place.  
 
Figure 1.46118b 
1.8.1.2 Amidine-based Catalysts (ABC’s) 
In 2004, Birman introduced a new class of acyl-transfer catalysts based on a 2,3-
dihydroimidazo[1,2-a]pyridine (DHIP) core. Thus 2-phenyl-6-trifluoromethyl-
dihydroimidazo[1,2-a]pyridine (CF3-PIP, Fig. 1.47) was tested in the kinetic resolution of 
secondary benzylic alcohols and gave selectivity factors up to 85.119a The π-system of the 
catalyst was expanded to include a 1,2-dihydroimidazo[1,2-a]quinoline (DHIQ) tricyclic core 
(ClPIQ, Fig. 1.47), which improved reaction rates and s-values compared to CF3-PIP.119b 




Figure 1.47. Birman’s catalysts. 
Birman proposed a trasnistion-state model in which the phenyl ring of the substrate stacks 
above the pyridinium ring of the N-acylated catalyst due to π-π and/or π-cation interactions 
(Fig. 1.48).119a 
 
Figure 1.48120c  
Birman and Houk performed computational studies to determine the origin of 
enantioselectivity, which supports a π-inteaction.119c They concluded that enantioselectivity 
depends on electrostatic attraction between the phenyl ring (substrate) and pyridinium ring 
(catalyst), and steric repulsion between the alkyl group of the substrate and the catalyst. The 
Birman group later extended the substrate scope to include propargylic and β-substituted 
cycloalkanols.119d  
1.8.1.3 Amino Acids Attached to DMAP-Type Catalysts 
In 2013 the Suga group introduced a chiral acyl-transfer catalyst containing a peptide as the 
chiral element into the C-3 position of DMAP.120 These chiral DMAP catalysts were 
synthesised using an Ugi multicomponent reaction to attach amino acids at the C-3-position. 
After testing a range of peptides containing different amino acids, they found that catalyst 82 





























The catalyst was tested in the kinetic resolution of a range of secondary alcohols, but 
reactivity was modest (low conversion) and selectivity as seen by the s-values varied for a 
range of secondary alcohols (Table 1.17), with the exception of one substrate, which gave a 
high s-value of 12.4 (at a low conversion of 8%) (Table 1.17, entry 4). 
Table 1.17 Kinetic resolution of secondary alcohols using catalyst 82. 
	  
Entry substrate C s-value 







4. R1 = Ph, R2 = t-Bu 8 12.4 
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Kawabata reported on a range of 4-PPY-catalysts containing amino acids as the chiral 
element attached to the pyrrolidine ring (Scheme 1.50).121a, 121b The catalysts were tested in 
the kinetic resolution of amino alcohols,121b meso-desymmetrization of diols.121c C2-
symmetric catalyst A has also proven to be efficient in the chemo- and regioselective 
acylation of monosaccharides.121d-121f  
	    
Figure 1.50. Kawabata’s PPY-based catalysts. 
Similarly, Campbell has demonstrated that chiral catalysts with the stereogenic centre in the 
4-pyrrolidino moiety as N-4’-pyridinyl-α-methyl proline kinetically resolved a range of N-
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1.9 Objectives of the Study 
This thesis discusses the use of amino acids and peptides in asymmetric catalysis. Chapter 2 
discusses the epoxidation of meso-epoxides by chiral Lewis acids. Chapter 3 discusses the 
kinetic resolution of secondary alcohols. Thus, the overall objectives of the project were the 
following: 
i. To synthesise and evaluate four chiral ligands that could coordinate to scandium(III) 
triflate for the meso-desymmetrization of epoxides (Chapter 2). 
ii. To synthesise and evaluate three classes of DMAP-type acyl-transfer catalysts in 
which the peptide is attached α, β, and γ to the pyridine nitrogen (Chapter 3). 
iii. To use computational modelling to determine a transition-state model for the stereo-
discriminating step. 




Chapter 2: Lewis Acid Catalysis 
2.1 Desymmetrization of Meso-Epoxides 
Epoxide ring opening is an important reaction in organic synthesis since it allows for the 
formation of chiral 1,2-difunctionalized chirons for fine chemicals in one step. The inherent 
ring-strain of three-membered heterocycles (approximately 113 kJ/mol) provides the driving 
force for this important reaction, which can occur via either nucleophilic SN2 (A) or acid-
catalysed SN1 or SN2 mechanisms (shown as SN1 in B) (Fig. 2.1).122 Strong nucleophiles (e.g. 
RSH, S-, CN-, RNH2) can open at the less-hindered carbon atom, while weak nucleophiles 
(e.g. ROH) need acid catalysis, in which regioselectivity depends on the degree of epoxide 
opening in the transition-state. 
	  
Figure 2.1. Mechanisms of epoxide ring opening: (A) Nucleophilic mechanism; (B) Acid-
catalysed mechanism. 
Epoxides can be opened by a wide range of nucleophiles such as alcohols (1,2-diol 
monoethers),123 thiols (1,2-mercaptoalcohols),124 halogens (1,2-halohydrins),125 etc. 
Enantioselective ring-opening can occur using either racemic or meso achiral epoxides via 
kinetic resolution and meso-desymmetrization respectively (Scheme 2.1). 
	  
Scheme 2.1. Enantioselective ring-opening of i) a racemic epoxide (kinetic resolution), and 
ii) a meso-epoxide (meso-desymmetrization).122 
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In the kinetic resolution (discussed in Chapter 1), a chiral catalyst must distinguish between 
the two enantiomers in the racemic mixture, and selectively promote reaction of one 
enantiomer over the other to give the ring-opened product together with the unreacted 
epoxide in as close to a 50:50 ratio as possible. In a meso-desymmetrization, a chiral catalyst 
has to distinguish between the two enantiotopic carbons in promoting formation of the 1,2-
disubstitued product. The advantage of the latter is that the desymmetrized compound (with 
two new contiguous stereogenic centres) can be formed in up to 100% yield.122 
This study focused on the desymmetrization of meso-epoxides using chiral Lewis acid 
complexes formed from trifluoromethanesulfonate (scandium triflate, Sc(OTf)3)126-129 – a 
water- and organic-soluble as well as recoverable Lewis acid that has been shown to be 
useful for ring-opening reactions127 – and chiral amino acid/peptide ligands. Benzyl alcohol 
was chosen as the nucleophile as a protected form of water, since chiral vicinal diols are 
important for the preparation of optically active compounds130 that can be used as auxiliaries, 
building blocks for complex molecules, and chiral catalysts. Figure 2.2 shows the general 
idea behind desymmetrization involving a chiral Lewis promotor.131 
	  
Figure 2.2. Basic idea behind epoxide desymmetrization using a C2-symmetric Lewis acid. 
2.1.1 Examples of meso-desymmetrization from the Literature 
The first reported addition of an oxygen nucleophile desymmetrizing a meso-epoxide was 
that of Jacobsen et al. who used the C2-symmetric cobalt(III)(salen) complex 83 as a chiral 
Lewis acid (Scheme 2.2). Carboxylic acids were used as nucleophiles under base catalysis to 
generate the more nucleophilic carboxylate ion in the formation of 1,2-monoesters ultimately, 
and in good yield and excellent enantioselectivity.132 





Scheme 2.2. Meso-desymmetrization using Jacobsen’s C2-symmetric cobalt(III)(salen) 
complex 83. 
Similarly, Shibasaki used a gallium-lithum bis(binaphthoxide) (GaLB) bifunctional complex 
84 for the addition of phenols to meso-epoxides (Scheme 2.3).133 
	  	  
Scheme 2.3. Proposed structure of (R)-Ga-Li-bis(binaphthoxide) (GaLB, 84).	  
They postulated that the bimetallic complex would overcome the low reactivity of oxygen 
nucleophiles towards epoxide ring opening, since the gallium centre could act as the Lewis 
acid to activate the epoxide, while the lithium alkoxide could act as a Brønsted base to 
activate the nucleophile. Epoxide-opened products were formed in good to high ee (67–93%), 
but yields were generally only modest (31–75%).133 
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The first addition of aliphatic alcohols to meso-epoxides was reported by Schneider et.al who 
used a scandium-bipyridine complex 85.134 According to the author, a chiral complex is 
formed via metal coordination to the pyridine nitrogen and hydroxyl donors.134 Meso-vicinal 
diols were formed in good to high ee (up to 96%), but yields were generally modest (Scheme 
2.4). 
	  
Scheme 2.4. Meso-desymmetrization using Schneider’s scandium-bipyridine complex 85. 
Snapper and Hoveyda use a titanium dipeptide Schiff base to furnish β-cyanohydrins from a 
meso-epoxide in good yield and ee, using either trimethylsilyl cyanide or HCN as a 
nucleophilic cyanide source (Scheme 2.5). The most efficient chiral ligand was shown to be 
the tert-leucine-threonine-based dipeptide ligand 86.135  
	  
Scheme 2.5. Meso-desymmetrization using Snapper and Hoveyda’s titanium dipeptide Schiff 
base ligand 86. 
 
	  




2.2 Ligand Design in this Project 
Our catalyst design was based on Trost’s C2-symmetric ligands, which consist of a phenolic 
template with two ortho side arms containing electron-donating groups that can coordinate to 
the Lewis acid. Trost’s catalyst 87 used two chiral diphenylprolinol units as the side arms, 
while diethylzinc was used as the Lewis acid in a stoichiometry of Lewis acid: ligand = 2:1 
and in which each equivalent of organometallic reacted in different ways. The first equivalent 
underwent two successive metal-hydrogen exchange reactions with the phenolic and one of 
the prolinol hydroxyl groups rendering a bonded zinc alkoxide, while the second zinc 
equivalent exchanged with the remaining prolinol hydroxyl group only, retaining one ethyl 
group as shown, albeit with extra coordination. This made for a highly Lewis acidic 
environment embedded within a C2-symmetric framework (Fig. 2.3).136,137 According to the 
researchers, the conformation of the diphenylprolinol moieties creates the chiral space 
responsible for the enantiodiscrimination.138 These catalysts were shown to return high 
enantiomeric excesses in the asymmetric aldol and nitro-aldol (Henry) reactions (Scheme 
2.6).139	  
	  
Figure 2.3. a) Trost’s chiral dinuclear zinc catalyst. 
	  
Scheme 2.6. Henry reaction using Trost’s C2-symmetric ligand 87. 
Figure 2.4 shows our catalyst design, in which the aim was to use a peptide as the chiral 
element. This would be attached to the template via an amide bond. It was hoped that the 
carbonyl group oxygen atoms and the phenolic oxygen would coordinate to the scandium to 
form a chiral complex 89 (Fig. 2.4). Template 88 was readily available via a short synthetic 
sequence.140 




Figure 2.4. Catalyst design showing: a) the template pre-catalyst, and b) the template 
coordinated to the Lewis acid to form a chiral catalytic complex. 
The next step was to decide on the nature of the amino acids used as chiral auxiliaries. The 
amino acid leucine was chosen to explore whether its bulky iso-butyl side chain might 
provide a chiral environment upon complexation with the Lewis acid. Tryptophan was also 
chosen because of its electron-rich indole ring, which might participate in π–stacking (the 
phenolic ring bears two carboxamides that might create a suitable acceptor for the indole) to 
create a tight chiral environment around the Lewis acid. Finally, cysteine was chosen because 
the bigger sulfur (compared to oxygen) might lead to better coordination with the Sc(OTf)3. 
2.3 Synthesis and Characterization of Peptide Ligands 
Diacid template 94 was synthesised in four steps using Pfaltz’ procedure, and is shown in 
Scheme 2.7. 
 




Thus, commercially available 4-tert-butyl phenol 90 was bis-ortho reacted with 
formaldehyde under basic conditions to give diol 91 in a yield of 33% after adjusting the pH 
with 1M HCl to protonate the phenoxide and extracting. The low yield was consistent with 
the literature value of 34%, while the 1H NMR spectrum of 91 showed diagnostic peaks 
resonating at δH 4.91 ppm for the four methylene protons (singlet), and δH 3.29 ppm for the 
two hydroxyl groups (broad singlets). In order to perform the oxidation to the diacid 93, the 
phenolic OH group of 91 first had to be protected as its methyl ether. This was achieved by 
exploiting the acidity of the phenolic proton in which 91 was refluxed with methyl iodide and 
K2CO3 in acetonitrile for 48 hours to give the phenoxy ether/diol 92 in 70% isolated yield. A 
new methoxy singlet resonated in the 1H NMR spectrum at δH 3.78 ppm, while the two 
hydroxyl groups resonated at δH 2.49 ppm, indicating a chemoselective protection of the 
phenolic hydroxyl group, since K2CO3 is not a strong enough base to deprotonate aliphatic 
alcohols.  
The next step involved oxidation with KMnO4 in the presence of a phase-transfer catalyst. 
The excess KMnO4 was quenched with ethanol, and the crude mixture filtered through Celite 
®. The filtrate was acidified with 1M HCl and the pure diacid 93 precipitated as a colourless 
solid in 72% yield. Compound 93 could be crystallized making for an attractive procedure 
overall. Its 1H NMR spectrum lacked the methylene signals of the starting material and 
showed the appearance of a broad singlet at δH 8.93 ppm corresponding to the two carboxylic 
OH protons. Scheme 2.8 shows the mechanism of the oxidation reaction involving a 
manganese ester intermediate. 
 
 




Scheme 2.8. General mechanism for the oxidation of an alcohol to a carboxylic acid with 
KMnO4.	  
With the diacid in hand, the next step was to remove the methyl group of 93 with HBr/AcOH 
by heating to 120 °C for 30 minutes. This involves protonation of the poorly nucleophilic 
phenolic oxygen (hence the high temperature) followed by nucleophilic attack by bromide at 
the methyl carbon (SN2) to effect demethylation. Following reaction, the mixture was cooled 
to room temperature and quenched with water resulting in precipitation of phenol 94 as a 
colourless solid in 87% yield. Its 1H NMR spectrum revealed that the methoxy group had 
been removed. With the diacid 94 in hand, coupling with the amino acids to form the chiral 
ligands could proceed. 
Fig. 2.5 shows the four molecules that were targeted for use as chiral peptide ligands for 
transition metal-based desymmetrization reactions, together with the structures of possible 
metal-ligand complexes. 





Figure 2.5. a. Structures of the target molecules. b. Possible metal-ligand complexes. 
Compounds 95 and 96 were formed from diacid 94 (Scheme 2.7)136 via double nucleophilic 
acyl substitution (SNAc) of the acid dichloride of 94 (prepared with SOCl2) by the requisite 
amino acid amines. Conversely, compound 97 was prepared by coupling NH2-Leu-Trp-OMe 
to 94 using standard peptide coupling conditions. For compound 98, the amino acid was 
added to the C2-symmetric dibromide (Scheme 2.15) via an SN2 reaction. The details of these 
reactions now follow. 
For ligand 95 involving coupling via the diacid dichloride, thionyl chloride was used as 
chlorinating agent. This involved heating the diacid 94 in neat thionyl chloride to reflux 
temperature to give 99 as the crude diacid dichloride. Following SOCl2 removal coupling was 
then carried out in dry DCM with commercially available HCl-Leu-OMe 100, and 
triethylamine in DCM at 0 °C. The reaction was monitored by TLC to reveal a fluorescent 
spot after one hour. Following work-up and column chromatography using ethyl 
acetate\hexane the compound was isolated in a 33% yield (Scheme 2.9).  




Scheme 2.9. Reagents and conditions: (i) HCl-Leu-OMe, NEt3, DCM, r.t., 20 min (33%). 
The 1H NMR spectrum of 95 (Fig. 2.6) showed that two amino acids had coupled to the 
diacid, with diagnostic peaks appearing at δH 1.26 ppm, a singlet for tert-butyl group (9H 
integration), and at δH 4.81 ppm, a multiplet for the two α-protons of leucine (2H). The amide 
hydrogens resonated at δH 8.1 ppm. The two diastereotopic methyl groups of the iso-butyl 
side chain appeared as two doublets resonating at δH 0.97 ppm and δH 0.98 ppm. Similarly, 
the 13C NMR spectrum showed two downfield singlets for the ester and the newly formed 
amide carbonyl carbons. Double substitution was confirmed by virtue of the presence of 14 
singlets as 2:4:8 for carbonyl:aromatic:aliphatic resonances. Elemental analysis was in 
agreement with the calculated values. 
 





Figure 2.6. A portion of 1H NMR (CDCl3) spectrum of compound 95. 
The tryptophan ligand 96 was synthesised in the same way by coupling dichloride 99 to HCl-
L-trp-OMe 101 (formed via Fischer esterification of tryptophan) to give product 96 in 62% 
yield after column chromatography (Scheme 2.10). The presence of the new amide bond was 
again confirmed by the 1H NMR spectrum with a diagnostic peak at δH 7.87 ppm for the NH 
(as 2H). The rest of the tryptophan signals were consistent with compound 101, while the 
template aromatic protons resonated at δH 7.76 ppm as a singlet and the tert-butyl protons at 
δH 1.15 ppm.	   
	  
Scheme 2.10. Reagents and conditions: (i) HCl-Trp-OMe, NEt3, DCM, r.t., 1 hr (62%). 
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For ligand 97, dipeptide 104 had to be synthesised. This was achieved by following a typical 
peptide protection and deprotection sequence (Scheme 2.11). 
 
Scheme 2.11. Reagents and conditions: (i) 97, EDC, HOBt, pyridine, r.t., 18 hrs (98%), (ii) 
piperidine, 0 °C, 2 hrs (68%). 
Thus, commercially available Fmoc-L-Leucine 102 and HCl-trp-OMe 101 were reacted with 
EDC and HOBt in pyridine at room temperature. HOBt is a catalyst and was used in a 
pseudo-catalytic (30%) amount to prevent racemization during coupling.141 Following an 
acidic workup (to remove the pyridine), and column chromatography product 103 was 
isolated as a colourless solid in 98% yield. The 1H NMR spectrum of the product showed 
characteristic peaks at δH 5.10 ppm for the new amide NH and the two multiplets at δH 4.90 
ppm and around δH 4.20 ppm for the α-protons of leucine and tryptophan respectively.  
Scheme 2.12 shows the general mechanism for a peptide coupling reaction using a 
carbodiimide (usually DCC or EDC), and HOBt. In the first step, the carboxylic acid is 
deprotonated by the carbodiimide to form intermediate I. This is followed by nucleophilic 
addition of the carboxylate to the imino-iminium ion to form II. HOBt then attacks the 
carbonyl to form benzotriazolyl ester III with loss of a urea by-product (which is either 
soluble (for EDC) or insoluble (for DCC) in water). Intermediate III finally undergoes SNAc 
with the amine to form the amide (peptide bond) with regeneration of the catalyst. 





Scheme 2.12. Mechanism of carbodiimide/HOBt peptide coupling mechanism 
The 13C NMR spectrum of Fmoc-dipeptide 103 showed only one set of peaks, which 
suggested that epimerization had not occurred, but in order to confirm the enantiomeric 
purity, chiral HPLC was performed. Therefore, the four stereoisomers of 103 were 
synthesised as a racemic diastereoisomeric mixture. 
Racemic HCl-Trp-OMe was synthesised by mixing equal amounts of L-tryptophan and D-
tryptophan and forming the methyl ester as previously described. Racemic Fmoc-Leu-OH 
was prepared by mixing equal amounts of L-leucine and D-leucine together and reacting the 
mixture with Fmoc-choride under basic conditions.142 The two racemic amino acids were 
then reacted under peptide coupling conditions according to Scheme 2.11. The diastereomeric 
mix of Fmoc-Leu-Trp-OMe and the supposed enantiomerically pure Fmoc-Leu-Trp-OMe 
(103) were evaluated using chiral HPLC, which revealed four peaks corresponding to the two 
diastereomers and their enantiomers (Fig. 2.7), and one peak for 103 (Fig. 2.8), confirming 
that epimerization had not occurred. 




Figure 2.6. Chromatogram of the racemic diastereomeric mix of dipeptide 103. 
 
Figure 2.7. Chromatogram of enantiomerically pure 103. 
The next step was to remove the Fmoc protecting group of 103 under basic conditions using 
piperidine. The reaction was followed by TLC using a polar solvent system of 10% methanol 
in DCM, which revealed a polar amine spot of Rf 0.5. Compound 104 was isolated in 64% 
yield following column chromatography. Scheme 2.14 shows the mechanism for the 




deprotection of the Fmoc group, which involves deprotonation of the acidic benzylic proton 
to form intermediate I, which fragments with elimination of CO2 and 9-methylene-9H-
fluorene to give the desired amine . 
 
Scheme 2.14. Mechanism of the Fmoc deprotection 
The coupling between the dipeptide 104 and the diacid 94 to form 97 was successfully 
achieved using EDC and HOBt in pyridine. The reaction gave the dipeptide catalyst 97 in a 
60% yield, which was assigned using a combination of 1D, 2D, NMR spectroscopy as well as 
high resolution mass spectrometry and infra-red spectroscopy. Its 1H NMR spectrum showed 
diagnostic peaks at δH 7.80 ppm for the amide and δH 4.93 ppm and δH 4.70 ppm for the two 
α-protons of the amino acids (Fig. 2.6), and once again 13C NMR confirmed its C2-symmetric 
character by the presence of 24 singlets (C-2” and OMe overlapping) as 3:12:9 for 
carbonyl:aromatic:aliphatic resonances. 




Figure 2.6. A portion of 1H NMR (CDCl3) spectrum of compound 97. 
Finally, the disulfide ligand 98 with sp3 rather than sp2 connecting atoms was synthesised 
using the dibrominated 105, which was prepared using reaction of 91 with HBr/AcOH (33%) 
at reflux temperature for one hour in order to form dibromide 105 (Scheme 2.15).143 
However, the 1H NMR spectrum showed the presence of two compounds as the expected 
product 105 as well as the acylated phenol 106. These were not separated, but taken to the 
next step together. 
 
 
Scheme 2.15. Reagents and Conditions: (i) HBr/AcOH (33%), 120 °C, 30 min. 




For the amino acid of ligand 98, commercially available HCl-Cys-OMe was Boc-protected 
with di-tert-butyl dicarbonate to give the Boc-Cys-OMe 107 in 89% yield shown in Figure 
2.8. Its 1H NMR spectrum showed the diagnostic peaks for the tert-butyl group at δH 1.43 




The thiol 107 (2 eq.) was then reacted with the mixture of dibromide compounds (105 and 
106) and triethylamine in DCM at room temperature. TLC confirmed the presence of two 
compounds after one hour. The solvent was removed in vacuo, the residue redissolved in 
MeOH, and the temperature lowered to −5 °C. K2CO3 was added and after 30 minutes TLC 
revealed the disappearance of the top spot with retention of the lower (phenolic). Following a 
work-up followed by column chromatography, compound 98 was obtained as a clear oil in 
66% yield. The structure of 98 was assigned on the basis of its spectroscopic data including 
1D, 2D, 1H (Fig. 2.9) and 13C NMR as well as IR spectroscopy and high resolution mass 
spectrometry. 




Figure 2.9. A portion of 1H NMR (CDCl3) spectrum of compound 98. 
The diastereotopic methylene protons (H-3) resonated at δH 2.84 ppm as two double doublets 
(due to coupling with the α-proton at H-2) in an ABX system. The benzylic methylene 
signals resonated further downfield at δH 3.76 ppm. Finally, a correct HRMS evaluation (m/z 
HRMS (ES) 645.2881 [M + H]+, C30H49N2O9S2 requires m/z, 645.28795 [M + H] +), 
confirmed the structure of 98. The four ligands were then tested in the desymmetrization of a 
meso-epoxide. 
2.4 Meso-Desymmetrization Reactions  
The ligands were screened in the meso-desymmetrization of cyclohexene oxide 108 as a 
model substrate and benzyl alcohol as a UV-active nucleophile (for HPLC evaluation) in the 
presence of a Sc(III)-ligand complex. The model reactions were studied with respect to 
ligand, temperature, and ligand/scandium ratio (Scheme 2.16). Catalyst formation between 
the scandium triflate and ligand was carried out with and without base (triethylamine or NaH 
via the phenoxide), as it was not clear to what extent triflic acid would be generated 
(coordination complex versus substitution), the acid being a danger for promoting a non-
asymmetric opening. 





Scheme 2.16. Model reaction for the scandium-ligand-catalysed ring-opening of meso-
cyclohexene oxide with benzyl alcohol. 
Control experiments were performed in the absence of a chiral ligand, but with scandium 
triflate, to form racemic alcohol 109 in 16% yield (Scheme 2.17) following vacuum 
distillation to remove excess benzyl alcohol (residual BnOH could not be easily removed by 
column chromatography). The stereochemistry of the scandium-catalysed ring opening was 
determined by 1H NMR analysis, which showed a multiplet for proton H-2 in the trans-
configuration. This was compared to the cis stereoisomer 111 (Scheme 2.18) – formed from 
cis-1,2-cyclohexane diol, benzyl bromide, and base – in which H-2 appeared with different 
multiplicity as a doublet of triplets (Fig. 2.10), confirming a cis arrangement of H-1 and H-2 
(in which H-2 is axial with just one large axial-axial coupling).  
	  
Scheme 2.17. Reagents and conditions: i. Sc(OTf)3 (1 mol%), BnOH (2 eq.), DCM, 4 hrs, 0 
°C (16%). 
	  
Scheme 2.18. Reagents and conditions: i. NaH (60%), BnBr, THF, 2 hrs, 0 °C (46%). 
 




Figure 2.10. Doublet of triplets for H-2 of compound 111. 
2.4.1 General procedure 
Thus, scandium triflate (1 mol%) was weighed in a glove box and suspended in 
dichloromethane. The chiral ligand (1.5 or 2.0 mol%, Table 2.1) was added to form the chiral 
complex in situ. In the cases where a base (NEt3 or NaH/THF) was added, this was added at 
this point as a slight excess to the ligand. After twenty minutes at room temperature, the 
temperature was lowered to −78 °C before adding the benzyl alcohol (2 eq.) and the epoxide 
substrate (1 mol eq.). After twelve hours an aliquot of the solution was removed and a mini-
work-up performed using ethyl acetate/1M HCl. The sample was dried and the solvent 
removed and the crude ee evaluated by chiral HPLC. This procedure was repeated 
continuously (i.e. every 12 hours) at −20 °C, 0 °C, and room temperature depending on the 
ligand; the ligand/scandium ratio was also varied. 
Since no column chromatography was performed, conversions were calculated from the 
HPLC data. The yields were not calculated, but were generally moderate (~20% between −78 
and 20 °C, ~70% between 0 °C and r.t.). In this, the reference had to be the benzyl alcohol, 
since the epoxide (limiting reagent) was not UV-active. Since the benzyl alcohol was present 
as two equivalents and 100% conversion only consumed one equivalent, the conversions 
were calculated according to the following equations in which AR = area in the HPLC trace 
for residual benzyl alcohol as a percentage of the total (the remaining percentage reflecting 
products as a total percentage). Importantly, however, was that the two enantiomers separated 
by almost a minute on the HPLC trace (Chiralpak AD column), and an ee could thus be easily 
calculated. The results of the study are shown in the following three tables. 
                                 1. C = 2(100  -  AR)  
                                 2. ee = EMajor -  EMinor
EMajor + EMinor
 
AR = Area of benzyl alcohol (residual) 
EMajor = Major Enantiomer 
EMinor = Minor Enantiomer 





i. Leucine-based Ligand 
	  
Table 2.2. Results of the meso-desymmetrization of cyclohexene oxide using chiral Lewis 










                      
C 
                   
ee (%) 
1. 95 1.5 −20 8 17 
2. 95 1.5 0 17 3 
3. 95 2.0 –78 11 14 
4. 95 2.0 r.t. 46 8 
 
ii. Tryptophan-based Ligand 
	  
Table 2.2. Results of the meso-desymmetrization of cyclohexene oxide using chiral Lewis 










                           
C 
                   
ee (%) 
1. 96 1.5 r.t. 24 25 
2. 
 
96 2.0 0 20 18 	   	   0	   20	   18	  
3. 96 2.0 r.t. 88 6 
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iii. Dipeptide- and Cysteine-based Ligands 
	  
Table 2.3. Results of the meso-desymmetrization of cyclohexene oxide using chiral Lewis 














1. 97 1.5 –20 100 39 
2. 98 1.5 –20 15 41 
3. 98 1.5 0 17 22 
4. 98 1.5 r.t. 99 10 
5. 98 2.0 −78 8 17 
6. 98 2.0 0 33 9 
7. 98 2.0 r.t. 97 11 
2.4.3 Conclusions 
This study attempted to develop an asymmetric alcoholysis of a meso-epoxide using a 
scandium Lewis acid bearing a chiral peptide ligand. Four different ligands were synthesised 
as 95–98. The reaction was studied with respect to ligand, temperature and ligand/scandium 
ratio (loading). Unfortunately, the different catalysts all gave modest to low 
enantioselectivities. However, some observations were noteworthy in which conversions 
increased with increasing temperature as expected, but enantioselectivity decreased with 
increasing temperature in all cases. Furthermore, the ligand/scandium ratio also affected the 
results giving higher enantiomeric excesses but lower conversions for the lower loading (1.5 
eq.). The optimal conditions appeared to occur at −20 °C for the cysteine ligand 98 (Table 
2.3, entry 3), which gave an ee of 41% (the highest ee) at a 15% conversion with a 1.5 
loading, while the dipeptide ligand 97 (Table 2.3, entry 1) also gave an encouraging ee of 
39% at 100% conversion at a 1.5 loading. These results suggest that conformational 
restriction imposed by having amide connections between template and “arms” is less 




optimal than an sp3 connection as in the cysteine case, where flexibility presumably allows 
for a better involvement of the chiral part of the arm with the Lewis acid. Moreover, having 
two amino acids rather than one in the arm improved the ee. Although it looked attractive to 
pursue developing the cysteine system with longer peptides there was a concern about the 
lack of transition-state understanding, notably regarding the association constant of the 
complex and whether triflic acid could be generated for promoting a non-asymmetric process. 
In this regard attempts to induce a greater association constant using base catalysis on the 
phenol of the ligand (e.g. using triethylamine or NaH) failed to improve results.  
In light of the low enantiomeric excesses and the difficulties in controlling the factors 
determining enantioselectivity (H-bonding, steric effects, π–stacking) the focus shifted to 
using amino acids and peptides in Lewis-base enantiocatalysis, specifically in the area of 
asymmetric DMAP catalysis. This is a field of asymmetric catalysis that is well established as 
far as transition-state models are concerned, and in which it was thus felt that predictive 
catalyst design involving developing and optimizing ligand structure and reaction conditions 
to yield a mature catalytic asymmetric method,144 was likely to be more feasible. These 
endeavours will be discussed in the next chapter. 
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Chapter 3: Lewis Base Catalysis 
This part of the study describes the shift away from using peptides in a Lewis acid context to 
one in which Lewis base catalysis was used as the theme of catalysis in the form of chiral 
DMAP-type catalysis for the kinetic resolution of secondary alcohols, a theme in current 
organocatalysis that was extensively reviewed in Chapter 1. In all cases the chiral element 
was either an amino acid or a short peptide (two or three amino acid residues long). It was 
natural to consider the influence of placing the chiral element (peptide) at the three possible 
positions on the pyridine ring (α, β, and γ), in which α was excluded based on the findings of 
Litvinenko and Kirichenko48 regarding the imposition of a severe steric parameter, which 
prompted the inclusion of the 8-hydroxyquinoline template where a resonance effect was 
hoped would offset the steric issue. Figure 3.1 shows the structures of the target templates A–
C, as well as the attachment sites for the chiral peptide groups R*. 
	  
Figure 3.1 
Of crucial importance in design was that R* include an electron-rich aromatic ring from the 
amino acids tryptophan or tyrosine that could potentially π–stack to the electron-deficient 
acyl-pyridinium cation (section 1.7) in a similar manner to Fuji’s induced-fit model. The 
synthesis, characterisation, and activity of the three classes of catalysts are discussed in the 
following three sections.	   
3.1 γ-Substituted DMAP Catalysis 
The γ-substituted DMAP catalysts were designed having the chiral group attached to alkyl 
chains on the nitrogen 4-substituent. Figure 3.2 shows the two target compounds belonging to 
this class of catalyst. A C-2 tether was selected as the minimum-length tether in which the 
idea was that the flexible alkyl chains might allow the electron-rich amino acids to π–stack to 
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the pyridine nitrogen. A C2-symmetric design was chosen because it would render the two 
faces of the pyridine equivalent (Fig. 3.3). Such a strategy was used by Spivey in the design 




Figure 3.3. Two rotamers of the iso-propyl moiety in a. C2-symmetric DMAP catalyst view 
from the top face. b. C2-symmetric DMAP catalyst view from the bottom face. 
Furthermore, the catalysts were designed to be synthetically easily accessible via Mitsunobu 
coupling to a 4-pyridine diol derivative. However, their inbuilt conformational flexibility, to 
allow π–stacking, was a concern regarding the possibility of incurring an entropic penalty in 
promoting a specific highly organised transition state. In this regards, encouragement was 
provided by the work of Kawabata who had shown that a C2-symmetric acyl-transfer catalyst 
114 could adopt a conformation containing two hydrogen bonds between the catalyst and a 
monosaccharide in the rate-determining step of the acylation reaction (Fig. 3.4), although he 
did have some preorganisation generated by the pyrrolidine scaffold. 




Figure 3.4. a) Kawabata’s C2-Symmetic acyl-transfer catalyst; b) Transition-state 
model for the regioselective and chemoselective acylation reaction of monosaccharides. 
For the synthesis, commercially available 4-chloro-pyridine 115 was converted to the target 
diol 116 by heating it in excess diethanolamine as both reagent and solvent with sodium 
hydroxide as base at 180 °C, followed by purification by vacuum distillation to remove the 
excess diethanolamine, and then column chromatography.145 The polar compound 116 was 
recovered as a viscous, brown oil in 55% yield (Scheme 3.1) 
 
Scheme 3.1. Reagents and conditions: (i) 6M NaOH (aq.), diethanolamine, 180 °C, 5 hrs 
(55%).  
Its 1H NMR spectrum was fairly simple due to the C2-symmetry revealing characteristic 
peaks for the four equivalent protons adjacent to the hydroxyl groups in the chain at δH 3.64 
ppm, as well as the four protons adjacent to the 4-nitrogen atom at δH 3.76 ppm – this was 
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somewhat downfield due to deshielding by resonance of the 4-nitrogen lone pair into the 
heteroaromatic ring as well as the inductive effect of the hydroxyl groups. In the aromatic 
region of the spectrum the two protons β to the pyridine nitrogen resonated at δH 6.74 ppm 
due to resonance from N-4, while the two protons α to the pyridine nitrogen appeared 
deshielded at δH 8.04 ppm. With the template in hand, the next step was to couple to aromatic 
amino acids using a Mistunobu reaction.146  
For the first catalyst based on the electron-rich indole ring, L-tryptophan was converted to its 
methyl ester 101 using thionyl chloride and methanol.147 The 1H NMR spectrum of the 
product obtained was consistent with published results as discussed earlier in section 2.3. The 
enantiomeric purity was determined by measuring the optical rotation, which gave a value of 
+ 19° in methanol (lit.147 + 18°). Since the NH proton of the amino acid was not acidic 
enough for carrying out a Mitsunobu reaction, the tryptophan methyl ester amino group was 
sulfonylated by reacting with tosyl chloride and triethylamine to form the sulfonamide 117 in 
75% yield (Scheme 3.2).148 Its 1H NMR spectrum was consistent with published results, 
showing a peak for the methyl group of the tosyl moiety at δH 2.73 ppm and two new signals 
in the aromatic region for the new symmetrical aryl group. Its optical rotation was measured 
in THF and pleasingly agreed with the literature value (recorded as + 16°, lit.148 + 17°). 
 
Scheme 3.2. Reagents and conditions: SOCl2, MeOH, r.t., 18 hrs, 98%, (ii) TsCl, NEt3, 
DCM, r.t., 3 hrs (75%), (iii) 116, DIAD, PPh3, DCM/DMF, r.t., 3 hrs (36%). 
In the next step of the synthesis (Scheme 3.2), 117 (2 equivalents) was coupled to template 
116 via a Mitsunobu reaction using triphenylphosphine and DIAD in a solution of THF and 
DMF (to dissolve the polar template). Compound 112 was obtained in 36% yield following 
column chromatography. The symmetrical nature of the 1H NMR spectrum, e.g. in the 
aromatic region, suggested that a bis-coupling had been achieved. Specifically, the spectrum 
showed a characteristic singlet for the tosyl methyl group at δH 3.17 ppm integrating for six 
protons, while the eight alkyl protons of the tether now resonated collectively at δH 3.53 ppm 
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in view of oxygen having been substituted by nitrogen. Similarly, a single resonance was 
observed for amino acid α-protons at δH 4.92 ppm. In addition, the protons of the pyridine 
ring resonated as an AB doublet pair δH 8.19 ppm (α) and δH 6.64 ppm (β), while the protons 
of the indole ring could be seen in the aromatic region as two doublets, two triplets, and a 
singlet. The 13C NMR spectrum for 112 displayed all the required signals as a 1:6:15 
carbonyl:aliphatic:aromatic split, confirming the C2-symmetry (Figure 3.4 shows an APT 
spectrum for compound 112). For the amino acid, the carbonyl carbon resonated at δC 171.4 
ppm, while the chiral carbon resonated at δC 59.5 ppm. The methoxy was present at δC 52.0 
ppm (Fig. 3.5). Finally, a correct HRMS evaluation for the product (m/z HRMS (ES): m/z 
891.3208 [M + H]+, calculated for C47H51N6O8S2, 891.3210 [M + H] +), confirmed the 
structure of 112. 
 
	  Figure 3.5. An APT spectrum of catalyst 112. 
Mechanistically, the Mitsunobu reaction starts with attack of the triphenylphosphine on 
DIAD to form zwitterion I, which deprotonates the acidic sulfonamide NH of 117 to form 
azaphosphonium cation II, which is rapidly intercepted by the hydroxyl group of diol 116 to 
form an activated oxyphosphonium ion of the reactant that rapidly undergoes SN2 reaction 
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with the sulfonamide anion to render the product 112 together with triphenylphosphine oxide 
as by-product. 
 
Scheme 3.3. Mechanism of the Mistunobu reaction 
The second target for the γ-substitued DMAP was compound 113, a tyrosine-containing 
compound that could also be synthesised by the Mitsunobu reaction, since tyrosine contains 
an acidic phenolic proton. For this purpose L-tyrosine was first protected at both C- and -N 
amino acid termini (Scheme 3.4). 
	  
Scheme 3.4 Reagents and conditions: (i) AcCl, MeOH, r.t., 18 hrs (98%), (ii) (Boc)2O, 
NaOH, EtOH, 18 hrs (92%), (iii) 116, DIAD, PPh3, DCM/DMF, r.t., 3 hrs (41%). 
Thus, the complete synthesis involved first protection of L-tyrosine as its methyl ester 119 
using acetyl chloride in MeOH at room temperature. The reaction could be monitored by 
TLC using ethyl acetate/water/n-butanol/acetic acid in a 1:1:1:1 ratio. The 1H NMR spectrum 
of 119 revealed a characteristic peaks for the methoxy singlet at δH 3.80 ppm and the α-
proton at δH 4.23 ppm. In the aromatic region the protons resonated between δH 7.08 ppm and 
δH 6.79 ppm. The optical rotation was measured in pyridine and gave a value of + 68.8°, 
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which agreed fairly well with that of the literature value of + 76°.149 The next step was to 
chemoselectively protect the N-terminus using a Boc-group under basic conditions; the amine 
is selectively protected because the lone pairs of the phenolic OH are delocalised into the π 
system of the aromatic ring by resonance, which makes the oxygen less nucleophilic. TLC 
revealed a less polar spot, which following an acidic work-up gave compound 120 in 33% 
yield (the low yield was due to some Boc substitution) after column chromatography. Its 1H 
NMR spectrum was consistent with published results in which the phenolic proton was 
observable and its optical rotation measured in chloroform gave excellent parity with that of 
the literature + 51.3° (lit.150 + 52.8°). 
Compound 120 was then reacted with 116 under Mitsunobu conditions as described 
previously to form catalyst 113 in 53% yield after column chromatography. Its 1H NMR 
spectrum showed a large singlet integrating for 18 protons (for the tert-butyl groups of the 
amino acid moieties) at δH 1.40 ppm, as well as a multiplet for the two equivalent α-protons 
at δH 4.51 ppm. The eight alkyl protons that linked the amino acid to the pyridine ring now 
resonated in two sets at δH 3.88 ppm and δH 4.15 ppm, the latter for the protons close to 
oxygen. As with 112 the four protons of the pyridine ring resonated as two AB doublet pairs 
at δH 6.61 ppm and δH 8.23 ppm. The 13C NMR showed all the required carbon atoms in a 
2:7:7 carbonyl:aromatic:aliphatic split as shown in the APT spectrum in Fig. 3.5. Notably, 
characteristic peaks for two carbonyl carbons as downfield singlets at δC 172.3 ppm and 
157.4 ppm were observed for ester and carbamate (N-resonance pushes value upfield) 
functionalities respectively. The chiral carbon resonated at δC 54.5 ppm, while the methoxy 
carbon resonated at δC 52.2 ppm. The carbons of the pyridine ring resonated at δC 149.4 ppm 
(β to the pyridine nitrogen), and at δC 106.7 ppm (α to the pyridine nitrogen) (Fig. 3.6). A 
correct HRMS evaluation (m/z HRMS (ES): m/z 737.3761 [M + H]+, calculated for 
C39H53N4O10, 737.37617 [M + H] +), confirmed the structure of 113.  




Figure 3.6. APT spectrum of catalyst 113. 
Catalysts 112 and 113 were then tested in the kinetic resolution of 1-(2-naphthyl)ethanol 121 
as a model compound (Table 3.1).The acylation reaction was performed using isobutyric 
anhydride (0.7 eq.) in the presence of 5 mol% catalyst (112 or 113) in DCM at −78 °C, with 
triethylamine as an auxiliary base. The reaction could be monitored by TLC, and a less polar 
spot appeared at Rf = 0.8 in 20% ethyl acetate/hexane after three hours. The reaction was 
quenched with 1 mL methanol (at −78 °C), followed by a basic work-up using NaHCO3 to 
give the product ester and the recovered starting material after separation by column 
chromatography using ethyl acetate and hexane. After purification, the ester was hydrolysed 
to the alcohol under basic conditions (1M NaOH) so that the both alcohols could be 
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1. 112 13 0.2 1.6 1.0 
2. 113 55 1.4 1.1 1.0 
a. All reactions were conducted in the presence of 5 mol% catalyst, 0.7 eq. of (i-PrCO)2O, and 0.9 eq. 
of Et3N at −78 °C for 3 hrs., unless otherwise noted. b. Conversion (%) = (ee of recovered 
alcohol)/(ee of recovered alcohol + ee of ester). c. hydrolysed (2M NaOH in MeOH/H2O) and ee 
calculated. d. Selectivity factor 𝑠   = 𝑙𝑛 1−𝐶 1−𝑒𝑒𝑙𝑛 1−𝐶 1+𝑒𝑒 . 
The results of the study show that both catalysts gave no kinetic resolution (s-values = 1) 
revealing that the rate of the reaction was the same for both R and S alcohol reactants in each 
case. However, there was a notable difference in the conversions, i.e. the rate of each reaction 
in which catalyst 113 promoted a much faster reaction than that of 112. Thus, attention was 
turned to molecular modelling to help assist with understanding conformational aspects of the 
transition state. 
Molecular Modelling 
Molecular modelling using the Spartan ’10 molecular modelling programme was performed 
on the acyl-pyridinium ions of 112 and 113 (only one configuration around the N-acyl centre 
in each due to C2-symmetry) in order to determine the lowest energy conformers (Fig. 3.7). 
	  
Figure 3.7. Acyl-pyridinium ions of catalysts 112 and 113. 
Thus, a conformer distribution was calculated using the MMFF94 force field,151 in which 
100000 conformers were analysed for the acylated cations (112a and 113a) in the gas phase. 
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The energies of the ten lowest energy conformers were then compared in a Boltzmann 
distribution. Figure 3.8 shows the lowest energy conformers of 112a with their relative 
energies. Catalyst 112a had four low-energy conformers which appeared in a 41:28:25:6 ratio 
based on the energies and are shown in Fig. 3.8 as conformer A, B, C, and D respectively. 
None of the conformers showed any favourable π–stacking interactions, since the indole ring 
did not overlap appreciably with the pyridine ring (Fig. 3.8, and Table 3.2). One possible 
explanation for the lack of overlap could be due to the presence of the bulky sulfonamide 
groups, which prevent appropriate stacking in 112a resulting in a lack of a suitable chiral 
environment being created for recognition. Additionally, it looks as though nucleophilic 
attack is possible from either N-acyl face meaning that the nucleophile was facing an 
“opposite” acyl configuration in each case – opposite, regarding which side (C=O or iso-
propyl) of the acyl moiety was closest to the bulky chiral chain. This presumably would have 
communicated an inverted stereo-information to the positioning preference of the incoming 
nucleophile. However, the pictures in Figure 3.8 also suggest that the low conversion (13 % 



























Figure 3.8. Four lowest energy conformers for the acyl-pyridinium ion (112a) of catalyst 
112. 
Table 3.2. Relative energies of the four lowest energy conformers of 112a. 






By comparison, for 113a only two dominant low-energy conformers were present, in a ratio 
of 49.3:49.3, with no difference in energy between them (Fig. 3.9 and Fig. 3.10). Here the 
two tyrosine residues (no sulfonamide groups) do both appear to interact better with each 
pyridinium face but stacking is not optimal either. It does seem that attack from either face of 
the acyl group is possible resulting one again in a transfer of “inverted” stereo-information as 
before. The conversion was decent (55 % in 3 hrs at −78 °C) so access of the nucleophile 
does not appear to have been a problem in this case. Possibly a longer connection tether 
might have placed the tyrosine rings more optimally over the pyridinium ring, and certainly it 
looks as though future catalyst design with tyrosine, albeit contained in a non C2-symmetric 
system might warrant further investigation. 
D 








Figure 3.10. Front view of catalyst 113a showing C2-symmetry. 
The inadequate s-values and the results of the modelling suggested that the catalyst design 
was not ideal for the purpose. Therefore, all things considered it was decided to bring the 
chiral element closer to the pyridinium centre by attaching it as a 3-carboxamide. In such a 
way it was hoped that in this non C2-symmetric case one of the pyridinium faces would be 
preferentially blocked. 
A B 
aromatic	  ring	  (tyrosine)	  
t-­‐butyl	  group	  
acyl	  group	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3.2  β-Substituted DMAP Catalysis 
3.2.1 Monopeptide and Dipeptide 
The decision to place the peptide in the β-position of the DMAP template was inspired by 
Connon and Yamada’s catalysts (Chapter 1) in which the chiral directing group was attached 
β to the pyridine nitrogen via an acyl connection. Access to a DMAP template was thus 
required that would allow attachment of an amino acid or peptide to the β-position, preferably 
via an amide bond (Fig. 3.11). A β-substituted catalyst would also have the advantage of not 
having its pyridinium ion hindered by the presence of a substituent in the α position. 
 
Figure 3.11. The template for the β-substituted DMAP catalysts. 
The chemistry adopted for catalyst was that used by Yamada in which commercially 
available 4-chloronicotinic acid 123 was first reacted with dimethylamine (40 wt. % in H2O) 
in toluene under reflux conditions (Scheme 3.5) via an SNAr reaction. The product was 
isolated as the β-substituted carboxylate salt 124 by removing the toluene in vacuo and 
dissolving the crude salt in aqueous potassium carbonate. Following filtration, the potassium 
salt was dried and isolated in 90% yield. Its 1H NMR spectrum in D2O confirmed substitution 
by revealing a characteristic peak for the two new methyl groups as a singlet resonating at δH 
3.06 ppm indicating free rotation around the N-Caryl bond in spite of resonance. In the 
aromatic region the three pyridine protons resonated at δH 6.85 ppm for H-5 (a doublet with J 
= 6.3 Hz), δH 8.14 ppm for H-6 (a doublet with J = 6.3 Hz), which coupled to the β-pyridine 
proton, and δH 8.21 ppm for H-2 (a singlet), which was strongly deshielded by the pyridine 
nitrogen and the carbonyl group. 




Scheme 3.5. Reagents and conditions: (i) dimethylamine, toluene, reflux, 2 hrs, (ii) K2CO3, 
30 min (90%). 
With the template 124 in hand, the first catalyst chosen to evaluate was one containing 
tryptophan in the hope of generating a π–stacking opportunity between the electron-rich 
indole and electron-deficient pyridinium rings. Scheme 3.6 shows the synthesis of the first 
catalyst. 
 
Scheme 3.6. Reagents and conditions: (i) SOCl2, reflux, 1 hr, (ii) HCl-Trp-OMe, NEt3, 
DCM, 0 °C, 30 min (25%). 
Following Yamada’s procedure for forming an amide via an acid chloride, compound 124 
was dissolved in thionyl chloride and heated to reflux temperature. After one hour the solvent 
was removed and the crude acid chloride residue dried on the vacuum pump. Since the amino 
acid was prepared as a hydrochloride salt, it was first suspended in DCM at 0 °C and treated 
with triethylamine (dropwise) to form the free amine. The acid chloride was then dissolved in 
dry DCM and added to the tryptophan (free amine) at 0 °C. After two hours, TLC showed the 
formation of a new UV spot below the amine, which appeared as a bright spot under 
anisaldehyde spray. Following a basic work-up, the product was purified by chromatography 
using 10% MeOH/DCM as eluent in a low 25% yield. The 1H NMR spectrum of 125 showed 
characteristic resonances for both pyridine and tryptophan moieties in a 1:1 ratio. Notably, a 
singlet for the two dimethylamino methyl groups at δH 2.68 ppm as well as the two 
diastereotopic benzylic methylene protons of the amino acid at δH 3.14 ppm (Fig. 3.12) were 
observed. The methoxy group resonated at δH 3.66 ppm while the α-proton resonated at δH 
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4.71 ppm. The protons of the pyridine ring appeared at chemical shifts that were consistent 
with the template (described previously). Similarly, the 13C NMR spectrum showed 19 
singlets corresponding to the 20 carbon atoms in the molecule (the two methyl group of the 
dimethylamino moiety resonated as one peak in accordance with the 1H NMR data). 
	  
Figure 3.12. A portion of the 1H NMR (CDCl3) spectrum of 125. 
This result validated the methodology of coupling, and this was used in the synthesis of 
subsequent catalysts. Unfortunately, tryptophan catalyst 125 was only soluble in DMSO and 
could therefore not be reacted in solvents such as DCM, which was the solvent of choice for 
acyl-transfer reactions. The next challenge was thus to determine how to improve the 
solubility of the molecule. 
One way perceived to increase the solubility was to replace the dimethylamino group with a 
pyrrolidino group containing two extra methylene groups. The use of a 4-PPY catalyst, 
instead of a 4-DMAP catalyst, also has the advantage of increased catalytic activity (Chapter 
1) due to inductive effects. Scheme 3.7 shows synthesis of the next target template 126 in 
which dimethylamine was substituted by pyrrolidine using the same isolation methodology as 
with 124 involving the carboxylate salt. 




Scheme 3.7. Reagents and conditions: (i) pyrrolidine, toluene, reflux, 2 hrs, (ii) K2CO3, 30 
min (95%). 
The 1H NMR spectrum of compound 126 showed characteristic peaks for the eight 
pyrrolidine protons: four at δH 1.68 ppm, and four at δH 3.09 ppm (deshielded by the 
pyrrolidine nitrogen). The three aromatic protons resonated at δH 6.37 ppm (doublet), δH 7.73 
ppm (doublet), and δH 7.81 ppm (singlet). Coupling the amino acid to 126 (following the acid 
chloride methodology) was successful, but the yield was low (varying between 20% and 
30%), so we decided to use the standard peptide coupling reagent EDC together with 
catalytic (30%) HOBt (Scheme 3.8). The advantage of this methodology was that the reaction 
could be done directly in a pyridine/water mix which easily solubilised the carboxylate salt. 
In such a way tryptophan catalyst 127 was obtained in 44% yield after a conventional work-
up and column chromatography. 
 
Scheme 3.8. Reagents and conditions: (i) 101, EDC, HOBt, pyridine/water, r.t., 2hrs (44%). 
Once again, the 1H NMR spectrum of 127 showed that coupling of the two fragments had 
occurred in which a new amide proton was present, resonating at δH 6.32 ppm, as well as the 
characteristic peak for the α-proton at δH 5.12 ppm and the pyridine protons at δH 6.42 ppm, 
δH 8.15 ppm, and δH 8.16 ppm. The 13C NMR for this compound showed that there were two 
singlets downfield at δC 171.4 ppm and δC 172.4 ppm for the ester and the amide carbonyl 
carbons along with all of the other carbon singlets expected. The IR spectrum showed a peak 
at 3289 cm-1 for the new secondary amide NH, while a C=O stretch typical of a secondary 
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amide was observed at 1617 cm-1.The structure was further confirmed by mass spectrometry 
data, which gave a value of HRMS (ES): m/z found 393.1928 [M + H]+, C22H25N4O3 requires 
m/z 393.1926 [M + H]+. 
The tryptophan-PPY catalyst 127, with its two extra methylene groups, was less polar than 
the tryptophan-DMAP catalyst 125, but it was still only partially soluble in DCM. Therefore 
it was decided to extend the chiral group by synthesizing a dipeptide also containing a non-
polar side chain in addition to a π–stacking moiety. L-leucine was chosen, since the bulky 
iso-butyl side chain was thought might impose restrictions to conformational freedom of the 
chain, even to the extent of promoting a helical twist so as to achieve facial selection for π–
stacking. As outlined in Chapter 2, the leucine-tryptophan dipeptide 104 (Fig. 3.13) was 
synthesised from commercially available Fmoc-Leu-OH and HCl-Trp-OMe using peptide 
coupling conditions, followed by deprotection with piperidine to form the amine dipeptide 
104 in 64% yield.  
	  
Figure 3.13. The structure of dipeptide 104. 
Subsequent coupling of peptide 104 to the PPY 126 salt using EDC and HOBt in pyridine 
and water as before successfully gave the desired product 128 in a 44% yield (Scheme 3.9). 
 
 
Scheme 3.9. Reagents and conditions: 104, EDC, HOBt, pyridine, H2O, 12 hrs (44%) 
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The 1H NMR spectrum of compound 128 revealed resonances for both starting materials 
indicating that successful coupling had taken place. This was confirmed by the presence of 
the two α-protons at δH 4.57 ppm and δH 4.91 ppm of leucine and tryptophan respectively, 
while the pyridine protons resonated at δH 6.43 ppm, δH 8.12 ppm and δH 8.14 ppm (Fig. 
3.14).  
	  
Figure 3.14. 1H NMR (CDCl3) spectrum of 128. 
The carbon atoms were assigned using 13C NMR, HSQC, and APT. Figure 3.12 shows an 
APT spectrum for compound 128. Three downfield singlets were present at δC 171.9 ppm, δC 
171.4 ppm, and δC 169.0 ppm corresponding to the two amides and the one ester group. The 
CH carbons of the pyridine resonated at δC 150.1 ppm, δC 149.2 ppm, and δC 108.6 ppm, 
while the chiral carbons resonated at δC 52.9 ppm and δC 52.4 ppm (which overlapped with 
the carbon of the methoxy group), (Fig.3.15). The enantiomeric purity of the compound was 
evaluated using chiral HPLC which showed one peak present, indicating that epimerization 
had not occurred (Fig. 3.16). 
 




Figure 3.15. APT (CDCl3) spectrum of 128. 
 
Figure 3.16. HPLC chromatogram of dipeptide catalyst 128. 
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Kinetic resolution of 1-(2-naphthyl)ethanol 
The two catalysts – 127 containing only tryptophan, and 128 containing both leucine and 
tryptophan – were then tested in the kinetic resolution of a secondary alcohol following the 
same procedure as before as shown in Table 3.3. TLC showed approximately 50% 
conversion of starting material to product after three hours without the need to warm the 
solution, boding well for catalysis having taken place 
















1. DMAP 43 1.2 1.0 1.0 – 
2.  no reaction – – – – 
3. 127 42 21.9 30.3 2.3 S 
4. 128 34 31.2 59.4 5.3 S 
a. All reactions were conducted in the presence of 5 mol% catalyst, 0.7 eq. of (i-PrCO)2O, and 0.9 eq. 
of Et3N at −78 °C for 3 hrs., unless otherwise noted. b. Conversion (%) = (ee of recovered 
alcohol)/(ee of recovered alcohol + ee of ester). c. hydrolysed (2M NaOH in MeOH/H2O) and ee 
calculated. d. Selectivity factor 𝑠   = 𝑙𝑛 1−𝐶 1−𝑒𝑒𝑙𝑛 1−𝐶 1+𝑒𝑒 . e. The absolute configuration of the faster 
reacting enantiomer was determined by comparison of [α]20D  values with those reported in the 
literature. 
Entry 1 shows the control reaction with DMAP used a catalyst. Although several studies have 
shown that the kinetics of the acylation DMAP catalysts is zero-order with respect to an 
auxiliary base such as triethylamine, a blank reaction was also performed (Table 3.3, entry 2), 
which showed no product on TLC under the reaction condition.	  The results for catalyst 127 
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gave disappointing enantiomeric excesses and a low s-value of 2.3, while the dipeptide 
catalyst 128 gave an improved ee and thus a slightly higher s-value of 5.3. The fast reacting 
enantiomer for both catalyst 127 and 128 was the S-enantiomer as determined by comparing 
the sign of optical rotation to literature values. To test the generality of 128 as a catalyst for 
kinetic resolution, a range of secondary alcohols were used as substrates (Table 3.4). 



































27 17.3 46.3 3.2 S 
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a. All reactions were conducted in the presence of 5 mol% 128, 0.7 eq. of (i-PrCO)2O, and 0.9 eq. of 
Et3N at −78 °C for 3 hrs., unless otherwise noted. b. Conversion (%) = (ee of recovered alcohol)/(ee 
of recovered alcohol + ee of ester. c. hydrolysed (2M NaOH in MeOH/H2O) and ee calculated. 
d. Selectivity factor 𝑠   = 𝑙𝑛 1−𝐶 1−𝑒𝑒𝑙𝑛 1−𝐶 1+𝑒𝑒 . e. The absolute configuration of the faster reacting enantiomer 
was determined by comparison of [α]20D   values with those reported in the literature. 
The results of this study gave generally low s-values, varying between 1.3–3.3, but the s-
value of 5.3 (obtained from catalyst 128) was encouraging, and we believed that it would be 
possible to improve the enantiomeric excess by making appropriate modifications to the 
catalyst. In order to help with insight into this, once again molecular modelling was carried 
out in order to determine the structure(s) of the low-energy conformer(s) and the possibility 
of π–stacking. In addition, the possibility of corroborating any π–stacking via observing 
chemical shift changes in the 1H NMR spectrum of the pyridinium ion was also considered.  
Computational Modelling 
A conformer distribution was calculated using MMFF94 force field. 100000 conformations 
were analysed for the acyl-pyridinium cation (128a in Fig. 3.17) of 128 in the gas phase, 
which showed that the lowest energy conformer was dominant at 81%. 
 
Figure 3.17. Acyl-pyridinium cation of catalyst 128. 
 
The ten lowest energy conformers were then optimised at  the M06/6-31G* level of theory. 
This resulted in minimum-enery conformers A and B, which were identified in a 93.8:6.2 
ratio (Fig. 3.18) with a 6.75 kJ/mol energy difference.  
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Figure 3.18. Lowest energy conformers of 128a, showing the tryptophan moiety on the 
underneath face. 
In both conformers (A and B) the peptide chain curves such that the indole ring is close to the 
acyl site and effectively blocks the si (underneath; O>N>C) face of the N-acyl carbonyl 
group which is in an s-trans conformation (C=O / C-2pyridine are trans) regarding the C(CO) to 
pyridine (N) bond, allowing the nucleophile to attack from the opposite exposed (top) face 
(re face) of the acyl carbonyl group. The s-transN(CO) preference for the N-acyl group (i.e. one 
rotomer) is important in the context of facial discrimination as will be discussed later. While 
it may seem counterintuitive that the bulky iso-propyl group is on the same side as the 
peptide substituent at C-3, this is in agreement with reports by Spivey67 and Connon.55 Spivey 
has suggested that while the preferred orientation of the N-acyl group is not sterically driven, 
the orientation of the iso-propyl group may be due to a stereoelectronic stabilisation due to 
partial conjugation with the C-3 substituent.67 At this stage it looked as though the π–stacking 
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1H NMR Study 
A 1H NMR study was performed to investigate conformational changes (π–stacking) in the 
catalyst upon acylation. This required a reference compound that lacked the tryptophan 
moiety. A leucine residue was chosen since the iso-butyl group could not π–stack to the 
pyridine ring. Scheme 3.10 shows the synthesis.  
	  
Scheme 3.10. Reagents and conditions: HCl-Leu-OMe, EDC, HOBt, pyridine, H2O, 12 hrs 
(80%), (ii) anisole, piperidine, DCM, 0 °C, 18 hrs, (67%), (iii) 126, EDC, HOBt, pyridine, 
H2O, 12 hrs (27%). 
Thus commercially available (S)-Fmoc-leucine was reacted with HCl-leu-OMe under peptide 
coupling conditions, and after 18 hours, TLC revealed that the reaction was complete. 
Following an acidic work-up to remove the pyridine, the N-protected dipeptide 136 was 
isolated in an 80% yield. The compound was characterised using a combination of 1D and 2D 
1H NMR (shown in Fig. 3.19), as well as 13C NMR. 




Figure 3.19. Partial 1H NMR spectrum (CDCl3) of dipeptide 136. 
In the aromatic region, the Fmoc protons resonated between δH 7.75 ppm and 7.29 ppm. The 
two α-protons of the leucine residues resonated at δH 4.61 ppm and 4.26 ppm, while the 
acidic proton of the Fmoc group resonated at δH 4.20 ppm. Downfield at δH 0.90 ppm and 
0.89 ppm two doublets indicated the presence of the four methyl groups as two diastereotopic 
sets for the two iso-butyl residues. The 13C NMR spectrum revealed three carbonyl peaks at 
δC 173.1 ppm, δC 172.0 ppm, and δC 156.2 ppm, while the two chiral carbons resonated at δC 
53.4 ppm and δC 50.7 ppm. Finally, an elemental combustion analysis of the compound 
corresponded well with the calculated values for C, H and N. The next step was to remove 
the Fmoc group under basic conditions (using piperidine at r.t.), which following flash 
chromatography afforded the amine 137 in 54% yield. Its 1H and 13C NMR spectra closely 
matched that of the starting material, but lacked the signals in the aromatic regions indicating 
that the Fmoc had indeed been removed.  
Coupling of the free amine 137 with the PPY template 126 via the EDC/HOBt coupling 
conditions from before successfully furnished 138 after 18 hours as a polar spot on TLC, 
which was isolated in 27% yield following column chromatography. The 1H NMR spectrum 
of 138 displayed aromatic protons for the pyridine ring resonating at δH 8.26 ppm, δH 8.13 
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ppm, and δH 6.47 ppm (Fig. 3.20). The two α-protons overlapped at δH 4.61 ppm, while the 
pyrrolidine ring protons resonated as two multiplets at δH 3.30 ppm and δH 1.94 ppm. Its 13C 
NMR spectrum revealed peaks for the carbonyl carbons at δC 173.1 ppm, δC 171.6 ppm, and 
δC 168.8 ppm, while the three pyridine carbons resonated at δC 149.3 ppm, δC 148.7 ppm, and 
δC 108.6 ppm. In the IR spectrum, the new amide NH stretch appeared at 3420 cm-1. Finally, 
a correct HRMS evaluation (m/z HRMS (ES) 433.2810 [M + H]+, C23H37N4O4 requires m/z 
433.28148 [M + H] +) confirmed the structure of 138. 
	  
Figure 3.20. A partial 1H NMR spectrum (CDCl3) of dipeptide 138.	  
With the reference compound in hand, the next step was to alkylate both 128 and 138 by 
reacting with methyl iodide. This was achieved by dissolving the compounds in DCM, 
followed by the addition of methyl iodide at room temperature. The reactions were monitored 
by TLC which showed a more polar spot in the case of 128 (= 128a) and a spot with an 
identical Rf to the starting material for 138 (= 138a) after sixteen hours at room temperature. 
Intermediate 128a precipitated and was filtered, dried and dissolved in CDCl3, while catalyst 
138a was soluble in DCM and was isolated as a solid following solvent removal. The 
structures of the alkylated catalysts were confirmed by 1D and 2D NMR, which indicated 
that the new methyl groups were present for both 128a and 138a. 
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Table 3.5 shows the chemical shifts of the three pyridine ring protons in the 1H NMR spectra 
of 128, 138 and their corresponding methylated derivatives 128a and 138a. The chemical 
shift difference between each proton of the pyridine ring (H-2, H-5, and H-6) for the 
unmethylated and methylated compounds are given by Δδ and Δδa respectively for each 
series (128 to 138 and 128a to 138a)  
Table 3.5. Selected 1H NMR chemical shifts (ppm) for 128, 138, and their methylated 
analogues. 
 
Proton δ128 δ138 Δδ c δ128a δ138a Δδac 
H-2 a,b 8.08 8.26 –0.18 8.30 8.87 –0.57 
H-5 a,b 6.35 6.47 –0.12 6.50 6.66 –0.16 
H-6 a,b 8.05 8.13 –0.08 8.77 9.01 –0.24 
a. Measured using CDCl3 as solvent. b. All pyridine protons where unambiguously assigned by NMR 
spectroscopy (1H, 13C, HSQC, and COSY). c. The Δδ values were calculated using the equations, Δδ 
= δ128 − δ138, and Δδa = δ128a − δ138a. 
For reference catalyst 138, all the protons of the pyridine ring were upfield form the 
corresponding ones of catalyst 128, which may indicate an interaction of the pyridine ring 
with the indole ring even in the unmethylated state. There was also a significant difference 
between H-2 in the unmethylated series (0.18) compared to H-5 and H-6 (0.12 and 0.08 
respectively), further indicating structural differences in the unmethylated compounds. Upon 
methylation, further deshielding of all three protons in each compound 128a and 138a was 
observed in accordance with the positive charge on the pyridine ring. However, the relative 
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degree of deshielding, proton for proton in the two methylated compounds was much more 
pronounced with H-2 and H-6. Here, going from unmethylated to methylated caused a three-
fold increase in chemical shift difference for H-2 and H-6 (0.57/0.18; 0.24/0.08 respectively) 
compared to only a 1.3 increase for H-5 (0.12/0.16). These results suggest a strong extra 
deshielding for H-2 and H-6 which suggests a π–stacking by the indole via its deshielding 
zone. This would involve interaction with the sides rather than the face (shielding zone) as 
suggested by conformation A in Fig. 3.18. These results are similar to Yamada’s previously 
reported cation–π complex (Chapter 1), and suggest that 128a has a fixed conformation in 
which there is interaction of the indole ring with the pyridinium face. This interaction is 
absent or less pronounced than in 128.  
3.2.2 Tripeptides and Derivatives of the Dipeptide Catalyst 
The results of the kinetic resolution using dipeptide catalyst 128 were promising enough to 
justify further investigation on the influence of structural changes in 128 on activity. The two 
sites on 128 that were chosen for potential development were the C-terminus of the peptide, 
and the nitrogen of the indole moiety (Fig. 3.21). 
	  
Figure 3.21. Possible sites for modification for catalyst 128. 
Extending the peptide at the C-terminus to form a tripeptide raised the question of which 
amino acid to use and it was decided to compare the effect of incorporating tryptophan (target 
139) as a potential π–stacking group against leucine as a provider of a steric influence only 
(catalyst 140). For extension at the indole nitrogen a Boc substitution was chosen (target 141) 
in view of its anticipated ease of synthesis, as well as its potential to provide both steric and 
H-bonding effects (Fig. 3.22). The synthesis and evaluation of tripeptides 139 and 140 will be 
described first. 
 






Tripeptide 139 was synthesised first (Scheme 3.11) by initially reacting commercially 
available Boc-Trp-OH with HCl-Trp-OMe 101 using standard peptide coupling conditions 
used in this project to form dipeptide 142 (Scheme 3.11). Its 1H NMR spectrum showed a 
doubling of peaks in the aromatic region between δH 7.88 ppm and δH 6.65 ppm, indicating 
that two indole rings were present. The two α-protons of the dipeptide resonated at δH 4.43 
ppm and δH 4.82 ppm, while the tert-butyl group appeared as a singlet at δH 1.40 ppm. The 
enantiomeric purity of 142 was determined by measuring the optical rotation, which gave a 
value of − 20.5° (lit.152 − 15°). 




Scheme 3.11. Reagents and conditions: (i) Boc-Trp-OH, EDC, HOBt, pyridine, r.t., 18 hrs  
(81%); (ii) TFA/DCM (20%), anisole, 0 °C, 2 hrs (99%); (iii) Boc-Leu-OH, EDC, HOBt, 
pyridine, r.t., 18 hrs (61%); (iv) TFA/DCM (20%), anisole, 0 °C, 2 hrs  (99%); (v) 107, EDC, 
HOBt, pyridine, r.t., 18 hrs (53%). 
The next step was to remove the Boc-protecting group under acidic conditions with TFA at 0 
°C, followed by a basic work-up using saturated NaHCO3, and then column chromatography 
with MeOH/DCM. In such a way, free amine 143 was isolated in an excellent yield of 99%. 
Its 1H NMR spectrum lacked the tert-butyl signal of the Boc group, and the α-proton adjacent 
to the free amine shifted upfield to δH 3.64 ppm, indicating removal of the Boc group. The 
enantiomeric purity was determined by measuring the optical rotation, which gave a value of 
−15.2° (lit.153 −11°). Dipeptide 143 was then extended to a tripeptide by coupling to Boc-
Leu-OH using EDC/HOBt to form tripeptide 144 in 61% yield. Its 1H NMR spectrum 
showed the two diastereotopic methyl groups of the iso-butyl moiety of leucine as two 
doublets resonating at δH 0.94 ppm and δH 0.85 ppm, and the tert-butyl group as a singlet 
resonating at δH 1.43 ppm, while the NH of the carbamate resonated at δH 4.65 ppm. The 
three α-protons resonated at δH 4.05 ppm, δH 4.70 ppm, and δH 4.77 ppm for one leucine and 
two tryptophans respectively (Fig. 3.23). 




Figure 3.23. A portion of 1H NMR (CDCl3) spectrum of 144. 
The 13C NMR spectrum revealed four carbonyl signals (one for the carbamate, two for the 
amides, and one for the ester) between δC 172.4 ppm and δC 155.6 ppm. The aromatic 
carbons of the two indole rings resonated between δC 136.4 ppm and δC 109.8 ppm, while the 
three chiral carbons resonated at δC 53.8 ppm, δC 52.8 ppm, and δC 52.1 ppm.The rest of the 
13C NMR spectrum of 144 was assigned using 2D NMR and APT spectroscopy. Elemental 
combustion analysis confirmed the correct molecular formula of C34H43N5O6 for compound 
144. Deprotection of the Boc group of 144 again using TFA was carried out to give the target 
molecule 145 in 99% yield, after isolation by column chromatography using 10% 
MeOH/DCM. The structure of 145 was assigned on the basis of its spectroscopic data using a 
combination of 1D, 2D, and APT, as well as IR spectropcopy. The 1H NMR spectrum of 145 
lacked the signals for the Boc group, and revealed an upfield shift (due to a lack of 
deshielding by the carbamate compared to the free amine) for the α-proton of leucine from δH 
4.05 ppm in 144 to between δH 3.32–3.06 ppm (a multiplet, together with the four methylene 
protons of the tryptophan moieties). The appearance of a broad singlet at δH 1.62 ppm for the 
two amine protons also supported the absence of the carbamate. The APT and 13C NMR 
spectrum was consistent with 144, but lacked the signals for the Boc-protecting group. 
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The final step was to couple the free amine 145 to the PPY-salt 126 using EDC/HOBt, which 
gave catalyst 139 in a 53% yield, following a work-up and column chromatography using 8% 
MeOH/DCM. Its 1H NMR spectrum confirmed that the coupling had occurred, since 
resonances for both starting materials were present. The pyridine protons resonated at δH 8.03 
ppm, δH 7.98 ppm, and δH 6.37 ppm, and the pyrrolidine protons at δH 3.19 ppm and δH 1.81 
ppm. A new amide peak was present at δH 6.80 ppm, and the leucine α-proton shifted 
downfield to δH 4.55 ppm. The structure of the molecule was confirmed using a combination 
of 2D, APT, and IR spectroscopy. The 13C NMR spectrum of 139 revealed the presence of 
four carbonyl singlets (including the newly formed amide carbonyl) between δC 171.9 ppm 
and δC 168.8 ppm. Three chiral carbons corresponding to three amino acids were present at δH 
53.5 ppm, δH 52.9 ppm, and δH 52.8 ppm.  
Similarly Scheme 3.12 shows the synthesis of the second tripeptide that was synthesised. In 
the first step, commercially available Boc-Trp-OH was coupled with HCl-Leu-OMe to form 
dipeptide 147 in a good yield of 85%. Its 1H NMR spectrum showed a characteristic singlet 
peak for the tert-butyl group of tryptophan at δH 1.54 ppm, while the methoxy protons of the 
newly introduced leucine resonated at δH 3.64 ppm indicating that the coupling had occurred. 
The aromatic region revealed the protons of the indole ring; the α-protons resonated at δH 
4.52 ppm and δH 4.42 ppm for tryptophan and leucine respectively. 
 
 




Scheme 3.12. Reagents and conditions: (i) HCl-Leu-OH, EDC, HOBt, pyridine, r.t., 18 hrs 
(85%); (ii) TFA/DCM (20%), anisole, 0 °C, 2 hrs (58%); (iii) Fmoc-Leu-OH, EDC, HOBt, 
pyridine, r.t., 18 hrs (60%); (iv) piperidine, DCM, 0 °C, 6 hrs (61%); (v) 126, EDC, HOBt, 
pyridine, r.t., 18 hrs (44%). 
The next step was to remove the Boc-protecting group of 147 using acidic conditions to form 
amine 148 in a 58% yield. Its 1H NMR spectrum revealed that the tert-butyl group was absent 
and the α-proton adjacent to the amine had shifted upfield to δH 3.71 ppm. The optical 
rotation of 148 measured in MeOH (−6.0°) (lit.154 −1.2°). The free amine was then reacted 
with commercially available Fmoc-Leu-OH to form tripeptide 149 in 60% yield – we decided 
to switch to the Fmoc protectiong group, since the amino peptides would not be subjected to 
a strongly acidic medium in the deprotection step. Fmoc deprotection also did not require 
workup, and the solvent could be removed in vacuo and the crude product could be directly 
purified by column chromatography. Its 1H NMR spectrum (Figure 3.24) confirmed that the 
coupling had occurred, as three NH protons were present; the carbamate resonating at δH 6.20 
ppm, and the two amides resonating at δH 6.62 ppm and δH 4.98 ppm. In the aromatic region, 
the protons of the Fmoc-protecting group and the indole ring resonated between δH 7.78 ppm 
and δH 7.04 ppm.The two sets of multiplets as diastereotopic pairs for the four methyl groups 
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of the two iso-butyl moieties resonated at δH 0.82 ppm and δH 0.89 ppm, while the three α-
protons of the tripeptide resonated at, δH 4.72 ppm, δH 4.48 ppm, and δH 4.13 ppm.  
 
Figure 3.24. A portion of 1H NMR (CDCl3) spectrum of 149. 
The 13C NMR spectrum was assigned using a combination of 2D and APT spectroscopy. 
Four carbonyls were present corresponding to the carbamate, the amides and the ester. The 
aromatic carbons and the quaternary carbons of the Fmoc-protecting group and the indole 
ring resonated between δC 143.9 ppm and δC 110.7 ppm. The three chiral carbons resonated at 
δC 53.9 ppm, δC 53.9 ppm, and δC 51.1 ppm, while the acidic proton of the Fmoc-protecting 
group appeared at δC 47.1 ppm. Chiral HPLC was performed on compound 149, and gave 
one peak corresponding to one diastereomer of the compound. 
The Fmoc group was then removed using piperidine. The reaction could be monitored by 
TLC, which showed the Fmoc-protected tripeptide 149 as a purple spot in 50% ethyl 
acetate/hexane with an Rf of 0.5. After 18 hours the starting material was gone and a new 
polar spot was present at Rf 0.5 in 10% MeOH/DCM. Following flash chromatography, 
compound 150 was obtained in 61% yield. Its 1H NMR spectrum revealed that the aromatic 
region lacked the signals corresponding to the Fmoc group and the NH of the carbamate. The 
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resonances of the indole ring were still present. An upfield shift for the α-proton of leucine to 
δH 3.34 ppm also confirmed the removal of the the Fmoc group (and the presence of the free 
amine); the two amides resonated at δH 7.83 ppm and δH 6.39 ppm. The 13C NMR spectrum 
was consistent with that of compound 149, but lacked the carbonyl singlet for the carbamate 
group, as well as the peaks for the Fmoc group in the aromatic region. No doubling of the 
peaks was observed, which indicated that epimerization had likely not occurred; this was 
confirmed by chiral HPLC, which only showed one peak corresponding to a single 
diastereomer of 150 (in our experience diastereomers (epimers) were always well separated 
on the Chiralcel OD and Chiralpak AD columns). In the IR spectrum a broad peak at 3020 
cm-1 indicated the presence of an amine group, further confirming the absence of the Fmoc 
group. For HRMS (ES), the parent ion was found to be 445.2815 (M+ + H) correlating to the 
correct molecular formula of C24H37N4O4 (requires (M+ + H) 445.2815), thus confirming the 
formation of 150. 
The free amine 150 was then coupled to the PPY-salt 126 in pyridine using the peptide 
coupling conditions from before to form the tripeptide-catalyst 140 in 44% yield after work-
up and chromatography (Scheme 3.13). Its 1H NMR spectrum confirmed that the coupling 
occurred based on signals for both partners, in which a new amide NH was observed 
resonating at δH 6.84 ppm. The protons of the pyridine ring resonated at δH 8.11 ppm, δH 8.05 
ppm, and δH 7.09 ppm, the α-protons of the tryptophan residue resonated at δH 4.81 ppm, and 
the α-protons of the leucine residues resonated further upfield at δH 4.60 ppm and δH 4.47 
ppm (Fig. 3.25). 
	  
Scheme 3.13. Reagents and conditions: (i) 150, EDC, HOBt, pyridine, DCM, r.t., 12 hrs 
(44%). 
 




Figure 3.25. A portion of 1H NMR (CDCl3) spectrum of compound 140. 
The 13C NMR spectrum was assigned using 2D NMR and APT spectroscopy. The amide and 
ester carbonyls resonated downfield between δC 172.9 ppm and δC 168.8 ppm. The carbons of 
the pyridine ring resonated at δC 149.4 ppm, δC 148.7 ppm, and δC 108.5 ppm, while the 
carbons of the indole ring resonated further upfield in the aromatic region. The three chiral 
carbons resonated at δC 52.5 ppm, δC 53.4 ppm, and δC 51.0 ppm, and the pyrroldine protons 
resonated at δC 49.5 ppm and δC 25.5 ppm. Finally, a correct HRMS evaluation (m/z HRMS 
(ES) 619.3606 [M + H]+, C34H47N6O5 requires m/z 619.3608 [M + H]+), confirmed the 
structure of 140. The enantiomeric purity of the compound was determined by chiral HPLC, 
which corresponded to a purity of 97% (Fig.3.26).  
 




Figure 3.26. Chiral HPLC of compound 140. 
Tripeptide catalysts 139 and 140 were then evaluated as asymmetric acylation catalysts in 
order to establish the effect on activity of having the extra amino acids in the chain compared 
to results for the current lead catalyst, dipeptide 128 Table 3.6 compares some results for the 
two tripeptide catalysts in the kinetic resolution of some standard secondary alcohols. Results 
of the equivalent reactions with dipeptide lead 128 are given in brackets for comparison 
purposes.  


























































51 21.6 21.1 1.9 S 
5. 140 
 
5.8 3.2 52.5 3.3 S 
6.e 140 
 
46 26.4 30.4 2.4 S 
a. All reactions were conducted in the presence of 5 mol% catalyst, 0.7 eq. of (i-PrCO)2O, and 0.9 eq. 
of Et3N at -78 °C for 3 hrs., unless otherwise noted. b. Conversion (%) = (ee of recovered alcohol)/(ee 
of recovered alcohol + ee of ester. c. hydrolysed (2M NaOH in MeOH/H2O) and ee calculated. 
d. Selectivity factor 𝑠   = 𝑙𝑛 1−𝐶 1−𝑒𝑒𝑙𝑛 1−𝐶 1+𝑒𝑒 . e. T = 12 hr. f. The absolute configuration of the faster 
reacting enantiomer was determined by comparison of [α]20D   values with those reported in the 
literature. 
Disappointingly, the study gave low enantiomeric excesses and s-values for both tripeptide 
catalysts. Interestingly, catalyst 139 having two tryptophan units gave poorer results than the 
Trp/Leu combination in 140, suggesting that it is favourable to have just one π–stacking unit 
to avoid conflicting conformations. Furthermore, catalyst 140 with the extra bulky Leucine 
fragment required a longer time (increase from 3 hrs to 12 hrs) to achieve 50% conversion as 
with catalyst 139, at least suggesting that the chain was reaching over to the acylation site. 
Overall, selectivity factors ranged between 1.8 and 3.3, which is much lower than the 
generally accepted threshold of s = 10 required for a synthetically useful kinetic resolution 
reaction. Importantly, though, the results suggested that “bigger” was not necessarily “better” 
and at this stage we resorted to modelling to assist in the direction of the project. 
Additionally, and this would be important for developing a transition-state model later, the 
configuration of the fast- reacting enantiomer as determined by measuring the optical 
rotations and comparing them to literature values was always determined to be the S-
enantiomer.  
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N-Boc-indole Dipeptide: Computational Modelling 
Having demonstrated varying degrees of enantioselectivity for catalyst 128 in the kinetic 
resolution of secondary alcohols, attention was turned to computational modelling in an 
attempt to elucidate the origin of the enantioselectivity, and determine whether π–stacking 
played a role in the enantiodiscriminating step. As stated earlier, the Boc-substituted 
dipeptide 141 was thought might provide steric and H-bonding effects, and on paper looked 
straightforward to synthesise.	   Once again, a conformer distribution was calculated for its 
acyl-pyridinium cation (Fig. 3.27) using MMFF94 force field.151 The ten lowest energy 
conformers (out of 100 0000 conformations) were optimised at the M06/6-31G* level of 
theory. This resulted in minimum-energy conformers, which were present in a 91:8.9 ratio 
(Fig. 3.28, as A and B respectively). 
 
Figure 3.27. Target 141 and its N-acyl-pyridinium cation. 
 
 
Figure 3.28. Results of the M06/6-31G*level. 
A B 
Rel.	  Energy	  =	  -­‐44.52	  kJ/mol	  	   	   	   Rel.	  Energy	  =	  -­‐38.76	  kJ/mol	  




The dominant conformer did not indicate a π–stacking interaction, because the indole ring did 
not overlap with the pyridine ring, and so the ten conformers were subjected to geometry 
optimization using density functional theory calculations, performed at the B3LYP/6-31G* 
level of theory followed by a single-point energy calculation using the ωB97X-D/6-31G* 
level of theory– a functional that is significantly superior for non-bonded interactions like π–
π stacking, compared to other empirical-dispersion density functionals.155 This time the 
conformers were distributed in a 96:2:1 ratio, shown in Fig. 3.29 as A, B and C respectively 
together with their relative energies. In conformer A, the lowest energy conformer, once 
again the N-acyl moiety was contained in an s-trans configuration as before and blocked on 
its si-face by the indole ring of the tryptophan. The bulky tert-butyl group of the Boc was 
now on the “left side” of the molecule on the side of C-5 and C-6. In conformer B, the same 
apply but now the tert-butyl group pointed to the other side (right) of the molecule. In 
conformer C the si face was blocked, but to a lesser extent. The population for the three 
conformers, A, B, and C supports the preference of conformer A.	   A more accurate 
calculation was not further pursued, due to lack of computational power. 
 
A Rel. Energy = -12.65 kJ/mol 




si	  face	  (underneath	  face)	  of	  the	  acyl	  
group	  blocked	  by	  the	  indole	  ring	  




B Rel. Energy = -2.81 kJ/mol 
 
C Rel. Energy = 5.16 kJ/mol 
Figure 3.29. Geometry optimized structures of 141 obtained at the ωB97X-D/6-31G* level. 
The results of the geometry optimization shown in Figure 3.29 lent support to our original 
hypothesis that the electron-deficient pyridine ring π–stacks to the electron-rich indole ring. 
Salient conformational features follow:  
indole	  ring	  on	  top	  face	  
peptide	  chain	  
Boc	  group	  on	  top	  face	  
peptide	  chain	  
indole	  ring	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1. The dipeptide chain coils such that the indole moiety blocks the underneath face of 
the pyridinium ion with C-3 on the “right”. This is the pyridine re-face w.r.t. the 
pyridine N (C of acyl C=O = priority 1; C-2 = priority 2; C-6 = priority 3. 
2. The catalyst adopts the conformation shown in Fig. 3.30, in which an intramolecular 
π–cation interaction exists between the indole ring and the pyridinium ion. 
3. The indole ring ends up on the si face of the N-acyl group, which is in an s-trans 
conformation. Hence, only the re face for approach of the alcohol onto the acyl group 
looks as though it is available.	  
	  
 
Figure 3.30. Top face of the catalyst, showing (a) indole ring covering the N-acyl 
underneath (si) face, (b) coiling of the peptide chain, (c) Boc group blocking one side 
(left) of the molecule, (d) re (top) face of the acyl group.  
4. The orientation of the iso-propyl group is in the direction of the C-3 substituent, 
similar to catalyst 128, and in agreement with Spivey and Connon’s observations. 
Only the N-acyl re face is available for attack by the nucleophile.  
5. Finally, the Boc provides a buttress on the opposite side to the iso-propyl group to 
ensure that the bulk of the alcohol is denied the open space.  
Encouraged by these results we set out to synthesise compound 141 and test it as an acyl-
transfer catalyst in kinetic resolution reactions. 
Catalyst 128 was reacted with di-tert-butyl dicarbonate in THF at 0 °C in which it was hoped 
that the relatively low temperature would avoid any epimerisation. The reaction did not go 
completion after four hours, according to TLC, even after the addition of a catalytic amount 
of DMAP and two equivalents of Boc-anhydride. Following a basic work-up, the crude 
product was purified by column chromatography using 10% MeOH/DCM, and catalyst 141 
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was isolated in 51% yield as a pale-yellow solid (Scheme 3.14). The low yield was because 
the starting material was so close to the product on TLC that only a few fractions of clean 
product could be isolated.  
 
Scheme 3.14. Synthesis of catalyst 141 
Mechanistically, the reaction proceeds via the same Lewis base catalysis as that in this 
project in which dipeptide 128 is perceived to react with di-tert-butyl dicarbonate to form the 
acyl-pyridinium ion (I) with elimination of tert-butoxide, which acts as a base to deprotonate 
the indole NH. THF is crucial as solvent to stabilise the ion-pair. The resulting anion then 
attacks the pyridinium ion to form the acylated peptide-catalyst 141 (Scheme 3.15). 
	  
Scheme 3.15. Mechanism of catalyst acylation 
The structure of compound 141 was unequivocally assigned on the basis of its spectroscopic 
data using a combination of 1D, 2D 1H and 13C NMR as well as IR and high resolution mass 
spectrometry. The 1H NMR spectrum of 141 (Fig. 3.31) lacked the singlet at δH 8.48 ppm for 
the indole NH and a new singlet was present downfield at δH 1.64 ppm integrating for nine 
protons corresponding to the tert-butyl protons of the Boc group, which together indicated 
that a successful reaction had occurred. The protons of the pyridine ring and the indole ring 
resonated between δH 8.25 ppm and δH 6.44 ppm; the rest of the spectrum was consistent with 
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dipeptide catalyst 128. A small amount of ethyl acetate could be observed (quartet at ~4.1 
ppm) that was not removed on the vacuum pump but this was not considered to be limiting. 
	  
Figure 3.31. 1H NMR spectrum (CDCl3) of compound 141. 
Figure 3.32 shows an APT spectrum for compound 141, which shows the four carbonyl 
groups, including that of the new carbamate group resonating at δC 150.1 ppm. The presence 
of the new Boc group was further confirmed by the appearance of resonances for the t-butyl 
group at δC 83.8 ppm for the quaternary carbon and at δC 28.2 ppm for the homotopic methyl 
groups. Finally, a correct HRMS evaluation (m/z HRMS (ES) 606.3290 [M + H]+, 
C33H44N5O6 requires m/z 606.3292 [M + H]+), confirmed the structure of 141. The purity was 
determined to be 92% by chiral HPLC. 




Figure 3.32. APT spectrum (CDCl3) of compound 141. 
Catalyst 141 was tested in the kinetic resolution of a range of secondary alcohols under the 
same conditions described previously (Table 3.7). The s-values of six substrates (entries 1–6) 
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a. All reactions were conducted in the presence of 5 mol% 141, 0.7 eq. of (i-PrCO)2O, and 0.9 eq. of 
Et3N at −78 °C for 3 hrs., unless otherwise noted. b. Conversion (%) C = (ee of recovered 
alcohol)/(ee of recovered alcohol + ee of ester. c. hydrolysed (2M NaOH in MeOH/H2O) and ee 
calculated. d. Selectivity factor 𝑠   = 𝑙𝑛 1−𝐶 1−𝑒𝑒𝑙𝑛 1−𝐶 1+𝑒𝑒 . e. The absolute configuration was determined by 
comparison of [α]20D   values with those reported in the literature. f. ee of ester (not hydrolysed) 
measured by chiral HPLC. §128, *139, and ‡140. 
The results of this study indicated that the presence of a bulky tert-butyl group of 141 greatly 
enhances the selectivity, since higher s-values were obtained compared to dipeptide 128, and 
tripeptides 139 and (Table 3.7, entries 1–6); we were especially pleased to observe s-values 
exceeding 10 (Table 3.7, entries 1 and 2). Entries 7–12 are new substrates that were only 
tested using 141, and s-values varied between 9.7 and 1.9, with two results approaching an s-
value of 10 (Table 3.7, entries 7 and 8). In all cases, the fast reacting enantiomer was the S-
enantiomer as determined by measuring the sign of the optical rotations and comparing them 
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Figure 3.33 shows one example of the chromatograms for the kinetic resolution of alcohol 







Figure 3.33. Chiral HPLC chromatograms of the kinetic resolution of 1-(1-naphthyl)ethanol 
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Figure 3.34 outlines transition-state models for the two enantiomers, which involves a 
stereoelectronic effect between one of the lone pairs of the nucleophile and the N-acyl-
pyridinium carbonyl carbon. One of the enantiomers of racemic sec-alcohol preferentially 
attacks the N-acyl-pyridinium cation from one side to give the corresponding ester. The S 
selectivity in the kinetic resolution can be explained by comparing the two possible 
transition-state models, TS-I and TS-II, for the acylation of (S)- and (R)-2-phenylethanol, 
respectively. 
 
Figure 3.34. Proposed transition-state models. 
The alcohols would approach the pyridinium ion in a face-to-face manner due to an 
intermolecular π–cation interaction between the pyridinium cation and the aromatic ring of 
each.3,4 The (S)-alcohol can effectively attack the re face of the N-acyl group, such that one of 
the lone pairs of the oxygen atom (sp3 hybridised, with a tetrahedral arrangement of two 
bonds and two lone pairs) is colinear to the p-orbital of the carbonyl group (n–π*C=O). This 
interaction is possible for both TS-I and TS-II, however, the (R)-alcohol experiences a steric 
repulsion between the benzylic methyl group and the tert-butyl group attached to the chiral 
element; therefore, the acylation would preferentially proceed through TS-I to give 
predominately the (S)-ester. The lower selectivities in the cases where the aromatic ring is 
further away from the hydroxyl group (Table 3.7 entries 9 and 12) may be attributable to a 
decrease in the intermolecular π–cation interactions between the aromatic ring and the 
pyridinium-cation. 
Figure 3.35 shows four alternate transition-state structures with different orientations of the 
groups at the chiral carbon and illustrates why these interactions are not as favourable as the 
TS-I model in Fig. 3.34.  




interaction A (S-enantiomer) B (R-enantiomer) 
methyl group/tert-butyl 
interaction • No interaction, since methyl and tert-butyl 
are on opposite “sides” 
of the molecule 
• Unfavourable steric 
hindrance between 
methyl group and bulky 
tert-butyl group 
lone pair/carbonyl-C interaction 
• Unfavourable 
interaction, due to 
orientation of the C-O 
bond. 
• Unfavourable 
interaction, due to 




interaction C (S-enantiomer) D (R-enantiomer) 
methyl group/tert-butyl 
interaction • No interaction, since methyl and tert-butyl 
are on opposite “sides” 
of the molecule 
• OH group is on the 
same “side” of the tert-
butyl group and may 
experience a steric 
affect. 
• No interaction, since 
methyl and tert-butyl 
are on opposite “sides” 
of the molecule 
• OH group is on the 
same “side” of the 
terbutyl group and may 
experience a steric 
affect. 
lone pair/carbonyl-C interaction 
• Unfavourable 
interaction, due to 
orientation of the C-O 
bond. 
• Unfavourable 
interaction, due to 




Figure 3.35. Four alternate transition-state interactions. 
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Derivatives of Dipeptide Catalyst  
The introduction of the Boc substituent clearly had a favourable effect on the 
enantioselectivity of catalyst 141. Our transition-state model (TS-I) showed that one 
explanation for the higher selectivity values displayed by 141 compared to 128 was the effect 
of the bulky tert-butyl group, which restricted the approach of the alcohol in the 
enantiodiscriminating step. Therefore, it was thought a good idea to extend this finding to 
synthesising derivatives of 141 varying the carbamate group. Figure 3.36 shows targets 
identified based on computational modelling performed at the MMFF94 Force Field level. 
 
 
Figure 3.36. Carbamate derivative modifications for catalyst 141. 
Results of the modelling indicated an interaction between the oxygen of the carbamate and 
the carbonyl carbon of the N-acyl-pyridinium ion for catalysts 158, 159, and 160; and the 
sulfur of the thiourea and the carbonyl of the N-acyl-pyridinium ion for catalysts 161 and 162 
in addition to the steric effect of the substituents. The carbamates 158-162 were synthesised 
by deprotonating the indole NH using a strong base (NaH), and reacting with an electrophile, 
either as a chloroformate or an isothiocyanate. DMF was found to be the preferred solvent, 
since no reaction occurred in THF (Scheme 3.16).  





Scheme 3.16. Reagents and conditions: (i) NaH, R’CO2Cl (or S=C=N-R”), DMF, 0 °C, 2hrs. 
All the reactions were performed with 0.9 equivalents of NaH to prevent potential 
epimerizaton at the α-positions of the amino acids. As a result, some starting material was 
always present in the reaction. This hampered isolation of the catalysts, since the product was 
very close to the starting material on TLC, and only a few clean fractions were obtained. 
Therefore the yields for these reactions were generally low. 
Compound 158 was isolated in a 30% yield following a work-up and column 
chromatography, and characterized using a combination of 1D, 2D 1H NMR and 13C NMR. 
Its 1H NMR spectrum lacked the singlet for the indole proton, which suggested that the 
reaction had taken place, and showed the appearance of a multiplet integrating for five 
protons between δH 7.38 ppm and δH 7.29 ppm corresponding to the new phenyl group. The 
rest of the spectrum was consistent with the 1H NMR spectrum of the dipeptide starting 
material 128. The 13C NMR spectrum confirmed the presence of the carbamate group. The 
new carbonyl carbon resonated at δC 157.7 ppm while the carbons of the phenyl group 
resonated in the aromatic region. Finally, a correct HRMS evaluation (m/z HRMS (ES) 
626.2973 [M + H]+, C35H40N5O6 requires m/z , 626.2979 [M + H] +), confirmed the structure 
of 158. Similarly, compound 159 was isolated in a 31% yield and characterized using a 
combination of 1D, 2D 1H NMR and 13C NMR. Its 1H NMR spectrum also lacked the indole 
peak, and showed two doublets in the aromatic region at δH 6.91 ppm and δH 7.18 ppm 
corresponding to the protons of the new 1,4-disubstituted phenyl group. The protons of the 
additional methoxy group resonated at δH 3.67 ppm upfield to those of the methyl ester at δH 
3.82 ppm (Fig. 3.37 displays a portion of the spectrum). 




Figure 3.37. Partial 1H NMR spectrum of 159 showing the two methoxy peaks at δH 3.67 
ppm and δH 3.82 ppm. 
Finally, compound 160 was isolated in 40% yield following work-up and column 
chromatogrpahy. Its 1H NMR spectrum also confirmed a successful reaction by virtue of the 
absence of the indole proton and the appearance of seven new protons of the naphthyl group 
resonating in the aromatic region. The 13C NMR spectrum showed a new singlet resonating at 
δC 150.2 ppm for the carbamate carbonyl group, while the carbons of the naphthyl ring 
appeared in the aromatic region. Finally, a correct HRMS evaluation (m/z HRMS (ES) 
676.3142 [M + H]+, (C39H42N5O6 requires m/z 676.31351 [M + H] +), confirmed the structure 
of 160. 
Synthesis and Characterisation of 161 and 162 
Compound 161 was isolated in a 24% yield and characterised by a combination of 1D and 2D 
NMR. Its 1H NMR spectrum showed the tert-butyl group resonating at δH 1.65 ppm, which 
indicated that the reaction was likely successful. The indole NH proton was absent, while the 
new NH proton of the thiourea appeared at δH 8.83 ppm. The 13C NMR spectrum showed a 
downfield singlet at δC 178.0 ppm for the thiourea thiocarbonyl carbon (C=S), while the 
carbons of the tert-butyl group resonated at δC 28.1 ppm. The infra-red spectrum revealed a 
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sharp peak at 1266 for the carbon sulfur double bond. Finally, a correct HRMS evaluation 
(m/z HRMS (ES) 621.3219 [M + H]+, C33H45N6O4S requires m/z 621.32230 [M + H] +), 
confirmed the structure of 161.  
In order to synthesise catalyst 162, isothiocyanate 164 first had to be synthesised from 
commercially available 3,5-bis(trifluoromethyl)aniline 163 and thiophosgene under basic 
conditions. Following workup and column chromatography, compound 164 was isolated in 
71% yield (Scheme 3.17).  
	  
Scheme 3.17. Reagents and conditions: (i) thiophosgene (1.2 eq.), Hünig’s base (2 eq), 
DCM, r.t., 5 hrs (71%).  
The 1H NMR spectrum of 164 lacked the protons of the amine in the starting material and 
showed two singlets for the three aromatic protons. The 13C NMR spectrum was more 
instructive, showing the C=S singlet resonating at δC 141.0 ppm, while the quaternary proton 
(C-1) resonated at δC 134.1 ppm. The CF3 groups (C-7) resonated as a quartet between δC 
118.4 ppm and δC 126.6 ppm with a C-F coupling constant of 273 Hz. Quaternary carbons C-
3 and C-5 appeared as a smaller quartet resonating at δC 133.4 ppm with a coupling constant 
of 34 Hz, also due to C-F (2J) coupling. The rest of the spectrum is shown in Fig. 3.38. 




Figure 3.38. 13C NMR (CDCl3) spectrum of isothiocyanate 164. 
The next step was to couple isothiocyanate 164 to dipeptide catalyst 128 under basic 
conditions, following workup and column chromatography, 162 was isolated in a 17% yield. 
Figure 3.39 shows a partial 1H NMR spectrum of compound 162. The three protons of the 
3,5-disubstituted aromatic ring resonated at δH 8.17 ppm (H-2”’ and H-6”), and δH 7.71 ppm 
(H-4”’). The proton α to the pyridine nitrogen, H-2”, shifted upfield to δH 6.94 ppm while the 
rest of the aromatic region contained the aromatic protons of the indole ring and the pyridine 
ring. The 13C NMR spectrum showed a downfield singlet at δC 179.4 ppm for the 
thiocarbonyl carbon, which further confirmed the presence of the thiourea group. The quartet 
corresponding to the two CF3 group could not be assigned (too small), but the quartet 
corresponding to C-3”’ and C-5”’ could be assigned and had a C-F coupling of 33.0 Hz. The 
IR spectrum which showed a peak at 1266 cm−1 corresponding to the C=S group. 




Figure 3.39. A portion (aromatic region) of the 1H NMR spectrum of compound 162. 
The purity of the five derivatives was evaluated using chiral HPLC, which unfortunately 
indicated varying degrees of what was assumed to be epimerization at the α-stereogenic 
centres for all five catalysts (Table 3.8). Therefore the strategy of lowering the amount of 
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Table 3.8. Purity evaluation of catalysts 158–162. 

















However, having synthesised the five compounds, screening of the catalysts in the kinetic 
resolution of 1-(2-naphthyl)ethanol went ahead (Table 3.9). Selectivity factors varied 
between 1.1 (for the tert-butyl thiourea derivative 161) and 7.0 (for the phenyl carbamate 
derivative 158). However, the tert-butyl carbamate substituted catalyst 141 still remained the 
most selective catalyst for this substrate (s-value = 8.1). The rest of the carbamates gave 
higher s-values (Table 3.9, entries 3, 4, and 5) than the free amine catalyst 128 (Table 3.9, 
entry 1) though, further suggesting that the presence of a carbamate substituent on the indole 
nitrogen plays an important role in the enantiodescriminating step in which steric aspects 
predominate. However, the thiocarbamate catalysts 161 and  162 both gave lower s-values 
than the free amine (Table 3.9, entries 7 and 8) indicating that the oxygen of the carbamate 
must play a role in the orientation of the tert-butyl group (and/ or other) groups. 
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All reactions were conducted in the presence of 5 mol% catalyst, 0.7 eq. of (i-PrCO)2O, and 0.9 eq. of 
Et3N at −78 °C for 3 hrs., unless otherwise noted. b. Conversion (%) = (ee of recovered alcohol)/(ee 
of recovered alcohol + ee of ester. c. hydrolysed (2M NaOH in MeOH/H2O) and ee calculated. 
d. Selectivity factor 𝑠   = 𝑙𝑛 1−𝐶 1−𝑒𝑒𝑙𝑛 1−𝐶 1+𝑒𝑒 .  
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3.3  α-Substituted Acylation Catalysts 
The final part of this thesis involved the development of two quinoline-based catalysts, which 
were inspired by Fu’s quinolone-based ferrocene complexes (section 1.7.3). Even though 
quinoline is known to be an inefficient acyl-transfer catalyst itself due to an α-steric effect, 
the iron atom in Fu’s catalyt increases the nucleophilicity of the quinoline nitrogen, and also 
provides a scaffold for a quinoline moiety. Therefore, it was rationalised that a chiral oxy-
substituent attached to C-8 of a 4-aminoquinoline template might present a catalytic effect in 
which extra mesomeric donation to the ring nitrogen from the oxygen might compensate for 
the well-known α-steric effect established by Litvinenko and Kirichenko. To test our 
hypothesis, catalysts 165 and 166 were synthesised by coupling an 8-hydroxy-4-
pyrrolidinoquinoline template to two different modified amino acids (Fig. 3.40). Catalyst 165 
was chosen because of success with the leucine/tryptohan dipeptide motif in π–stacking. 
Catalyst 166 was chosen based on work done by Connon et.al. who found that for 4-
pyrrolidinopyridine-based catalysts (e.g. 32, Chapter 1), the pyrrolidine substituents with a 
hydroxyl group were more active than those lacking the hydroxyl group. The observed 
enantioselectivity was affected by substrate H-bonding interaction during the 
enantiodiscriminating step, as determined by computational modelling calculations. 
	  
Figure 3.40. a. Structure of target quinoline catalysts. b. Connon’s PPY-based catalyst. 
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Scheme 3.18 shows the five step synthesis of the quinoline template 172, which was based on 
recent literature. Thus, commercially available xanthurenic acid was decarboxylated by 
refluxing in diphenyl ether, to afford 168 in 92% yield following filtration.156 Its 1H NMR 
spectrum lacked the acidic proton of the carboxylic acid, indicating that a successful 
decarboxylation had occurred, and also revealed broad singlets at δH 11.21 ppm and δH 10.61 
ppm for the protons of the two hydroxyl groups. In addition a characteristic AB doublet pair 
for H-2 and H-3 was noted. The next step was to chemoselectively protect the C-8 phenoxide 
as a tosylate. This was possible because the C-4 phenoxide is less reactive than its C-8 
counterpart due to resonance stabilization of the former directly onto nitrogen. Thus, 168 was 
reacted with p-toluenesulfonyl chloride in water with sodium hydroxide as base, and after 
twelve hours a grey compound precipitated, which was filtered and isolated in 96% yield. Its 
1H NMR spectrum showed the diagnostic singlet peak at δH 2.36 ppm corresponding to the 
methyl group of the tosylate 169. 
 
Scheme 3.18. Reagents and condtions: (i) diphenyl ether, reflux, 3 hrs, 92%; (ii) TsCl, 1M 
NaOH, r.t., 18 hrs, 96%; (iii) POCl3, reflux, 3 hrs, 74%; (iv) pyrrolidine, K2CO3, toluene, 100 
°C, 18 hrs, 67%; (v) 2M NaOH, ethanol, reflux, 3 hrs, 96%.  
As expected, the hydroxyl group at C-4 did not react and resonated as a broad singlet at δH 
11.43 ppm. The C-4 hydroxyl group was then substituted for a chloride in a nucleophilic 
aromatic substitution by refluxing 169 in phosphoryl chloride for three hours. Following a 
basic work-up, chloride 170 was isolated in 74% yield. Its 1H NMR lacked the singlet for the 
hydroxyl group, the rest of the spectrum was consistent with published results. The chloride 
was then substituted in a further SNAr reaction using pyrrolidine and K2CO3 in toluene. After 
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18 hours the mixture was filtered and then purified by column chromatography to give 
compound 171 in a 67% yield. Its 1H NMR spectrum confirmed that the reaction was 
successful by the appearance of two multiplets at δH 3.90 ppm and δH 2.01 ppm 
corresponding to the eight protons of the pyrrolidine ring. Finally, the tosylate was removed 
under basic conditions using sodium hydroxide. The reaction was quenched with 
hydrochloric acid and compound 172 was isolated as a tosylate salt in a 96% yield, which 
could be used as the nucleophilic template in the coupling to follow on the understanding that 
the tosic acid moiety would be taken care of by the base (in excess). With the template in 
hand, the next step was to synthesise the peptide to be attached to the template (Scheme 
3.19). Here, it was envisaged that a bis-electrophilic coupling tether based on chloroacetate 
could be used to join the two nucleophilic sites of the peptide and template respectively.  
 
Scheme 3.19. Reagents and conditions: (i) piperidine, DCM, 0 °C, 12 hrs, 67%; (ii) 
chloroacetic acid, DCC, HOBt, DCM, 0 °C, 18 hrs, 92%; (iii) 172, CsCO3, CH3CN, r.t., 60 
°C, 7 hrs, 60%. 
The synthesis of the dipeptides, Fmoc-Leu-Trp-OH and NH2-Leu-Trp-OH, have been 
previously discussed (Chapter 2). The free amine was reacted with chloroacetic acid under 
peptide coupling conditions used in this project. Following a work-up and column 
chromatography, the chloride 173 was isolated in 92% yield. Its 1H NMR spectrum in CDCl2 
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revealed a new amide NH singlet at δH 6.86 ppm, while the α-proton of the leucine moiety 
shifted downfield to δH 4.52 ppm, indicating that the coupling was successful. The presence 
of the new methylene protons where confirmed by the appearance of two doublets at δH 3.87 
ppm and δH 3.65 ppm (Fig. 3.41). The 13C NMR spectrum of 173 revealed three carbonyl 
singlets including the carbonyl of the amide group. The methylene carbon resonated at δC 
42.2 ppm. The rest of the 13C NMR spectrum was consistent with that of the starting material. 
Further evidence was given by mass spectrometry data, HRMS (ES): m/z 408.1691, which 
correlated with the calculated value 408.16901 for the molecular formula of C20H27ClN3O4. 
 
	  
Figure 3.41. 1H NMR spectrum of compound 173. 
Finally, the dipeptide was coupled to the template 172 in an SN2 reaction onto its chloride by 
refluxing in acetonitrile with caesium carbonate as base, and following work-up target 
catalyst 165 was isolated in 60% yield. Its 1H NMR spectrum indicated that the reaction was 
successful, since the protons for both starting materials were present in the product, and the 
protons of the tosylate group were absent. In the aromatic region, the protons of the quinoline 
ring and the indole ring were both present. The amino acid α-protons resonated distinctively 
at δH 4.80 ppm and δH 4.65 ppm, while the methylene protons, which were now adjacent to 
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an oxygen, shifted downfield and appeared as two doublets at δH 4.63 ppm and δH 4.53 ppm. 
In the 13C NMR of 165 the carbonyls (the ester and the two amides) were present at δC 172.4 
ppm, δC 172.1 ppm and δC 167.8 ppm. The methylene carbon also shifted upfield to δC 69.0 
ppm. For HRMS (ES), the parent ion was found to be 586.3038 [M + H]+ correlating to the 
calculated molecular formula of C33H40N5O5 (requires (M+ + H) 586.3029), thus confirming 
the formation of 165. 
The next catalyst to be synthesised was compound 166. The first step was to couple 
commercially available (S)-(-)-α,α-diphenyl-2-pyrrolidinemethanol 174 with chloroacetyl 
chloride and triethylamine as base, again with the intention of installing a tether. Following 
work-up and column chromatography, 175 was isolated in 90% yield (Scheme 3.20).  
	  
Scheme 3.20. Reagents and conditions: (i) chloroacetyl chloride, NEt3, DCM, 0 °C, 1 hr 
(90%).  
Its 1H NMR spectrum indicated that the reaction was successful. Figure 3.42 reveals a fully 
assigned 1H spectrum showing the ten protons of the two phenyl rings resonated in the 
aromatic region as two multiplets (integrating for four and six protons), while the hydroxyl 
group resonated as a singlet at δH 6.13 ppm. The α-proton at the chiral centre resonated at δH 
5.21 ppm, while the methylene protons of the pyrrolidine ring resonated between δH 3.45 
ppm and δH 1.09 ppm. The 13C NMR spectrum of 175 displayed a new peak at δC 168.6 ppm 
corresponding to the carbonyl carbon of the amide group. The carbon corresponding to the 
methylene group between the carbonyl and the chloride resonated at δC 42.1 ppm. 




Figure 3.42. 1H NMR spectrum of compound 175. 
The next step was to couple chloride 175 to the template using the SN2 conditions. However, 
unfortunately the reaction produced several spots on TLC, so it was decided to substitute the 
chloride with an iodide in the hope of facilitating the substitution. Thus compound 175 was 
reacted with potassium iodide in CH3CN at reflux temperature. TLC revealed a new, slightly 
less polar spot just above the starting material. Following basic work-up and column 
chromatography, compound 176 was isolated in 83% yield. Its 1H NMR was consistent with 
that of 176, in which the methylene hydrogens adjacent to iodide had shifted upfield to δH 
3.63 ppm. Its 13C NMR spectrum was also consistent with that of an iodide based on a 
significant upfield shielding of the same methylene (carbon) to δC −2.1 ppm, consistent with 
the presence of an iodide. Finally, a correct HRMS evaluation (m/z HRMS (ES) of 422.0614 
[M + H]+, agreed favourably with the calculated value of 422.0617 for C19H21INO2. 




Scheme 3.21. Reagents and conditions: (i) 172, CsCO3, CH3CN, reflux, 7 days (44%). 
With the compound in hand the final step was to couple the template 172 to the iodide 176 
under basic conditions using cesium carbonate in acetonitrile. Following work-up and 
extraction compound 166 was isolated in 44% yield. Its 1H NMR spectrum indicated that the 
reaction was successful since protons of the starting material and product were present. The 
two phenyl rings and the quinoline protons resonated in the aromatic region. The hydroxyl 
group appeared as a singlet at δH 6.49 ppm. The methylene protons resonated at δH 5.30 ppm 
and δH 4.86 ppm, while the protons of the pyrrolidine ring resonate at δH 3.84 ppm and δH 
2.12 ppm. The 13C NMR spectrum of the 166 revealed singlets for both starting materials, 
with diagnostic peaks at δC 169.5 ppm corresponding to the carbonyl of the amide and a peak 
at δC 68.6 ppm corresponding to the methyl group of the tether. Finally, a correct HRMS 
evaluation (m/z HRMS (ES) of 508.2600 [M + H]+, agreed favourably with the calculated 
value of 508.2607 for C33H34N3O3. 
The two quinoline catalysts 165 and 166 were tested in the kinetic resolution of 1-(2-
naphthyl)ethanol with iso-butyric anhydride as acylating agent (Table 3.10). The quinoline 
compounds were less reactive as acyl-transfer catalysts than the β-substituted pyridine-based 
catalysts, based on no reaction occurring at −78 °C. Therefore the temperature was increased 
to −20 °C, but even at this temperature TLC monitoring indicated that 10 days were needed 
to achieve a reasonable conversion for the peptide catalyst 165 while virtually no conversion 
was achieved for 166. A higher temperature was not investigated as it was felt that there 
would be no enantioselectivity. 
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1. 165 31 0.6 1.3 1.0 
2. 166 3 0.06 2.15 1.0 
a. All reactions were conducted in the presence of 5 mol% catalyst, 0.7 eq. of (i-PrCO)2O, and 0.9 eq. 
of Et3N at −20 °C for 10 days, unless otherwise noted. b. Conversion (%) = (ee of recovered 
alcohol)/(ee of recovered alcohol + ee of ester. c. hydrolysed (2M NaOH in MeOH/H2O) and ee 
calculated. d. Selectivity factor 𝑠   = 𝑙𝑛 1−𝐶 1−𝑒𝑒𝑙𝑛 1−𝐶 1+𝑒𝑒 . 
Table 3.10 shows that the dipeptide catalyst 165 gave a conversion of 31% compared to the 
pyrroldine catalyst 166, which only gave a conversion of 3%. Enantioselectivities for both 
catalysts were non-existent with reactions giving s-values of only 1 – meaning the rates of the 
reaction for the two enantiomers were essentially identical. Hence, unfortunately, the concept 
pursued failed to bear fruit.  
Molecular Modelling 
Molecular modelling was performed using Spartan ’10 on the acyl-pyridinium ions of 165 
and 166 in order to determine the lowest energy conformers (Fig. 3.43). A conformer 
distribution was calculated using MMFF94 force field151 for the acylated cations (165a and 
166a), as previously described. 




Figure 3.43. Acyl-pyridinium ions of catalysts 165 and 166. 
Figure 3.44 shows the three lowest energy conformers of 165a in a 63:18:17 ratio and their 
relative energies as A, B, and C respectively. None of the conformers showed any favourable 
π–stacking interaction between the indole of the tryptophan and the pyridine ring of the 
quinoline; however, in each case the quinoline si face (w.r.t. the quinoline N; C of C=O of N-
acyl group = priority 1, C-8a = priority 2, C-2 = priority 3) was blocked by the peptide chain, 
although probably too far away from the N-acyl group. In the major conformer, A, the bulky 
iso-propyl group of the N-acyl substituent (in an s-cis conformation – priority change 
compared to the pyridine 3-carboxamide catalysts), points away from the chiral substituent 
probably due to steric hindrance, while in the minor conformers, B and C, the iso-propyl 
group points towards the chiral substituent. This could explain the low selectivity, based, as 
explained previously, on an inversion of stereo-information transfer. However, the low 
conversion at a higher temperature suggests that several unfavourable factors are operating 
compared to reaction with catalyst 141.  
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Figure 3.44. Lowest energy conformers pyridinium cation 165a. 
Turning to the other quinoline-based catalyst, the three lowest energy conformers of 166a 
appeared in a 90:8:1 ratio (A, B, and C respectively, Fig. 3.45). As with 165a in all three 
conformers, the quinolone si face was blocked by the chiral group, in which H-bonding 
between the hydroxyl group of the pyrrolidino moiety and the oxygen at C-8 of the quinoline 
ring may be important (Fig. 3.45). Furthermore, in contrast to 165a all three conformers 
preferred placing the N-acyl group into an s-trans conformation with the carbonyl group 
pointing away from the quinoline benzene ring. It is unclear why the selectivity was low, 
since conformer A is present in 90% and the chiral chain appears to effectively block one 
face. However, once again the chiral chain does lie more over the benzene ring quite far away 
from the carbonyl site, and there is no buttressing on the other (C=O) side. The very low 
conversion (Table 3.9, entry 2) suggests that the alcohol reagent is associating with the 
hydroxyl group of the bulky chain through H-bonding (cf. Connon55 discussed mentioned 
previously), rather than approaching from the more exposed face. Future studies could study 
the influence of protecting the tertiary hydroxyl group (as in Jørgensen’s organocatalyst)157 to 









Figure 3.45. Lowest energy conformers pyridinium cation 166a. 
A     B    C 




Chapter 4: Conclusion 
This part of the thesis has described the synthesis of three classes of asymmetric acyl-transfer 
catalyst based on DMAP and 4-PPY substituted at the α, β, and γ positions of the pyridine, 
and in which the chiral directing group was either an amino acid or peptide. The catalysts 
were designed to explore possible π–stacking effects between the tryptophan and the N-
acylpyridinium ion. The catalysts were tested in the kinetic resolution of secondary alcohols. 
γ- and α-substituted catalysts gave no selectivity. A leu-trp β-substituted dipeptide catalyst 
128 gave moderate to good selectivity (s = 5.3) with 1-(2-naphthyl)ethanol 121. Further 
development of the system culminated in the synthesis of two tripeptide catalysts, which did 
not improve the s-values, while the Boc-protected dipeptide catalyst of 128 as 141 did lead to 
an improvement, with the highest s-value of 10.7 with 1-(1-naphthyl)ethanol 132. 
Throughout the study computational modelling using Spartan ’10 (using molecular 
mechanics and quantum mechanics) was instrumental in assisting with explanations on 
selectivity via the generation of putative transition-state (TS) models. The TS model for the 
successful catalyst 141 suggests a tight π–cation interaction between the pyridinium cation 
and the indole ring of a tryptophan moiety during the stereodifferentiation step.  
Future work could include varying the pyridine alkyl substituent of the 4-amino group, since 
it is known to influence the selectivity.66,69 The catalyst could also be modified by changing 
the ester substituent (e.g. from methyl to hexyl) in order to decrease its polarity to make the 
catalyst more soluble in non-polar solvents. This would allow a study of solvent effects. 
Finally, the catalysts could be tested in different substrates and reactions: for example, in the 
kinetic resolution of azlactones, or diamines, the desymmetrization of meso-diols, the 




Chapter 5: Experimental  
5.1 General procedures 
All reactions were performed in oven-dried glassware under an inert atmosphere of dry 
nitrogen. All starting materials were purchased from either Sigma-Aldrich (South Africa) or 
Abbliss Chemicals (USA), except for solvents, acids, and common salts. The following 
reaction solvents were distilled from the indicated drying agents: DCM (P2O5), diethyl ether 
(P2O5), THF (Na, benzophenone), acetonitrile (CaH2), NEt3 (CaH2), toluene (CaH2). Nuclear 
Magnetic Resonance spectra were recorded on a Varian Mercury 300 MHz (75.5 MHz for 
13C) or a Bruker 400 MHz (101 MHz for 13C) instrument. The spectra were recorded in 
CDCl3, Acetone-d6, CD3OD-d4, or DMSO-d6 with tetramethylsilane as the internal standard. 
Chemical shifts are reported in ppm (δ). Coupling constants, J, are reported in Hertz. Mass 
spectra were recorded on a JEOL GCmatell and were recorded in Electron Ionisation mode. 
Infrared spectra were recorded on Perkin-Elmer Paragon 1000 FT-IR spectrophotometer on 
NaCl plates. Melting points/decomposition temperatures were determined using a Reichert-
Jung Thermovar hot-stage microscope and are uncorrected. Elemental analyses were 
performed using a Fisons EA 1108 CHNS elemental analyser. Optical rotations were 
obtained using a Perkin Elmer 343 polarimeter at λ = 589 nm and 20 °C. The concentration c 
refers to g/100mL. Chiral HPLC was performed on an Agilent 1220 Infinity LC system. 
Analytical chiral HPLC was performed on Chiralpak AD 4.6 mm × 25 cm column, Chiralpak 
IC 4.6 mm × 25 cm column, or Chiralcel OD 4.6 mm × 25 cm column, using HPLC grade 
solvent purchased from Merck. The reaction progress was monitored by TLC using Merck 
silica-gel 60 F254. Visualisation was accomplished with UV light or spraying with 
anisaldehyde or cerium ammonium sulfate spray reagents and then heating at 150 °C. 
Column chromatography was performed with Merk silica-gel 60 (70-230 mesh). Flash 
chromatography: Chrom Tech Flash 150 pump; Foxy R1 fraction collector; Biotage® SNAP 




5.2 Phenolic Ligands 
4-tert-butyl-2,6-bis(hydroxymethyl)phenol (91)136  
 
To a stirred mixture of aq. formaldehyde (37%, 16 mL) and aq. NaOH (10%, 40 mL) at r.t., 
was added 4-(tert-butyl)phenol (15 g, 100 mmol) in one portion. After 48 hrs the white 
precipitate was filtered off, washed with H2O and treated with aq. HCl (1M, 100 mL). After 
stirring for 30 minutes the product was filtered off, washed with water, and dissolved in 
DCM and dried with MgSO4 to give a colourless solid (6.9 g, 33%), 1H NMR (300 MHz, 
CDCl3) δ 8.11 (br. s, 1H, OHphenol), 7.09 (s, 2H, H-3, H-5), 4.91 (s, 4H, H-1’), 3.29 (s, 2H, 2 x 
OH), 1.27 (s, 9H, t-Bu). 
(4-(tert-butyl)-1-methoxy-2,6-phenylene) (92)136 
 
To a stirred suspension of 91 (2.78 g, 13.2 mmol) and K2CO3 (909 mg, 6.58 mmol) at r.t., in 
acetonitrile (50 mL), was added methyl iodide (1.65 mL, 26.5 mmol) in one portion.  After 
48 hrs at 65 °C, the mixture was cooled to r.t. and filtered.  The solvent was removed under 
reduced pressure and the residue dissolved in DCM, washed with aq. (sat.) NaHCO3 followed 
by aq. (sat.) NaCl, dried over MgSO4, and the solvent removed to give a colourless solid 
(2.04 g, 70%), 1H NMR (300 MHz, CDCl3) δ 7.32 (s, 2H, H-3, H-5), 4.67 (s, 4H, H-1’), 3.78 








5-tert-butyl-2-methoxybenzene-1,3-dioic acid (93)136 
 
To a stirred solution of 92 (2.83 g, 12.6 mmol), NaOH (2.02 g, 122 mmol) and Adogen 464 
(5 drops) at 50 °C in H2O (50 mL), was added KMnO4 (19.3 g, 122 mmol) in one portion. 
After 2 hrs, the reaction mixture was heated to reflux temperature for 10 minutes, after which 
it was cooled to r.t., filtered through Celite ®, washed with 5% aq. NaOH and cooled to 0 °C. 
The resulting solution was acidified with 1M HCl to pH 1 to give a white precipitate (2.29 g, 
72%), which was dried under vacuum at 50 °C, 1H NMR (400 MHz, CDCl3) δ 8.93 (br. s, 
2H, 2 x COOH), 8.33 (s, 2H, H-4, H-6), 4.09 (s, 3H, OMe), 1.36 (s, 9H, t-Bu). 
5-tert-butyl-2-hydroxybenze-1,3-dioic acid (94)136 
 
Compound 93 (1.00 g, 3.69 mmol) as added to 33% HBr/AcOH (5 mL) and the resulting 
suspension was heated at 120 °C for 30 minutes. The resulting orange mixture was cooled to 
r.t. and diluted with ice cold water (25 mL), to give a pale-yellow precipitate. The product 
was filtered, washed with water and dried under vacuum to give a white powder (822 mg, 
87%) that was used in the next step without further purification, 1H NMR (400 MHz, 









2,6-bis(bromomethyl)-4-(tert-butyl)phenol (105) and 2,6-bis(bromomethyl)-4-(tert-
butyl)phenyl acetate (106)  
 
Compound 91 (1.013 g, 4.818 mmol) was dissolved in 33% HBr/AcOH (7 mL) and stirred at 
r.t.  After 24 hrs, ice (20 g) was added followed by petroleum ether (30 mL). The aqueous 
layer was washed twice more with petroleum ether (30 mL). The combined organic layer was 
washed with water and dried over MgSO4, and the solvent removed to give a brown solid, 
which was used in the next step without further purification (1.66 g), 105: 1H NMR (300 
MHz, CDCl3) δ 7.27 (s, 2H, H-3, H-5), 5.49 (s, 1H, OH), 4.57 (s, 4H, H-1’), 1.29 (s, 9H, t-
Bu); 106: 1H NMR (300 MHz, CDCl3) δ 7.39 (s, 2H, H-3, H-5), 4.38 (s, 4H, H-1’), 2.44 (s, 
3H, CH3), 1.32 (s, 9H, t-Bu). 
L-Tryptophan methyl ester (101)147  
 
Thionyl chloride (7.2 mL, 99 mmol) was added dropwise to MeOH (120 mL) at 0 °C over 5 
minutes. After 20 minutes L-tryptophan (10.0 g, 49.0 mmol) was added and the resulting 
solution stirred at r.t. After 10 hrs, the solvent was removed at reduced pressure to afford a 
crude solid that purified by recrystallization using MeOH/diethyl ether to give 101 as a 
colourless solid (8.4 g, 67% mmol), [α]20D   + 19.0 (c 5.0, MeOH) (+ 18 Sigma-Aldrich);
 1H 
NMR (400 MHz, CD3OD) δ 10.57 (s, 1H, N-Hindole), 7.54 (d, J = 8.0 Hz, H-7), 7.40 (d, J = 
8.0 Hz, 1H, m, H-10), 7.21 (s, 1H, H-5), 7.14 (m, 1H, H-9), 7.07 (m, 1H, H-8), 4.33 (m, 1H, 







To a stirred solution of Fmoc-Leu-OH (606 mg, 1.72 mmol) and HCl-Trp-OMe (524 mg, 
2.06 mmol) in pyridine (10 mL) at r.t., was added EDC (349 mg, 2.06 mmol) followed by 
HOBt (28 mg, 0.21 mmol). After 18 hrs 1M HCl (15 mL) was added followed by ethyl 
acetate (3 x 25 mL). The combined organic extracts was washed with 1 M HCl (3 x 50 mL) 
and dried over anhydrous MgSO4. The solvent was removed to give a yellow residue that was 
purified by ethyl acetate/hexane (40/60) to afford Fmoc-Leu-Trp-OMe as a colourless solid 
(927 mg, 97%), mp 146–148 °C; [α]20D   − 4.5 (c 0.5, MeOH); IR (DCM) 3055, 2989, 2309, 
1422, 1266 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.97 (s, 1H, N-Hindole), 7.77 (d, J = 7.5 Hz, 
2H, H-7”, 10”), 7.55 (m, 2H, H-4”, H-13”), 7.50 (m, 1H, H-7), 7.41 (m, 2H, H-5”, H-12” or 
H-6”, H-11”), 7.31 (m, 2H, H-5”, H-12” or H-6”, H-11”), 7.26 (m, 1H, H-10), 7.13 (ddd, J 
= 8.1, 7.1, 1.2 Hz, 1H, H-9), 7.07 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H, H-8), 6.95 (br. s, 1H, H-5), 
6.51 (d, J = 7.9 Hz, 1H, N-HTrp), 5.10 (d, J = 8.6 Hz, 1H, N-HLeu), 4.90 (m, 1H, H-2), 4.39 
(m, 1H, H-1”), 4.26 (m, 1H, H-1”), 4.22 –4.13 (m, 2H, H-2’, H-2”), 3.66 (s, 3H, OMe), 3.30 
(d, J = 5.5 Hz, 2H, H-3), 1.60 (m, 2H, H-3’, H-4’), 1.44 (m, 1H, H-3’), 0.89 (br. s, 6H, H-5’); 
13C NMR (101 MHz, CDCl3) δ 172.0 (CO), 171.9 (CO), 171.8 (CO), 143.8 (q), 141.3 (q), 
136.1 (q), 127.8 (C-5”, C-12” or C-6”, C-11”), 127.1 (C-5”, C-12” or C-6”, C-11”), 125.1 (C-
4” or C-13”), 125.0 (C-4” or C-13”), 123.0 (C-5), 122.2 (C-9), 120.0 (C-7”, C-10”), 119.6 
(C-7), 118.5 (C-8), 111.7 (q), 111.7 (C-10), 109.7 (q), 67.0 (C-1”), 53.5 (C-3), 52.8 (C-2), 
52.4 (OCH3), 47.1 (C-2”), 41.5 (C-3’), 27.6 (C-3), 24.6 (C-4’), 22.9 (C-5’), 21.9 (C-5’); Anal. 
Found C, 70.67; H, 6.67; N, 7.75 C33H35N3O5 requires C, 71.59; H, 6.37; N, 7.59; Chiralcel 









To a stirred solution of 103 (150.3 mg, 0.2715 mmol) in DCM (2 mL) at 0 °C, was added 
piperidine (0.05 mL, 0.5 mmol). After 18 hrs, the solvent was removed in vacuo to give a 
crude product that was purified by column chromatography using MeOH/DCM (10/90) to 
afford 104 as a clear oil (58.0 mg, 64%), [α]20D   + 39.8 (c 1.0, DCM, 91% ee); IR (DCM) 3412 
(NH), 2958, 1740 (CO2Me), 1659 (CO)amide, 1514, 1216 cm−1;1H NMR (400 MHz, CDCl3) δ 
8.27 (br. s, 1H, N-Hindole), 7.71 (d, J = 8.3 Hz, 1H, N-HTrp), 7.55 (m, 1H, H-7), 7.34 (m, 1H, 
H-10), 7.17 (m, 1H, H-9), 7.10 (m, 1H, H-8), 6.99 (s, 1H, H-5), 4.92 (m, 1H, H-2), 3.69 (s, 
3H, OMe), 3.31 (m, 3H, H-3, H-2’), 1.63 (m, 2H, H-4’, H-3’), 1.18 (m, 1H, H-3’), 0.91 (d, J 
= 6.4 Hz, 3H, H-5’), 0.87 (d, J = 6.4 Hz, 3H, H-5’); 13C NMR (101 MHz, CDCl3) δ 175.4 
(CO),172.6 (CO), 136.1 (q), 127.7 (q), 122.6 (C-5), 122.1 (C-9), 119.5 (C-8), 118.7 (C-7), 
111.2 (C-10), 110.4 (q), 53.4 (C-2), 52.7 (C-2’), 52.2 (OCH3), 43.9 (C-3’), 27.8 (C-3), 24.8 
(C-4’), 23.4 (C-5’), 21.3 (C-5’); HRMS (ES): m/z 332.1962 [M + H]+. Calculated for 
C18H26N3O3, 332.1974 [M + H]+; Chiralpak AD 30% isopropyl alcohol/hexane, 1.0 mL/min, 
254 nm, 6.628 min. 
Methyl (tert-butoxycarbonyl)-L-cysteinate (107) 
 
To a stirred suspension of HCl-cys-OMe (1.000 g, 5.827 mmol) in DCM (30 mL) at 0 °C was 
added Boc2O (1.304 g, 5.975 mmol) and NaHCO3 (1.477 g, 17.58 mmol). After 18 hrs water 
(30 mL) was added followed by DCM (3 x 30 mL). The combined organic extracts were 
washed with brine (3 x 90 mL) and dried over anhydrous MgSO4. The solvent was removed 




further purification (1.347 g, 98%), 1H NMR (400 MHz, CDCl3) δ 5.38 (br. s, 1H, N-H), 4.60 




Compound 94 (2.004 g, 8.412 mmol) was dissolved in thionyl chloride (10 mL, 137 mmol) 
and the resulting solution stirred at reflux temperature. After 45 minutes, the thionyl chloride 
was removed under reduced pfressure to give the crude acid chloride that was dissolved in 
DCM (25 mL). Triethylamine (4.5 mL, 33 mmol) was added dropwise to a suspension of 
HCl-L-leucine-OMe (4.583 g, 19.425.25 mmol) in DCM (25 mL) at 0 °C. After 20 minutes 
the solution of free amine was added dropwise to the crude acid chloride, and the resulting 
mixture stirred at r.t. After 1 hour 1M HCl (50 mL) was added and the aqueous layer 
extracted with DCM (3 x 50 mL). The combined organic extracts were dried over anhydrous 
MgSO4 and the solvent evaporated to afford a yellow residue that was purified by column 
chromatography using ethyl acetate/hexane (20/80), to provide 97 as a pale-yellow solid 
(1.352 g, 33%), mp 63–66 °C; [α]20D   + 19.3 (c 1.0, DCM); IR (DCM) 3386 (OH), 3055, 2963, 
1744 (CO2Me), 1660, 1527, 1422, 1266 cm−1; 1H NMR (300 MHz, CDCl3) δ 13.90 (s, 1H, 
OH), 8.11 (d, J = 7.7 Hz, 2H, N-H), 7.92 (s, 2H, H-4’, H-6’), 4.81 (m, 2H, H-2), 3.79 (s, 3H, 
OMe), 1.75 (m, 6H, H-3, H-4), 1.26 (s, 9H, t-Bu), 0.98 (d, J = 4.7 Hz, 6H, H-5), 0.97 (d, J = 
4.7 Hz, 6H, H-5); 13C NMR (75 MHz, CDCl3) δ 173.8 (CO), 167.6 (CO), 158.3 (q), 141.2 
(q), 130.3 (C-4’, C-6’), 116.8 (q), 52.3 (OCH3), 51.3 (C-2,), 41.1 (C-3), 34.3 (q), 31.2 
(C(CH3)3), 25.0 (C-4), 22.8 (C-5), 21.8 (C-5); Anal. Found C, 63.77; H, 8.19; N, 5.37 









Compound 94 (600 mg, 2.52 mmol) was dissolved in thionyl chloride (3 mL, 41 mmol) and 
the resulting solution was stirred at reflux temperature. After 45 minutes, the thionyl chloride 
was removed under reduced pressure to give the crude acid chloride that was dissolved in 
DCM (10 mL). Triethyl amine (1.6 ml, 11 mmol) was added dropwise to a suspension of 
HCl-L-tryptophan-OMe (1.935 g, 7.600 mmol) in DCM (10 mL) at 0 °C. After 20 minutes 
the free amine was added dropwise to the crude acid chloride, and the resulting mixture 
stirred at r.t. After 1 hour 1 M HCl (20 mL) was added and the aqueous layer extracted with 
DCM (3 x 20 mL). The combined organic extracts were dried over anhydrous  MgSO4 and the 
solvent evaporated to afford a yellow residue that was purified by column chromatography 
using ethyl acetate/hexane (50:50), to provide 96 as a pale- yellow solid (992 mg, 62%), mp 
121–124 °C; [α]20D   + 13.5 (c 1.0, CHCl3); IR (DCM) 3413 (OH), 2104, 1729 (CO2Me), 1653, 
1525, 1265 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.22 (s, 2H, N-Hindole), 7.87 (d, J = 6.9 Hz, 
2H, N-Hamide), 7.76 (s, 2H, H-4”, H-6”), 7.57 (d, J = 8.0 Hz, 2H, H-4’), 7.34 (d, J = 8.0 Hz, 
2H, H-7’), 7.17 (td, J = 7.6 Hz, 1.2 Hz, 2H, H-6’), 7.09 (td, J = 7.6 Hz, 1.2 Hz, 2H, H-5’), 
7.06, (d, J = 2.4 Hz, 2H, H-2’), 5.08, (m, 2H, H-2) 3.71 (s, 6H, OMe), 3.43 (d, J = 5.7 Hz, 4H, 
H-3), 1.15 (s, 9H, t-Bu); 13C NMR (101 MHz, CDCl3) δ 172.2 (CO), 167.4 (CO), 158.3 (q), 
141.4 (q), 136.2 (q), 130.2 (C-4”, C-6”), 127.5 (q), 122.9 (C-2’), 122.3 (C-6’), 119.9 (C-5’), 
118.4 (C-4’), 117.0 (q), 111.3 (C-7’), 109.9 (q), 53.6 (C-2), 53.6 (OCH3), 34.1 (q), 31.1 
(C(CH3)3), 27.5 (C-3); HRMS (ES): m/z 639.2817 [M + H]+. Calculated for C36H39N4O7, 









To a stirred solution of 94 (154.4 mg, 0.6481 mmol) and NH2-Leu-Trp-OMe (493.0 mg, 
1.488 mmol) in pyridine (10 mL), at r.t., was added EDC (311.0 mg, 1.622 mmol) followed 
by HOBt (174.8 mg, 1.293 mmol). After 18 hrs 1M HCl (15 mL) was added followed by 
extraction with ethyl acetate (3 x 30 mL). The combined organic extracts were washed with 
1M HCl (3 x 100 mL) and dried over anhydrous MgSO4. The solvent was removed to give a 
yellow residue that was purified by ethyl acetate/hexane (40/60) to afford 97 as a colourless 
solid (377 mg, 60%), mp 124–127 oC; [α]20D   − 9.1 (c 0.28, MeOH); IR (DCM) 3290, 3052, 
1738, 1664, 1368 cm−1; 1H NMR (400 MHz, CDCl3) δ 13.76 (s, 1H, OHphenolic), 8.42 (s, 2H, 
N-Hindole), 7.89 (s, 2H, H-4”’, H-6”’), 7.80 (d, J = 7.8 Hz, 2H, N-HLeu), 7.50 (d, J = 7.7 Hz, 
2H, H-4’), 7.21 (d, J = 7.7 Hz, 2H, H-7’), 7.03 (m, 4H, H-5’, H-6’), 6.98 (s, 2H, H-2’), 6.82 
(d, J = 7.5 Hz, 2H, N-HTrp), 4.93 (m, 2H, H-2), 4.70 (m, 2H, H-2”), 3.68 (s, 6H, OMe), 3.34 
(m, 4H, H-3), 1.73 (m, 6H, H-3”, H-4”), 1.30 (s, 9H, t-Bu), 0.93 (br. s, 6H, H-5”), 0.92 (br. 
s, 6H, H-5”); 13C NMR (101 MHz, CDCl3) δ 172.3 (CO), 171.8 (CO), 167.7 (CO), 158.1 (q), 
141.7 (q), 136.4 (q), 130.2 (C-4”’, C-6”’), 127.6 (q), 123.2 (C-2’), 122.1 (C-5’ or C-6’), 
119.5 (C-5’ or C-6’), 118.4 (C-4’), 117.2 (q), 111.4 (C-7’), 109.5 (q), 53.2 (C-2), 52.3 (C-2”, 
OCH3), 41.0 (C-3”), 34.4 (q), 31.3 (C(CH3)3), 27.6 (C-3’), 25.0 (C-4”), 22.9 (C-5”), 22.1 (C-












Triethylamine (0.52 mL, 3.7 mmol) was added dropwise to stirred solution of Boc-Cys-OMe 
(622 mg, 2.64 mmol), 105 and 106 (320 mg), in DCM (5 mL). After 30 minutes, the solvent 
was removed at reduced pressure to afford a yellow residue that was dissolved in dry MeOH 
(5 mL). To this mixture, K2CO3 (171 mg, 1.24 mmol) was added, and the resulting 
suspension stirred for 30 minutes at −5 °C. The K2CO3 was filtered off and following solvent 
removal the residue purified by column chromatography (ethyl acetate/hexane) (30:70) to 
afford a yellow oil that solidified after drying under vacuum (528 mg, 66%), [α]20D   − 15 (c 1.0, 
DCM); IR (DCM) 3423 (OH), 2958, 1745 (CO2Me), 1713 (Boc), 1504, 1367, 1266 cm−1; 1H 
NMR (400 MHz, CDCl3) δ 7.08 (s, 2H, H-4”, H-6”), 6.67 (s, 1H, OH), 5.37 (br. s, 2H, N-H), 
4.54 (m, 2H, H-2), 3.84 (d, J = 12.9 Hz, 2H, H-1’), 3.79–3.69 (m, 6H, H-1’, OMe), 2.91 (dd, 
J = 14.0, 4.6 Hz, 2H, H-3), 2.76 (dd, J = 14.0, 6.8 Hz, 2H, H-3), 1.44 (s, 18H, 2 x t-Bu), 1.27 
(s, 9H, t-Bu); 13C NMR (101 MHz, CDCl3) δ 171.6 (CO), 155.4 (q), 150.8 (CO), 143.2 (q), 
127.1 (C-4”, C-6”), 123.5 (q), 80.3 (q), 52.9 (C-2), 52.8 (OCH3), 34.2 (C-3), 32.3 (C-1’), 31.4 
(C(CH3)3), 28.3 (C(CH3)3); HRMS (ES): m/z 645.2881 [M + H]+. Calculated for 
C30H49N2O9S2, 645.2880 [M + H] +. 
General Prodedure for the Scandium-ligand-catalysed alcoholysis of cyclohexne oxide: 
To a stirred suspension of Sc(OTf)3 (0.01 mmol) and ligand (0.015 mmol or 0.020 mmol) in 
DCM (5 mL) at −78 °C – and in the cases where a base was used (NEt3 (0.016 mmol) or NaH 
(0.016 mmol)/THF (5 mL)) – was added BnOH (4.1 mmol) followed by cyclohexene oxide 
(1.0 mmol). After 12 hrs an aliquot of the solution was removed and a mini-work-up 
performed using EtOAc (1 mL)/1M HCl (1 mL). This was repeated at −20 °C, 0 °C, and r.t. 
The sample was dried (MgSO4) and the solvent removed and the crude ee evaluated by chiral 
HPLC, Chiralpak AD (4.6 mm x 25 cm), isopropyl alcohol/hexane (10/90), 1.0 mL/min, 254 






To a stirred solution of cyclohexene oxide (210 mg, 2.14 mmol) and BnOH (441 mg, 4.09 
mmol) at 0 °C in DCM (5 mL), was added Sc(OTf)3 (11 mg, 0.022 mmol). After 4 hrs, (sat.) 
NaHCO3 (5 mL) was added followed by DCM (3 x 5 mL). The combined organic layer was 
dried over anhydrous MgSO4 and the solvent removed under reduced pressure to give a crude 
oil that was purified by vacuum distillation to afford the 109 as a pale-yellow oil (71 mg, 
16%), 1H NMR (300 MHz, CDCl3) δ 7.35 (s, 5H, H-Ar), 4.68 (d, J = 12 Hz, 1H, H-1’), 4.48 
(d, J = 12 Hz, 1H, H-1’), 3.56–3.41 (m, 1H, H-1), 3.31–3.12 (m, 1H, H-2), 2.71 (s, 1H, OH), 
2.20–2.08 (m, 1H, H-6), 2.08–1.94 (m, 1H, H-6), 1.79–1.61 (m, 2H, H-3), 1.40–1.10 (m, 4H, 
H-4, H-5).  
cis-2-(benzyloxy)cyclohexan-1-ol (111) 
 
To a stirred solution of cis-1,2-cyclohexanediol (100.5 mg, 0.865 mmol) in THF (3.5 mL) at 
0 °C was added NaH (60%) (27.6 mg, 1.15 mmol). After 20 minutes, BnBr (0.082 mL, 0.69 
mmol) was added. After 2 hrs, water (10 mL) was added, followed by EtOAc (3 x 10 mL). 
The combined organic layer was dried over anhydrous MgSO4, and the solvent removed 
under reduced pressure to give a crude compound that was purified by column 
chromatography suing ethyl acetate/hexane (30/70) to afford 111 as a clear oil (82 mg, 46%), 
1H NMR (300 MHz, CDCl3) δ 7.33 (m, 5H, H-Ar), 4.63 (d, J = 11.8 Hz, 1H, H-1’), 4.52 (d, J 
= 11.8 Hz, 1H, H-1’), 3.87 (m, 1H, H-1), 3.52 (dt, J = 8.1, 3.2 Hz, 2H, H-2), 2.33 (s, 1H, 





5.3 γ-Sustituted Catalysts 
4-(bis-2-hydroxyethyl) aminopyridine (116)145 
 
4-Chloropyridine-HCl (10 g, 0.067 mmol) was dissolved in water (50 mL). NaOH 6M (20 
mL) was added until the pH rose to 14. The free amine was extracted with ethyl acetate (3 x 
70 mL) and the combined organic layers dried over anhydrous MgSO4 to give a brown oil 
that was used in the next step without further purification. 4-Chloropyridine and 
diethanolamine (25 mL, 0.23 mmol) were heated to 180 °C. After 5 hrs the mixture was 
added to a slurry of Na2CO3 (10 g) in 2-propanol (150 mL) and refluxed for 30 minutes. The 
mixture was filtered, washed with 2-propanol, and the solvent removed under reduced 
pressure to give a viscous oil that was purified by vacuum distillation followed by column 
chromatography using MeOH/DCM (10/90) to provide 116 as an orange solid (3.9 g, 32%), 
1H NMR (400 MHz, CD3OD) δ 8.04 (m, H-2, H-6), 6.79 (m, 2H, H-3, H-5), 3.76 (m, 4H, H-
1’, H-1’), 3.64 (m, 4H, H-2, H-2’).  
Methyl tosyl-L-tryptophanate (117)148 
 
To a stirred suspension of 101 (3.26 g, 12.8 mmol) in DCM (50 mL), at 0 °C, was added 
triethylamine (5.35 mL, 38.8 mmol) dropwise over 2 minutes. After 10 minutes, 
toluenesulfonyl chloride (3.67 g, 19.2 mmol) was added. After 90 minutes, water (50 mL) 
was added, the organic layer was separated and washed with brine (50 mL), dried over 
MgSO4 and the solvent removed to give a crude oil that was purified by chromatography 




16.3 (c 1.7, THF) (lit.148 + 17); 1H NMR (400 MHz, CDCl3) δ 8.08 (s, 1H, N-Hindole), 7.61 (m, 
2H, H-2’, H-6’), 7.43 (m, J = 8.0 Hz, 1H, H-7), 7.32 (m, 1H, H-10), 7.16 (m, 3H, H-3’, H-5’, 
H-9), 7.07 (ddd, 1H, J = 8.0, 7.0, 1.0 Hz, H-8), 7.02 (d, 1H, J = 2.3, H-5), 5.15 (d, 1H, J = 





To a stirred solution of 116 (772.3 mg, 4.241 mmol), triphenylphosphine (2.785 g, 10.62 
mmol) and 117 (3.636 g, 9.761 mmol) in DMF (7.0 mL) and THF (1.5 mL), at r.t. was added 
DIAD (2.1 mg, 11 mmol). After 3 hrs, the solvent was removed in vacuo to yield a crude 
residue that was purified by column chromatophraphy using ethyl acetate/hexane (80/20), 
followed by MeOH/DCM (5/95) to afford 112 as a pale-yellow solid (1.325 g, 36%), mp 
106–109 °C; [α]20D   − 30.8 (c 0.51, CHCl3); IR (DCM) 1740, 1642, 1342, 1162 cm
−1; 1H NMR 
(400 MHz, CDCl3) δ 8.59 (s, 2H, N-Hindole), 8.19 (d, J = 5.6 Hz, 2H, H-2’”, H-6’”), 7.62 (d, J 
= 8.3 Hz, 4H, H-2””, H-6””), 7.51 (d, J = 8.1 Hz, 2H, H-4’), 7.31 (d, J = 8.1 Hz, 2H, H-7’), 
7.16 (m, 6H, H-6’, H-3””, H-5””), 7.07 (m, 4H, H-2’, H-5’), 6.64 (d, J = 5.6 Hz, 2H, m, H-
3’”, H-5’”), 4.92 (m, 2H, H-2), 3.53 (m, 15H, H-1”, H-2”, H-3, OMe), 3.17 (m, 1H, m, H-3), 
2.36 (s, 6H, H-7””); 13C NMR (101 MHz, CDCl3) δ 171.4 (CO), 152.5 (q), 149.7 (C-2”’, C-
6’”), 143.7 (q), 136.2 (q), 135.8 (q), 129.5 (C-3””, C-5””), 127.4 (C-2””, C-6””), 127.0 (q), 
123.1 (C-2’), 122.1 (C-6), 119.5 (C-5), 118.3 (C-4), 111.3 (C-7), 109.6 (q), 106.5 (C-3”’, C-
5”’), 59.5 (C-2), 52.0 (OCH3) 50.7 (C-1’) 41.8 (C-2’), 27.0 (C-3), 21.9 (C-7””); HRMS (ES): 





L-Tryrosine methyl ester hydrochloride (119)149  
 
Acetyl chloride (28.0 mL, 329 mmol) was added dropwise to MeOH (220 mL) at 0 °C over 5 
minutes. After 20 minutes L-tyrosine (10.0 g, 55.2 mmol) was added and the resulting 
solution stirred at reflux temperature. After 12 hrs, the solvent was removed at reduced 
pressure to afford a colourless solid (12.3 g, 96%) that was used in the next step without 
further purification, [α]20D   + 68.8 (c 3.0, pyridine) (lit.
150 +76); 1H NMR (400 MHz, CD3OD) δ 
7.08 (m, 2H, H-6, H-8), 6.79 (m, 2H, H-5, H-9), 4.23 (m, 1H, H-2), 3.80 (d, J = 2.9 Hz, 3H, 
OMe), 3.14 (dd, J = 14.5, 6.7 Hz, 2H, H-3). 
Methyl (tert-butoxycarbonyl)-L-tyrosinate (120)149 
 
Di-tert-butyl dicarbonate (5.6 g, 26 mmol) was added to a stirred slurry of 119 (5.0 g, 22 
mmol) and NaHCO3 (2.2 g, 26 mmol) in ethanol (102 mL) at r.t. After 18 hrs the solution 
was filtered and the solvent evaporated to give a crude solid that was purified by column 
chromatography using ethyl acetate/hexane (20/80) to afford 120 as a colourless solid (2.2 g, 
33%), [α]20D   + 51.3 (c 1.0, CHCl3) (lit.
159 + 52.8); 1H NMR (300 MHz, CDCl3) δ 6.96 (m, 2H, 
H-6, H-8), 6.72 (d, J = 8.3 Hz, 2H, H-5, H-9), 5.85 (s, 1H, OH), 5.01 (d, J = 7.5 Hz, 1H, N-











To a stirred solution of 116 (400.0 mg, 2.195 mmol) in DMF (1 mL) and THF (8 mL), were 
added triphenylphosphine (1.444 g, 5.505 mmol), 120 (1.640 g, 5.534 mmol) and DIAD 
(1.08 mL, 5.49 mmol). The resulting mixture heated in a microwave reactor to 100 °C. After 
30 minutes, the solvent was removed in vacuo to yield a crude residue that was purified by 
column chromatography using ethyl acetate/hexane (80/20), followed by MeOH/(5/95) to 
afford 113 as a pale-yellow solid (844 mg, 53%), mp 72–74 °C; [α]20D   + 46.4 (c 0.10, CHCl3); 
IR (CHCl3) 2978, 1847, 1739 (CO2CH3), 1711 (CO)amide, 1597, 1512, 1366 cm−1; 1H NMR 
(400 MHz, CDCl3) δ 8.23 (d, J = 5.8 Hz, 2H, H-2”’, H-6”’), 7.01 (d, J = 8.5 Hz, 4H, H-2’, 
H-6’), 6.78 (d, J = 8.6 Hz, 4H, H-3’, H-5’), 6.61 (d, J = 5.8 Hz, 2H, H-3”’, H-5”’), 4.96 (br. 
s, 2H, N-H), 4.51 (br. s, 2H, H-2), 4.15 (t, J = 5.7 Hz, 4H, H-1”), 3.88 (t, J = 5.7 Hz, 4H, H-
2”), 3.69 (s, 6H, OMe), 3.11–2.89 (m, 4H, H-3), 1.40 (s, 18H, t-Bu); 13C NMR (400 MHz, 
CDCl3) δ 172.3 (CO), 157.5 (CO), 155.7 (q), 152.7 (q), 149.5 (C-2”’, C-6”’), 130.4 (C-3’, C-
5’), 128.7 (q), 114.5 (C-2’, C-6’), 106.8 (C-3”’, C-5”’), 79.9 (C(CH3)3), 65.0 (C-1”), 54.6 (C-
2), 52.2 (OCH3), 50.2 (C-2”), 37.5 (C-3), 28.3 (C(CH3)3); HRMS (ES): m/z 737.3761 [M + 
H]+, Calculated for C39H53N4O10, 737.3762 [M + H] +.  
5.4 β-Substituted Catalysts 
Potassium 4-(pyrrolidino) nicotinate (126)160  
 
To as stirred suspension of 4-chloropyridine-3-carboxylic acid (153 mg, 0.97 mmol) in 
toluene (4 mL), was added pyrrolidine (0.35 mL, 4.2 mmol) and the resulting solution stirred 




mixture concentrated on the rotary evaporator. Saturated K2CO3 (10 mL) was added and the 
mixture stirred for 30 minutes and concentrated. Ethanol was added to the residue, and the 
solution was filtered through Celite ® to remove potassium salts. The ethanol was removed 
and the residue was dissolved in ethanol and filtered through Celite ® again. The solvent was 
removed under reduced pressure to give 126 as a brown solid (211 mg, 95%). The salt was 
used in the next step without further purification. 1H HMR (400 MHz, D2O) δ 7.81 (s, 1H, H-
2), 7.73 (d, J = 6.2 Hz, 1H, H-6), 6.37 (d, J = 6.2 Hz, 1H, H-5), 3.09 (s, 4H, H-7, H-10), 1.68 
(s, 4H, H-8, H-9). 
N-4-Pyrrolidinyl Nicotinamido-L-tryptophan methyl ester (127) 
 
To a stirred solution of salt 126 (65.0 mg, 0.282 mmol) and HCl-Trp-OMe (107.8 mg, 0.423 
mmol), at r.t. in pyridine (1.5 mL) and water (3 drops), were added EDC (108.1 mg, 0.564 
mmol) and HOBt (15.2 mg, 0.112 mmol). After 18 hrs, (sat.) aq. NaHCO3 (10 mL) was 
added and the aqueous layer extracted with ethyl acetate (3 x 15 mL). The combined organic 
extracts were dried over anhydrous MgSO4, and the solvent evaporated to afford a yellow oil 
that was purified by column chromatography using ethyl acetate/hexane (80/20) followed by 
MeOH/DCM (5/95) to provide 127 as a colourless solid (49.0 mg, 44%), mp 214–217 °C; 
[α]20D   − 29.0 (c = 0.13, DCM); IR (DCM) 3289, 2957, 1740 (CO2Me), 1617, 1588 cm
−1; 1H 
NMR (400 MHz, CDCl3) δ 8.16 (s, 1H, H-2’), 8.15 (d, J = 6.1 Hz, 1H, H-6’), 8.09 (s, 1H, N-
Hindole), 7.59 (d, J = 8.0 Hz, 1H, H-7), 7.35 (d, J = 8.0 Hz, 1H, H-10), 7.20 (t, J = 7.2 Hz, 1H, 
H-9), 7.13 (t, J = 7.2 Hz, 1H, H-8), 7.06 (d, J = 2.3 Hz, 1H, H-5), 6.42 (d, J = 6.1 Hz, 1H, H-
5’), 6.32 (d, J = 7.4 Hz, 1H, N-HTrp), 5.12 (d, J = 6.5 Hz, 1H, H-2), 3.76 (s, 3H, OMe), 3.46 
(dd, J = 15.0, 6.0 Hz, 1H, H-3), 3.38 (dd, J = 15.0, 6.0 Hz, 1H, H-3), 3.29–3.14 (m, 4H, H-7’, 
H-10’), 1.91–1.78 (m, 4H, H-8’, H-9’); 13C NMR (400 MHz, CDCl3) δ 172.4 (CO), 171.4 
(CO), 168.6 (q), 150.4 (C-2’),149.6 (C-6’),136.5 (q), 127.6 (q), 122.7 (C-5), 122.6 (C-9), 




(OCH3), 49.4 (C-7’, C-10’), 27.8 (C-3), 25.6 (C-8’, C-9’); HRMS (ES): m/z 393.1928 [M + 
H]+. Calculated for C22H25N4O3, 393.1927 [M + H]+. 
N-4-Pyrrolidinyl Nicotinamido-L-leucine-L-tryptophan methyl ester (128) 
 
Salt 126 (98 mg, 0.426 mmol) and NH2-Leu-Trp-OMe 103 (127 mg, 0.384 mmol) were 
dissolved in pyridine (2.0 mL) and water (3 drops) at r.t. EDC (as its hydrochloride) (112 mg, 
0.587 mmol) and HOBt (21 mg, 0.16 mmol) were then added. After 12 hrs, (sat.) aq. 
NaHCO3 (10 mL) was added and the aqueous layer extracted with ethyl acetate (3 x 15 mL). 
The combined organic extracts were dried over anhydrous MgSO4 and the solvent evaporated 
to afford a yellow oil that was purified by column chromatography using ethyl acetate/hexane 
(80/20) followed by MeOH/DCM (5/95) to provide 128 as a pale-yellow solid (85 mg, 44%), 
mp 102–105 °C; [α]20D   − 5.8 (c 0.12, DCM); IR (DCM) 3289, 2957, 1742 (CO2Me), 1640, 
1593, 1510 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.48 (s, 1H, N-Hindole), 8.14 (d, J = 6.1 Hz, 
1H, H-6”), 8.12 (s, 1H, H-2”), 7.53 (d, J = 7.9 Hz, 1H, H-7), 7.30 (d, J = 7.9 Hz, 1H, H-10), 
7.20–7.02 (m, 3H, H-5, H-8, H-9), 6.73 (d, J = 7.8 Hz, 1H, N-HTrp), 6.45 (s, 1H, N-HLeu), 6.43 
(d, J = 6.1 Hz, 1H, H-5”), 4.91 (m, 1H, H-2), 4.57 (m, 1H, H-2’), 3.68 (s, 3H, OMe), 3.32 (d, 
J = 5.6 Hz, 2H, H-3), 3.25 (m, 4H, H-7”, H-10”), 1.85 (m, 4H, H-8”, H-9”), 1.77–1.54 (m, 
3H, H-3’, H-4’), 0.93 (m, 6H, H-5’); 13C NMR (400 MHz, CDCl3) δ ; 171.9 (CO), 171.4 
(CO), 169.0 (CO), 150.5 (C-6”), 150.0 (q), 149.1 (C-2”), 136.2 (q), 127.5 (q), 123.4 (C-5 or 
C-9), 122.1 (C-5 or C-9), 119.6 (C-8), 118.4 (C-7), 117.2 (q), 111.4 (C-10), 109.5 (q), 108.6 
(C-5”), 52.9 (C-2), 52.4 (C-2’, OCH3), 49.5 (C-7”, C-10”), 40.9 (C-3’), 27.6 (C-3), 25.5 (C-
8”, C-9”), 24.9 (C-4’), 22.9 (C-5’), 21.9 (C-5’); HRMS (ES); m/z 506.2767 [M + H]+. 
Calculated for C28H36N5O4, 506.2767 [M + H]+; Chiralpak AD 30% isopropyl 








To a stirred solution of Fmoc-Leu-OH (748.6 mg, 2.118 mmol) and HCl-Leu-OMe 100 
(577.0 mg, 3.160 mmol) in pyridine (10 mL), at r.t., was added DCC (570.0 mg, 2.796 mmol) 
followed by HOBt (288.1 mg, 2.132 mmol). After 18 hrs, 1M HCl (20 mL) was added 
followed by an extraction with ethyl acetate (3 x 20 mL). The combined organic extracts 
were washed with 1M HCl (3 x 60 mL), dried over anhydrous MgSO4 and the solvent 
removed to give a yellow residue that was purified by ethyl acetate/hexane (40/60) to afford 
136 as a colourless oily solid (818.2 mg, 80%), mp 111–113 °C; [α]20D   − 39.2 (c 0.52, MeOH); 
IR (CHCl3) 3321 (NH), 1742 (CO2Me), 1674 (CO)amide cm−1; 1H NMR (400 MHz, CDCl3) δ 
7.75 (dd, J = 7.6, 0.6 Hz, 2H, H-7”, H-13”, or H-4”, H-10”), 7.58 (d, J = 7.5 Hz, 2H, H-7”, 
H-13”, or H-4”, H-10”), 7.39 (t, J = 7.5 Hz, 2H, H-5”, H-12”, or H-6”, H-11”), 7.29 (m, J = 
7.4, 1.3 Hz, 2H, H-5”, H-12”, or H-6”, H-11”), 6.54 (d, J = 6.7 Hz, 1H, N-HLeu), 5.41 (d, J = 
7.9 Hz, 1H, N-HLeu), 4.61 (td, J = 8.6, 5.2 Hz, 1H, H-2 or H-2’), 4.41 (m, 2H, H-1” ), 4.26 
(m, 1H, H-2 or H-2’), 4.20 (m, 1H, H-2”), 3.71 (s, 3H, OMe), 1.63 (m, 6H, H-3, H-3’, H-4, 
H-4’), 0.95 (m, 6H, H-5 or H-5’), 0.90 (d, J = 3.1 Hz, 3H, H-5 or H-5’), 0.89 (d, J = 3.3 Hz, 
3H, H-5 or H-5’); 13C NMR (101 MHz, CDCl3) δ 173.1 (CO), 172.0 (CO), 156.2 (CO), 143.8 
(q), 143.7 (q), 127.7 (C-10”, C-7” or C-4, C-13”), 127.0 (C-10”, C-7” or C-4”, C-13”), 125.0 
(C-5”, C-12” or C-6”, C-11”), 119.9 (C-5”, C-12” or C-6”, C-11”), 67.1 (C-1”), 53.4 (C-2 or 
C-2’), 52.2 (OCH3), 50.7 (C-2 or C-2’), 47.1 (C-2”), 41.5 (C-3, C-3’), 41.4 (C-3, C-3’), 24.8 
(C-4 or C-4’), 24.6 (C-4, C-4’), 22.8 (C-5 or C-5’), 22.7 (C-5 or C-5’), 22.0 (C-5 or C-5’), 
21.9 (C-5 or C-5’); Anal. Found C, 69.58; H, 7.40; N, 5.53 C28H36N2O5 requires C, 69.98; H, 









To a stirred solution of 136 (1.163 g, 2.421 mol) in DCM (10 mL) was added piperidine (0.5 
mL, 5.0 mmol) at 0 °C. After 18 hrs the solvent and piperidine were removed to give a crude 
residue that was purified column chromatography using MeOH/DCM (5/95) to afford the title 
compound as a clear oil (337.7 mg, 54%), 1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 8.1 Hz, 
1H, N-HLeu), 4.61 (m, 1H, H-2), 3.73 (s, 3H, OMe), 3.43 (m, 1H, H-2’), 1.79–1.54 (m, 5H, H-
3, H-4, H-3’, H-4’), 1.39–1.28 (m, 1H, H-3’), 0.98–0.90 (m, 12H, H-5, H-5’); 13C NMR (101 
MHz, CDCl3) δ 175.4 (CO), 173.6 (CO), 53.5 (C-2’), 52.1 (OCH3), 50.3 (C-2), 44.1 (C-3’), 
41.5 (C-3), 24.9 (C-4 or C-4’), 24.8 (C-4 or C-4’), 23.3 (C-5 or C-5’), 22.8 (C-5 or C-5’), 
21.9 (C-5 or C-5’), 21.4 (C-5 or C-5’). 
N-4-Pyrrolidinyl nicotinamido-L-leucine-L-leucine methyl ester (138) 
 
To a stirred solution of salt 126 (451.6 mg, 1.961 mmol) and 137 (337.7 mg, 1.307 mmol) in 
pyridine (5 mL) and water (0.5 mL), at r.t., was added EDC (326.0 mg, 1.700 mmol) 
followed by HOBt (212.0 mg, 1.569 mmol). After 18 hrs NaHCO3 (10 mL) was added 
followed by ethyl acetate (3 x 15 mL). The combined organic extracts dried over anhydrous 
MgSO4 and the solvent removed to give a yellow residue that was purified by column 
chromatography using MeOH/DCM (8/92) to afford 138 as a pale-yellow oil (151.2 mg, 
27%), [α]20D   − 25.3 (c 0.51, CHCl3); IR (CHCl3) 3420 (NH), 3022 (NH), 1742 (CO)ester, 1644 
(CO)amide cm−1; 1H NMR (400 MHz, CDCl3) δ 8.26 (s, 1H, H-2”), 8.13 (s, 1H, H-6”), 6.86 




2H, H-2, H-2’), 3.72 (s, 3H, OMe), 3.30 (m, 4H, H-7”, H-10”), 1.94 (m, 4H, H-8”, H-9”), 
1.52–1.80 (m, 6H, H-3, H-4, H-3’, H-4’ ), 0.97 (d, J = 6.2 Hz, 3H, H-5 or H-5’), 0.95 (d, J = 
6.2 Hz, 3H, H-5 or H-5’), 0.92 (d, J = 2.5 Hz, 3H, H-5 or H-5’), 0.91 (d, J = 2.5 Hz, 3H, H-5 
or H-5’); 13C NMR (101 MHz, CDCl3) 173.1 (CO), 171.6 (CO), 168.8 (CO), 150.2 (q), 149.3 
(C-2”), 148.7 (C-6”), 117.4 (q), 108.6 (C-5”), 52.4 (C-2 or C-2’), 52.2 (OCH3), 50.8 (C-2 or 
C-2’), 49.5 (C-7”, C-10”), 41.5 (C-3 or C-3’), 41.0  (C-3 or C-3’), 25.5 (C-8”, C-9”), 24.9 (C-
4 or C-4’), 24.8 (C-4 or C-4’), 22.9 (C-5 or C-5’), 22.8 (C-5 or C-5’), 22.0 (C-5 or C-5’), 21.9 
(C-5 or C-5’); HRMS (ES): m/z 433.2810 [M + H]+. Calculated for C23H37N4O4, 433.2814 
[M + H]+; Chiralpak AD 30% isopropyl alcohol/hexane, 1.0 mL/min, 254 nm, 7.651 min;. 
Boc-Trp-Trp-OMe (142)161  
 
To a stirred solution of 101 (460.1 mg, 1.807 mmol) and N-Boc-Trp-OH (500.3 mg, 1.664 
mmol) in pyridine (6.5 mL), at r.t., was added EDC (347.6 mg, 1.813 mmol) followed by 
HOBt (91.0 mg, 0.673 mmol). After 18 hrs 1M HCl (15 mL) was added followed by ethyl 
acetate (3 x 15 mL). The combined organic extracts were washed with 1M HCl (3 x 45 mL) 
and dried over anhydrous MgSO4. The solvent was removed to give a yellow residue that was 
purified by ethyl acetate/hexane (40/60) to afford 142 as a colourless solid (674 mg, 81%), 
[α]20D   − 20.5 (c 1.0, MeOH) (lit.
161 [α]25D   − 15 (c 0.9, MeOH); 
1H NMR (400 MHz, CDCl3) δ 
7.88 (s, 1H, N-Hindole), 7.86 (s, 1H, N-Hindole), 7.65 (d, J = 7.8 Hz, 1H, H-7 or H-7’), 7.30 (m, 
3H, Ar-H), 7.22–7.09 (m, 3H, Ar-H), 6.97 (t, J = 7.5 Hz, 1H, Ar-H), 6.90 (s, 1H, H-5 or H-
5’), 6.65 (s, 1H, H-5 or H-5’), 6.24 (d, J = 7.6 Hz, 1H, N-H), 5.01 (s, 1H, N-H), 4.82 (dd, J = 
13.4, 5.6 Hz, 1H, H-2 or H-2’), 4.43 (dd, J = 12.8, 7.4 Hz, 1H, H-2 or H-2’), 3.60 (s, 3H, 





NH2-Trp-Trp-OMe (143)153  
 
To a stirred suspension of 142 (358 mg, 0.710 mmol) and anisole (0.23 mL, 2.1 mmol) in 
DCM (5.5 mL), at 0 °C was added TFA (1.4 mL). After 2 hrs aqueous NaHCO3 (15 mL) was 
added with cooling until a pH of 8 was reached. The organic layer was separated and the 
aqueous layer was washed with DCM (2 x 15 mL). The combined organic extracts were dried 
over anhydrous MgSO4 and the solvent was removed to give a yellow residue that was 
purified by MeOH/DCM (10/90) to afford 143 as a colourless solid (286 mg, 99%), [α]20D   − 
15.2 (c 0.5, MeOH) (lit.153 [α]25D   − 11.0 (c 0.75, MeOH); 
1H NMR (400 MHz, CDCl3) δ 8.37 
(s, 1H, N-Hindole), 8.25 (s, 1H, N-Hindole), 7.79 (d, J = 8.3 Hz, 1H, Ar-H), 7.58 (d, J = 7.9 Hz, 
1H, Ar-H), 7.39 (d, J = 7.9 Hz, 1H, Ar-H), 7.31 (d, J = 4.3 Hz, 1H, Ar-H), 7.16 (m, 2H, Ar-
H), 7.09 (m, 1H, Ar-H), 7.01 (m, 1H, Ar-H), 6.79 (m, 1H, H-5 or H-5’), 6.69 (d, 1H, J = 2.3 














To a stirred solution of 143 (233.5 mg, 0.5773 mmol) and N-Boc-Leu-OMe (200.1 mg, 
0.8651 mmol) in pyridine (3.0 mL), at r.t., were added EDC (168.7 mg, 0.8800 mmol) and 
HOBt (36.0 mg, 0.266 mmol). After 18 hrs, 1M HCl (15 mL) was added and the aqueous 
layer extracted with ethyl acetate (3 x 15 mL). The combined organic extracts were washed 
with 1M HCl (3 x 50 mL), dried over anhydrous MgSO4, and the solvent evaporated to afford 
a yellow oil that was purified by column chromatography using ethyl acetate/hexane (50/50) 
to provide 144 as a colourless solid (218 mg, 61%), mp 107–109 °C; [α]20D   − 23.2 (c 1.0, 
MeOH); IR (DCM) 3313 (NH), 1741 (CO2Me), 1649 (CO)amide, 1169 (C-N) cm−1; 1H NMR 
(400 MHz, CDCl3) δ 8.07 (s, 1H, N-Hindole), 7.90 (s, 1H, N-Hindole), 7.70 (d, J = 7.8 Hz, 1H, 
H-7 or H-7’), 7.31 (m, 3H), 7.19 (m, 1H), 7.13 (m, 2H), 7.01 (t, J = 7.5 Hz, 1H), 6.96 (s, 1H, 
H-5 or H-5’), 6.68 (d, J = 7.7 Hz, 1H, N-HTrp), 6.66 (s, 1H, H-5 or H-5’), 6.26 (d, J = 7.4 Hz, 
1H, N-HTrp), 4.77 (m, 1H, H-2 or H-2’), 4.70 (m, 1H, H-2 or H-2’), 4.65 (d, J = 8.0 Hz, 1H, 
N-HLeu), 4.05 (m, 1H, H-2”), 3.61 (s, 3H, OMe), 3.32 (dd, J = 14.6, 6.6 Hz, 1H, H-3 or H-3’), 
3.15 (d, J = 5.7 Hz, 2H, H-3 or H-3’), 3.10 (dd, J = 14.6, 6.6 Hz, 1H, H-3 or H-3’), 1.55 (m, 
2H, H-3”, H-4”), 1.43 (s, 9H, t-Bu), 1.27 (m, 1H, H-3”), 0.86 (d, J = 6.3 Hz, 3H, H-5”), 0.85 
(d, J = 6.3 Hz, 3H, H-5”); 13C NMR (400 MHz, CDCl3) δ 172.4 (CO), 171.7 (CO), 170.6 
(CO), 155.6 (CO), 136.4 (q), 136.3 (q), 127.7 (q), 127.5 (q), 123.6 (C-5 or C-5’), 123.2 (C-5 
or C-5’), 122.3, 122.2, 119.9 (C-7 or C-7’), 119.6, 119.1, 118.6, 111.2 (q), 109.8 (q), 80.3 (q), 
53.8 (C-2 or C-2’, C-2”), 52.8 (C-2 or C-2’), 52.1 (OCH3), 41.5 (C-3”), 28.4 (C(CH3)3), 28.0 
(C-3 or C-3’), 27.6 (C-3 or C-3’), 24.9 (C-4”), 22.9 (C-5”), 21.8 (C-5”); Chiralpak AD 30% 
isopropyl alcohol/hexane, 1.0 mL/min, 254 nm, 6.185 min; Anal. Found C, 65.94; H, 7.06; N, 







To a stirred suspension of 144 (216 mg, 0.350 mmol) and anisole (0.11 mg, 1.0 mmol) in 
DCM (2.8 mL), at 0 °C, was added TFA (0.7 mL) dropwise over 1 minute. After 2 hrs, (sat.) 
NaHCO3 (10 mL) was added, with cooling, until a pH of 8 was reached. The aqueous layer 
was extracted with DCM (3 x 10 mL), the combined organic extracts dried over anhydrous 
MgSO4, and the solvent evaporated to afford an orange oil that was purified by column 
chromatography using ethyl acetate/hexane (50/50) followed by MeOH/DCM (10/90), to 
give 145 as a pale-yellow oily-solid (180 mg, 99%), [α]20D   + 3 (c 0.10, CHCl3); IR 3308, 2956, 
1739 (CO2CH3), 1657 (CO)amide,1458, 1343, 1216; 1H NMR (400 MHz, CDCl3) δ 8.09 (s, 
1H, N-Hindole), 7.98 (s, 1H, N-Hindole), 7.72 (d, J = 8.0 Hz, 1H, N-HTrp), 7.68 (d, J = 7.9 Hz, 
1H, Ar-H), 7.30 (t, J = 7.9 Hz, 3H, Ar-H), 7.21–7.05 (m, 3H, Ar-H), 6.96 (m, 2H, Ar-H), 6.68 
(d, J = 1.9 Hz, 1H, Ar-H), 6.43(d, J = 7.5 Hz, H, N-HTrp), 4.80 (m, 1H, H-2 or H-2’), 4.73 (m, 
1H, H-2 or H-2’), 3.62 (s, 3H, OMe), 3.32–3.06 (m, 5H, H-3, H-3’, H-2”), 1.62 (br. s, 3H, 
NH2, H-4”), 1.49(m, 1H, H-3”), 1.11(m, 1H, H-3”), 0.85 (d, J = 6.4 Hz, 3H, H-5), 0.80 (d, J 
= 6.4 Hz, 3H, H-5); 13C NMR (400 MHz, CDCl3) δ 175.6 (CO), 171.9 (CO), 171.2 (CO), 
136.2 (q), 136.0 (q), 127.6 (q), 127.4 (q), 123.4 (C-5 or C-5’), 123.2 (C-5 or C-5’), 122.1, 
122.0, 119.6, 119.5, 119.1, 118.5, 111.2, 111.1, 110.8 (q), 109.6 (q), 53.4 (C-2”), 52.7 (C-2, 
C-2’), 52.3 (OCH3), 43.6 (C-3”), 27.9 (C-3 or C-3’), 27.4 (C-3 or C-3’), 24.7 (C-4”), 23.3 (C-










To a stirred solution of 126 (78 mg, 0.339 mmol), and 145 (160 mg, 0.309 mmol) in pyridine 
(5 mL) and water (5 drops), at r.t., were added EDC (71 mg, 0.37 mmol) and HOBt (20 mg, 
0.15 mmol). After 12 hrs, (sat.) NaHCO3 (20 mL) was added and the aqueous layer extracted 
with DCM (3 x 20 mL). The combined organic extracts were dried over anhydrous MgSO4 
and the solvent evaporated to afford a yellow oil that was purified by column 
chromatography using ethyl acetate/hexane (20/80) followed by MeOH/DCM (8/92) to 
provide 139 as a pale-yellow solid (113 mg, 53%), mp 136–138 °C; [α]20D   − 46.0 (c 0.28, 
DCM); IR (DCM) 1738, 1648 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.52 (s, 1H, N-Hindole), 
8.49 (s, 1H, N-Hindole), 8.03 (d, J = 6.2 Hz, 1H, H-6”’), 7.98 (s, 1H, H-2”’), 7.63 (d, J = 7.9 
Hz, 1H, Ar-H), 7.30 (t, J = 7.3 Hz, 2H Ar-H), 7.22 (d, J = 8.0 Hz, 1H, Ar-H), 7.04 (m, 6H, 4 
x Ar, N-HTrp, H-5 or H-5’), 6.80 (s, 1H, N-HLeu), 6.71 (s, 1H, N-HTrp), 6.56 (s, 1H, H-5 or H-
5’), 6.37 (d, J = 6.2 Hz, 1H, H-5”’), 4.82 (m, 1H, H-2 or H-2’), 4.73 (m, 1H, H-2 or H-2’), 
4.55 (m, 1H, H-2”), 3.59 (s, 3H, OMe), 3.19 (m, 8H, H-3, H-3’, H-7”’, H-10”’), 1.81 (m, 
4H, H-8’”, H-9”’), 1.66–1.42 (m, 3H, H-3”, H-4”), 0.87–0.80 (2 x d, J = 6.0 Hz, 6H, H-5”); 
13C NMR (400 MHz, CDCl3) δ 171.9 (CO), 171.8 (CO), 170.8 (CO), 168.8 (CO), 150.2 (q), 
148.9 148.3 136.2 (q), 136.1 (q), 127.4 (q), 127.2 (q), 123.8 (C-5 or C-5’), 123.2 (C-5 or C-
5’), 122.0, 121.9, 119.6, 119.3, 118.8,118.3, 117.2 (q), 111.5, 111.3, 109.9 (q), 109.4 (q), 
108.6 (C-5”’), 53.5 (C-2 or C-2’), 52.9 (C-2 or C-2’), 52.8 (C-2”), 52.3 (OCH3), 49.5 (C-7”’, 
C-10”’), 40.8 (C-3”), 28.0 (C-3 or C-3’), 27.4 (C-3 or C-3’), 25.4 (C-8”’, C-9”’), 25.0 (C-4”), 








To a stirred solution of HCl-Leu-OMe (575 mg, 3.17 mmol) and Boc-Trp-OH (800 mg, 2.63 
mmol), in pyridine (10 mL) at r.t., were added EDC (756 mg, 3.94 mmol) and HOBt (180 
mg, 1.33 mmol). After 18 hrs, 1M HCl (5 mL) was added and the aqueous extracted with 
ethyl acetate. The combined organic extracts were washed with 1M HCl and dried over 
anhydrous MgSO4 to give a crude product that was purified by column chromatography using 
ethyl acetate/hexane to yield 147 as a colourless solid (966 mg, 85%); [α]20D   − 29.4 (c 0.49, 
MeOH); 1H NMR (300 MHz, CDCl3) δ 8.12 (s, 1H, N-Hindole), 7.67 (m, 1H, H-7’), 7.35 (m, 
1H, H-10’), 7.24–7.06 (m, 3H, H-8’, H-9’, H-5’), 6.18 (d, J = 8.0 Hz, 1H, N-H), 5.14 (s, 1H, 
N-H), 4.52 (m, 1H, H-2’), 4.42 (m, 1H, H-2), 3.64 (s, 3H, OMe), 3.30–3.19 (m, 2H, H-3’), 




To a stirred solution of anisole (0.27 mL, 2.5 mmol), in 30% TFA/DCM (10 mL) at 0 °C was 
added 147 (533.8 mg, 1.237 mmol). After 2 hrs, sat. NaHCO3 (25 mL) was added until a pH 
of approximately 9 was reached. The aqueous layer was washed with DCM (3 x 25 mL), the 
combined organic extracts were dried over anhydrous MgSO4, and the solvent removed under 




MeOH/DCM (10/90) to afford 148 as a clear oil (238 mg, 58%); [α]20D   − 6.0 (c 0.50, MeOH) 
(lit.154 [α]20D   − 1.2 (c 0.50, MeOH); 
1H NMR (300 MHz, CDCl3) δ 8.71 (s, 1H, N-Hindole), 7.70 
(d, J = 8.4 Hz, 1H, N-HTrp), 7.64 (d, J = 8.0 Hz, 1H, H-7’), 7.36 (d, J = 8.0 Hz, 1H, H-10’), 
7.18 (m, 1H, H-9’), 7.09 (m, 1H, H-8’), 7.05 (d, J = 2.4 Hz, 1H, H-5’), 4.62 (m, 1H, H-2’), 
3.71 (m, 4H, H-2, OMe), 3.37 (dd, J = 14.5, 4.1Hz, 1H, H-3’), 2.92 (dd, J = 14.5, 9.0 Hz, 1H, 
H-3’), 1.65–1.49 (m, 3H, H-3, H-4), 0.91 (m, 6H, H-5).  
Fmoc-Leu-Trp-Leu-OMe (149) 
 
To a stirred solution of 148 (482.0 mg, 1.454 mmol) and Fmoc-Leu-OMe (666.2 mg, 1.885 
mmol), in pyridine (6 mL), at r.t., were added EDC (408.3 mg, 2.130 mmol) and HOBt 
(196.0 mg, 1.450 mmol). After 18 hrs, 1M HCl (10 mL) was added followed by ethyl acetate 
(3 x 10 mL). The combined organic extracts were washed with 1M HCl (3 x 50 mL) and 
dried over anhydrous MgSO4 to give a crude product that was purified by column 
chromatography using ethyl acetate/hexane (40/60) to afford 149 as a pale-yellow solid 
(584.2 mg, 60%), mp 170–172 °C; [α]20D   − 39.5 (c 0.57, CHCl3); 
1H NMR (300 MHz, CDCl3) 
δ 7.93 (s, 1H, N-Hindole), 7.78 (d, J = 7.4 Hz, 2H, H-6”’, H-7”’), 7.76 (m, 1H, H-7’), 7.56 (d, 
J = 7.4 Hz, 1H, H-3”’, H-10”’), 7.41 (m, 2H, H-9”’, H-4”’), 7.31 (m, 2H, H-5”’, H-8”’), 
7.24 (m, 1H, H-10’), 7.14 (ddd, J = 8.1, 7.1, 1.3 Hz, 1H, H-9’), 7.08 (ddd, J = 8.1, 7.1, 1.3 
Hz, 1H, H-9’), 7.04 (d, J = 2.3 Hz, 1H, H-5’), 6.62 (s, 1H, N-HTrp), 6.20 (d, J = 7.9 Hz, 1H, 
N-HLeu), 4.98 (d, J = 8.0 Hz, 1H, N-HLeu), 4.72 (m, 1H, H-2’), 4.48 (m, 1H, H-2 or H-2’), 
4.42 (m, 1H, H-1”’), 4.31 (m, 1H, H-1”’), 4.18 (t, J = 6.8 Hz, 1H, H-2”’), 4.13 (m, 1H, H-2, 
H-2’), 3.66 (s, 3H, OMe), 3.30 (dd, J = 14.7, 7.5 Hz, 1H, H-3’), 3.18 (dd, J = 14.7, 7.5 Hz, 
1H, H-3’), 1.59–1.34 (m, 6H, H-3, H-3” and H-4, H-4”), 0.89 (m, 6H, H-5 or H-5”), 0.82 
(m, 6H, H-5 or H-5”); 13C NMR (400 MHz, CDCl3) δ 172.7 (CO), 172.0 (CO), 170.7 (CO), 
143.9 (q), 141.4 (q), 136.4 (q), 127.8 (C-4”’, C-9”’), 127.5 (q), 127.1 (C-5”’, C-8”’), 125.1 




119.9 (C-8’), 118.9 (C-7’) 111.2 (C-10’), 110.7 (q), 67.1 (C-1”’), 53.9 (C-2 or C-2”), 53.8 
(C-2’), 52.1 (OCH3), 51.1 (C-2, C-2”), 47.3 (C-2”’), 41.5 (C-3, C-3”), 27.9 (C-3’), 24.8 (C-4, 
C-4”), 24.8(C-4, C-4”), 22.9 (C-5, C-5”), 22.6 (C-5, C-5”), 22.0 (C-5, C-5”), 21.9 (C-5, C-
5”); HRMS (ES): m/z 667.3508 [M + H]+. Calculated for C39H47N6O6, 667.3496 [M + H]+; 
Chiralpak AD 30% isopropyl alcohol/hexane, 1.0 mL/min, 254 nm, 4.701 min; 
NH2-Leu-Trp-Leu-OMe (150)  
 
To a stirred solution of 149 (173.6 mg, 0.261 mmol) in DCM (2 mL) at 0 °C, was added 
piperidine (0.06 mL, 0.6 mmol). After 18 hrs, the solvent was removed in vacuo to give a 
crude product that was purified by column chromatography using MeOH/DCM (10/90) to 
afford 150 as a colourless solid (84.3 mg, 61%), mp 118–120 °C; [α]20D   − 37.8 (c 0.51, 
CHCl3); IR (CHCl3) 3020 (NH2), 1772 (CO2Me), 1659 (CO)amide, 1516 (NH) cm−1; 1H NMR 
(300 MHz, CDCl3) δ 8.57 (s, 1H, N-Hindole), 7.83 (d, J = 8.1 Hz, 1H, N-HTrp), 7.73–7.68 (d, J 
= 8.1 Hz, 1H, H-7’), 7.34 (d, J = 8.1 Hz, 1H, H-10’), 7.17 (m, 1H, H-9’), 7.14–7.07 (m, 2H, 
H-5’, H-8’), 6.39 (d, J = 7.9 Hz, 1H, N-HLeu), 4.76 (m, 1H, H-2’), 4.49 (m, 1H, H-2), 3.65 (s, 
3H, OMe), 3.34 (dd, J = 9.6, 4.1 Hz, H-2”), 3.30–3.17 (m, 2H, H-3’), 1.59–1.38 (m, 6H, H-3, 
H-3”, H-4, H-4”), 1.18 (m, 1H, H-3,or H-3”), 0.89 (d, J = 6.4 Hz, 3H, H-5 or H-5”), 0.87 (d, 
J = 6.4 Hz, 3H, H-5, H-5”), 0.84 (m, 6H, H-5, H-5”); 13C NMR (400 MHz, CDCl3) δ 175.7 
(CO), 172.9 (CO), 171.2 (CO), 136.2 (q), 127.6 (q), 123.3 (C-5’), 122.1 (C-9), 119.6 (C-8’), 
119.0 (C-7’), 111.1 (C-10), 110.9 (q), 53.6 (C-2’) 53.5 (C-2, C-2”), 52.2 (OCH3) 51.0 (C-2, 
C-2”), 43.8 (C-3 or C-3”), 41.4 (C-3 or C-3”), 27.9 (C-3’), 24.8 (C-4, C-4”), 23.3 (C-5, C-
5”), 22.6 (C-5, C-5”), 22.0 (C-5, C-5”), 21.4 (C-5, C-5”); HRMS (ES): m/z 445.2815 [M + 
H]+. Calculated for C24H37N4O4, 445.2815 [M + H]+; Chiralpak AD 30% isopropyl 






N-4-Pyrrolidinyl nicotinamido-L-leucine-L-tryptophan-L-leucine methylester (140) 
 
 
To a stirred solution of 107 (160 mg, 0.694 mmol) and 126 (365 mg, 0.821 mmol), in 
pyridine (5 mL) and DCM (4 mL), at r.t., were added EDC (200 mg, 1.04 mmol) followed by 
HOBt (47 mg, 0.35 mmol). After 12 hrs, (sat.) NaHCO3 (20 mL) was added and the aqueous 
layer extracted with DCM (3 x 20 mL). The combined organic extracts were dried over 
anhydrous MgSO4 and the solvent evaporated to afford a yellow oil that was purified by 
column chromatography using ethyl acetate/hexane (80/20), followed by MeOH/DCM (5/95) 
to provide 140 as a pale-yellow solid (188 mg, 44 %), mp 186–189 °C; [α]20D   − 54.7 (c 0.5, 
CH3OH); IR (DCM) 1741 (CO2Me), 1641 (CO)amide cm−1; 1H NMR (400 MHz, CDCl3) δ 
8.60 (s, 1H, N-Hindole), 8.11 (d, J = 6.2 Hz, 1H, H-6”’), 8.05 (s, 1H, H-2”’), 7.62 (d, J = 8.1 
Hz, 1H,  H-7’), 7.30 (d, J = 8.1 Hz, 1H, H-10’), 7.13 (t, J = 7.1 Hz, 1H, H-9’), 7.09 (d, J = 
2.2 Hz, 1H, H-5’), 7.05 (t, J = 7.1 Hz, 1H, H-8’), 6.93 (d, J = 7.9 Hz, 1H, N-HTrp), 6.84 (d, J 
= 7.9 Hz, 1H, N-HLeu), 6.73 (d, J = 7.9 Hz, 1H, N-HLeu), 6.40 (d, J = 6.2 Hz, 1H, H-5”’), 4.81 
(m, 1H, H-2’), 4.60 (m, 1H, H-2 or H-2”), 4.47 (m, 1 H, H-2 or H-2”), 3.63 (s, 1H, OMe), 
3.21 (m, 6H,  H-3’, H-7”’, H-10”’), 1.84 (m, 4H,  H-8”’, H-9”’), 1.65 (m, 3H, H-3, H-3”, H-
4 or H-4”), 1.44 (m, 3H, H-3, H-3”, H-4 or H-4”), 0.93 (m, 6H, H-5 or H-5”), 0.82 (d, J = 
6.1 Hz, 3H, H-5 or H-5”), 0.79 (d, J = 6.1 Hz, 3H, H-5 or H-5”); 13C NMR (400 MHz, 
CDCl3) δ 172.9 (CO), 171.7 (CO), 170.9 (CO), 168.8 (CO), 150.1 (q), 149.4 (C-6”’), 148.7 
(C-2”’), 136.3 (q), 127.4 (q), 123.5 (C-5’), 122.0 (C-9’), 119.5 (C-8’), 118.7 (C-7’), 117.2 
(q), 111.4 (C-10’), 110.1 (q), 108.6 (C-5”’), 53.4 (C-2’), 52.5 (C-2 or C-2”), 52.1 (OCH3), 
51.0 (C-2 or C-2”), 49.5 (C-7”’, C-10”’), 41.1 (C-3 or C-3”), 28.1 (C-3’), 25.5 (C-8”’ and C-
9”’), 25.0 (C-4 or C-4”), 24.8 (C-4 or C-4”), 23.0 (C-5 or C-5”), 22.6 (C-5 or C-5”), 21.8 (C-
5 or C-5”); HRMS (ES): m/z 619.3606 [M + H]+. Calculated for C34H47N6O5, 619.3608 [M + 





methyl ester (141) 
 
To a stirred solution of 128 (72 mg, 0.14 mmol) in THF (4 mL), was added di-tert-butyl 
dicarbonate (45 mg, 0.21 mmol). After 5 hrs, (sat.) NaHCO3 (10 mL) was added and the THF 
removed in vacuo. The aqueous layer was extracted with ethyl acetate (3 x 10 mL), the 
combined organic extracts were dried over anhydrous MgSO4 and the solvent evaporated to 
afford a yellow oil that was purified by column chromatography using MeOH/DCM (5/95) to 
provide 141 as a pale-yellow solid (44 mg, 51%), mp 102–104 °C; [α]20D   − 4.5 (c 0.5, CHCl3, 
92% de); IR (DCM) 3420 (NH), 1736 (CO2Me), 167 (CO)amide cm−1; 1H NMR (400 MHz, 
CDCl3) δ 8.25 (s, 1H, H-2”), 8.14 (d, J = 6.1 Hz, 1H, H-6”), 8.08 (d, J = 8.2 Hz, 1H, H-7), 
7.51 (d, J = 8.2 Hz, 1H, H-10), 7.46 (s, 1H, H-5), 7.26 (m, 1H, H-9), 7.21 (m, 1H, H-8), 6.79 
(d, J = 6.1 Hz, 1H, N-HTrp), 6.49 (d, J = 6.1 Hz, 1H, N-HLeu), 6.44 (d, J = 6.1 Hz, 1H, H-
5”),4.09 (m, 1H, H-2), 4.58 (m, 1H, H-2’), 3.67 (s, 3H, OMe), 3.24 (m, 6H, H-3, H-7”, H-
10”), 1.86 (m, 4H, H-8”, H-9”), 1.71 (m, 2H, H-3’, H-4’), 1.64 (m, 10H, H-3’, t-Bu), 0.95 
(m, 6H, H-5’); 13C NMR (400 MHz, CDCl3) δ 171.7 (CO), 171.6 (CO), 168.8 (CO), 150.1 
(CO), 150.0 (C-6”), 149.5 (q), 149.2 (C-2”), 135.4 (q), 130.4 (q), 124.6 (C-9), 124.3 (C-5), 
122.6 (C-8), 118.7 (C-10), 117.3 (q), 115.3 (C-7), 114.7 (q), 108.6 (C-5”), 83.8 (q), 52.8 (C-
2), 52.4 (C-2’, OCH3), 49.5 (C-7”, C-10”), 41.2 (C-3’), 28.2 (C(CH3)3), 27.6 (C-3), 25.5 (C-
8”, C-9”), 25.0 (C-4’), 23.0 (C-5’), 21.9 (C-5’); Chiralpak AD 30% isopropyl alcohol/hexane, 
1.0 mL/min, 254 nm, 8.469 min; HRMS (ES): m/z 606.3290 [M + H]+. Calculated for 







4-Pyrrolidinyl nicotinamido-L-leucine-L-(N-phenyl-carboxylate)tryptophan methyl 
ester (158) 
 
To a stirred solution of 128 (140 mg, 0.277 mmol) in DMF (1 mL) was added sodium 
hydride (10.4 mg, 0.26 mmol) at 0 °C. After 20 minutes, phenyl chloroformate (0.042 mL, 
0.33 mmol) was added. After 1 hr (sat.) NaHCO3 (2 mL) was added followed by ethyl acetate 
(3 x 3 mL). The combined organic layer was washed with water (3 x 10 mL). The organic 
layer was dried over anhydrous MgSO4 and the solvent removed to give a yellow residue that 
was purified by column chromatography using MeOH/DCM (5/95), to yield 158 as a pale-
yellow solid (52 mg, 30%), mp 80–82 °C; [α]20D   + 6.1 (c 0.72, CHCl3, 45% de); IR (DCM) 
3413 (NH), 1744 (CO2Me), 1657 (CO)amide cm−1; 1H NMR (400 MHz, CDCl3) δ 8.30 (s, 1H, 
H-2”), 8.20 (d, J = 8.0 Hz, 1H, H-7), 8.07 (s, 1H, H-6”), 7.70 (s, 1H, H-5), 7.61 (d, J = 7.1 
Hz, 1H, H-10), 7.45 (t, J = 7.9 Hz, 2H, H-8, H-9), 7.38–7.29 (m, 5H, Ar-H), 7.12 (d, J = 7.8 
Hz, 1H, N-HTrp), 6.46 (s, 1H, H-5”), 4.97 (m, 1H, H-2), 4.63 (m, 1H, H-2’), 3.71 (s, 3H, 
OMe), 3.32 (m, 6H, H-3’, H-7”, H-10”), 1.90 (m, 4H, H-8”, H-9”), 1.78–1.69 (m, 3H, H-3’, 
H-4’), 0.97 (d, J = 4.8 Hz, 1H, H-5’), 0.95 (d, J = 4.8 Hz, 1H, H-5’); 13C NMR (101 MHz, 
CDCl3) δ 171.8 (CO), 171.6 (CO), 168.0 (CO), 157.7 (CO), 150.7 (q), 150.3 (q), 147.0 (C-2” 
or C-6”), 146.9 (C-2” or C-6”), 145.5 (q), 130.5 (q), 129.6 (C-8, C-9), 126.3, 125.2, 124.2, 
123.4 (C-5), 121.5, 119.1 (C-10), 117.3 (q)116.6 (q), 115.5 (C-7), 108.6 (C-5”), 52.9 (C-2’, 
OCH3), 52.5 (C-2), 49.8 (C-7”, C-10”), 40.9 (C-3’), 27.6 (C-3), 25.4 (C-8”, C-9”), 25.0 (C-
4’), 22.9 (C-5’), 21.8 (C-5’); HRMS (ES): m/z 626.2973 [M + H]+, Calculated for 








tryptophan methyl ester (159) 
 
To a stirred solution of 128 (157 mg, 0.311 mmol) in DMF (1 mL) was added sodium 
hydride (11.2 mg, 0.28 mmol) at 0 °C. After 20 minutes, 4-methoxy-phenyl chloroformate 
(0.055 mL, 0.37 mmol) was added. After 1 hr, (sat.) NaHCO3 (2 mL) was added followed by 
ethyl acetate (3 x 3 mL). The combined organic layer was washed with water (3 x 10 mL). 
The organic layer was dried over anhydrous MgSO4 and the solvent removed to give a yellow 
residue that was purified by column chromatography using MeOH/DCM (5/95), to yield 159 
as a pale-yellow solid (60.4 mg, 31%), mp 86–89 °C; [α]20D   + 6.7 (c 0.52, CHCl3, 85% de); IR 
(DCM) 3268 (NH), 1746 (CO2Me), 1650 (CO)amide, 1542 cm−1; 1H NMR (300 MHz, CDCl3) 
δ 8.19 (m, 1H, H-2”), 8.16 (d, J = 7.2 Hz, 1H, H-7), 8.09–7.99 (m, 1H, H-6”), 7.65 (s, 1H, 
H-5), 7.57 (d, J = 7.2 Hz, 1H, H-10), 7.36–7.25 (m, 2H, H-8, H-9), 7.20–7.14 (m, 2H, H-2”’, 
H-6”’), 7.04 (d, J = 7.3 Hz, 1H, N-HTrp), 6.93–6.87 (m, 2H, H-3”’, H-5”’), 6.42 (s, 1H, H-
5”), 4.93 (m, 1H, H-2), 4.59 (m, 1H, H-2’), 3.82 (s, 3H, OMe), 3.67 (s, 3H, OMe), 3.28 (m, 
6H, H-3, H-7”, H-10”), 1.86 (s, 4H, H-8”, H-9”), 1.74–1.61 (m, 3H, H-3’, H-4’), 0.94 (d, J 
= 4.0 Hz, 3H, H-5’), 0.92 (d, J = 4.0 Hz, 3H, H-5’); 13C NMR (101 MHz, CDCl3) δ 171.8 
(CO), 171.7 (CO), 168.1 (CO), 157.7 (CO), 150.6 (q), 149.5 (q), 148.6 (q), 147.7 (C-2” or C-
6”), 147.3 (C-2” or C-6”), 146.0 (q), 143.9 (q), 130.5 (q), 125.2 (C-8 or C-9), 124.1 (C-5), 
123.4 (C-8 or C-9), 122.3 (C-2”’, C-6”’), 119.0 (C-10), 116.5 (q), 115.5 (C-7), 114.6 (C-3”’, 
C-5”’), 108.6 (C-5”), 55.7 (OCH3), 52.8 (C-2’), 52.5(OCH3, C-2), 49.7 (C-7”, C-10”), 41.0 
(C-3’), 27.6 (C-3), 25.4 (C-8”, C-9”), 25.0 (C-4’), 22.9 (C-5’), 21.8 (C-5’); HRMS (ES): m/z 







l)tryptophan methyl ester (160) 
 
To a stirred solution of 128 (110 mg, 0.218 mmol) in DMF (1 mL) was added sodium 
hydride (7.8 mg, 0.20 mmol) at 0 °C. After 20 minutes, 2-naphthyl chloridocarbonate (54 mg, 
0.26 mmol) was added. After 1 hr, (sat.) NaHCO3 (2 mL) was added followed by ethyl 
acetate (3 x 3 mL). The combined organic layer was washed with water (3 x 10 mL). The 
organic layer was dried over anhydrous MgSO4 and the solvent removed to give a yellow 
residue that was purified by column chromatography using MeOH/DCM (5/95), to yield 160 
as a pale-yellow solid (59 mg, 40 %), mp 96–99 °C; [α]20D   + 9.4 (c 0.90, CHCl3, 44% de); IR 
(DCM) 3408 (NH), 2959, 1746 (CO2Me), 1657 (CO)amide, 1455 cm−1; 1H NMR (400 MHz, 
CDCl3) δ 8.26 (s, 1H, H-2”), 8.22 (d, J = 8.1 Hz, 1H, H-7), 8.09 (br. s, 1H, H-6”), 7.91–7.83 
(m, 2H, Naphth-H), 7.79 (m, 1H, Naphth-H), 7.74 (s, 1H, H-5), 7.73 (s, 1H, Naphth-H), 7.59 
(d, J = 8.1 Hz, 1H, H-10), 7.54–7.47 (m, 2H, Naphth-H), 7.40 (m, 1H, Naphth-H), 7.38–7.28 
(m, 2H, H-8, H-9), 7.00 (d, J = 7.6 Hz, 1H, N-HTrp), 6.78 (d, J = 6.8 Hz, 1H, N-HLeu), 6.35 (d, 
J = 6.1 Hz, 1H, H-5”), 4.96 (m, 1H, H-2), 4.65–4.55 (m, 1H, H-2’), 3.71 (s, 3H, OMe), 3.38–
3.25 (m, 2H, H-3), 3.20 (m, 4H, H-7”, H-10”), 1.80 (m, 4H, H-8”, H-9”), 1.76–1.66 (m, 3H, 
H-3’, H-4’), 0.95 (d, J = 8.0 Hz, 3H, H-5’), 0.93 (d, J = 8.0 Hz, 3H, H-5’); 13C NMR (101 
MHz, CDCl3) δ 171.8 (CO), 171.7 (CO), 168.6 (CO), 150.2 (CO), 149.1 (C-6”), 148.5 (C-
2”), 147.9 (q), 133.7 (q), 131.7 (q), 130.6 (q), 129.6 (C-Ar), 127.8 (C-5), 126.7 (C-Ar), 126.0 
(C-Ar), 125.2 (C-Ar), 124.1 (C-Ar), 123.5 (C-9), 120.7 (C-8), 119.1 (C-Ar), 118.6 (C-10), 
117.2 (q), 116.8 (q), 116.6 (q), 115.5 (C-7), 108.6 (C-5”), 52.6 (C-2), 52.5 (C-2’, OCH3), 
49.53 (C-7”, C-10”), 41.0 (C-3’), 27.6 (C-3), 25.4 (C-4’), 25.0 (C-8”, C-9”), 23.0 (C-5’), 21.8 






N-4-Pyrrolidinyl nicotinamido-L-leucine-L-(N-tert-butylcarbamothioyl) tryptophan 
methyl ester (161) 
 
To a stirred solution of 128 (100 mg, 0.198 mmol) in DFM (0.8 mL) was added sodium 
hydride (7.1 mg, 0.178 mmol) at −5 °C. After 20 minutes, tert-butyl isothiocyanate (0.033 
mg, 0.26 mmol) was added. After 2 hrs, the reaction was quenched with (sat.) NaHCO3 (2 
mL) and extracted with ethyl acetate (3 x 2 mL). The organic layer was washed with 
NaHCO3 (3 x 5 mL), dried over anhydrous MgSO4, and the solvent removed to give a yellow 
oil that was purified by column chromatography using MeOH/DCM (4/96), to yield 161 as a 
colourless solid (30 mg, 24%), mp 96–98°C; [α]20D   + 24.4 (c 0.41, MeOH, 50% de); IR 
(DCM) 3054, 2986, 1742 (CO2Me), 1679 (CO)amide, 1422, 1266 (S=C) cm−1; 1H NMR (400 
MHz, CDCl3) δ 8.83 (s, 1H, N-HThiourea), 8.08 (d, J = 6.1 Hz, 1H, H-6”), 7.94 (m, 1H, H-7), 
7.72 (s, 1H, H-5), 7.52 (m, 1H, H-10), 7.40 (s, 1H, H-2”), 7.25–7.13 (m, 2H, H-8, H-9), 6.86 
(d, J = 7.5 Hz, 1H, N-HTrp), 6.40 (d, J = 6.1 Hz, 1H, H-5”), 6.10 (d, J = 8.2 Hz, 1H, N-HLeu), 
4.92 (m, 1H, H-2), 4.54 (m, 1H, H-2’) 3.80 (s, 3H, OMe), 3.45 (m, 1H, H-3), 3.26–3.14 (m, 
2H, H-7, H-10), 3.04 (m, 2H, H-7, H-10), 1.89–1.67 (m, 7H, H-3’, H-4’, H-8”, H-9”), 1.65 
(s, 9H, t-Bu), 1.02 (d, J = 6.3 Hz, 3H, H-5’), 0.96 (d, J = 6.3 Hz, 3H, H-5’); 13C NMR (101 
MHz, CDCl3) δ 178.0 (C=S), 171.7 (CO), 171.2 (CO), 169.0 (CO), 149.8 (q), 149.5 (C-6”), 
148.4 (C-2”), 134.8 (q), 130.9 (q), 127.5 (C-5), 123.6 (C-8 or C-9), 121.8 (C-8 or C-9), 119.0 
(C-10), 116.8 (q), 113.5 (C-7), 112.8 (q), 108.4 (C-5”), 52.6 (OCH3), 52.5 (C-2), 52.4 (C-2’), 
49.4 (C-7”, C-10”), 39.8 (C-3’), 28.1 (C(CH3)3), 27.0 (C-3), 24.9 (C-4’), 23.1 (C-5’), 21.5 (C-







3,5-bis(trifluoromethyl)phenyl isothiocyante (164) 
 
To a solution of 3,5-bis(trifluoromethyl)aniline (673.8 mg, 2.941 mmol) in DCM (8.7 mL) at 
0 °C was added thiophosgene (406.0 mg, 3.532 mmol) followed by Hünig’s base (802.7 mg, 
6.210 mmol). After 5 hrs, aq. NaHCO3 (15 mL) was added and the aqueous layer washed 
with DCM (3 x 15 mL). The combined organic extracts were dried over anhydrous MgSO4 
and the solvent removed in vacuo to afford a pale-yellow oil that was purified by column 
chromatography using heptane (100%) to give 164 as a clear oil (570 mg, 71%), 1H NMR 
(300 MHz, CDCl3) δ 7.76 (s, 1H, H-4), 7.64 (s, 2H, H-2, H-6); 13C NMR (101 MHz, CDCl3) 
δ 141.0 (N=C=S), 134.1 (q), 133.5 (quart., JCF = 34.3 Hz, C-3, C-5), 125.7 (d, JCF = 2.9 Hz, 
C-2, C-6), 120.5 (dt, JCF = 7.5, 3.8 Hz, C-4), 118.4–126.6 (q, JCF = 273.0 Hz, C-7). 
N-4-Pyrrolidinyl nicotinamido-L-leucine-L-(N-3,5-
bis(trifluoromethyl)phenyl)carbamothioyl) tryptophan methyl ester (162)  
 
To a stirred solution of 128 (70.0 mg, 0.138 mmol) in DFM (1.5 mL) was added sodum 
hydride (9.5 mg, 0.24 mmol) at 0 °C. After 20 minutes, 3,5-bis(trifluoromethyl)phenyl 
isocyanate (0.043 mg,0.097 mmol) was added and the solution warmed to r.t. After 4 hrs, the 
reaction was quencehed with (sat.) NaHCO3 (5 mL) and extracted with ethyl acetate (5 mL). 
The organic layer was washed with NaHCO3 (3 x 5 mL), dried over anhydrous MgSO4, and 
the solvent removed to give a brown oil that was purified by column chromatography using 
MeOH/DCM (5/95), to yield 162 as a pale-yellow solid (18 mg, 17%); [α]20D   − 20.8 (c 0.36, 
CHCl3, 53% de); IR (DCM) 3402 (NH), 1742 (CO2Me), 1659 (CO)amide, 1266 (C=S); 1H 




Hz, 1H, H-6”),7.74 (s, 1H, H-5),7.71 (s, 1H, H-4”’), 7.51 (m, 1H, H-10), 7.18 (m, 2H, H-8, 
H-9), 6.94 (s, 1H, H-2”), 6.68 (d, J = 7.5 Hz, 1H, N-HTrp), 6.30 (d, J = 6.2 Hz, 1H, H-5”), 
5.74 (d, J = 7.9 Hz, 1H, N-HLeu), 4.96 (m, 1H, H-2), 4.55 (m, 1H, H-2’),  3.83 (s, 3H, OMe), 
3.59 (dd, J = 14.7, 4.7 Hz, 1H, H-3), 3.20 (m, 3H, H-3, H-7” or H-10”), 2.98 (m, 2H, H-7” 
or H-10”), 1.88 (m, 3H, H-3’, H-8” or H-9”), 1.73–1.58 (m, 4H, H-3’, H-4’, H8” or H-9”), 
1.00 (d, J = 6.4 Hz, 3H, H-5’),0.93 (d, J = 6.4 Hz, 3H, H-5’); 13C NMR (101 MHz, CDCl3) δ 
179.4 (C=S), 171.6 (CO),170.9 (CO), 169.2 (CO),149.7 (q), 149.0 (C-6”), 147.6 (C-2”), 
141.3 (q), 135.3 (q), 132.1 (quart., JCF = 33.0 Hz, C-3”’, C-5”’), 131.5 (q), 126.7 (C-5), 124.2 
(C-8 or C-9), 124.1 (C-8”’ or C-9”’, C-2”’ and C-6””),124.0 (C-8”’ or C-9”’, C-2”’ and C-
6”’), 122.5 (C-8 or C-9), 119.1 (C-10, C-4”’), 119.0 (C-2”), 116.5 (q),115.1 (C-7), 114.8 (C-
7), 108.6 (C-5”), 52.9 (OCH3), 52.6 (C-2), 52.2 (C-2’), 49.3 (C-7”, C-10”), 39.5 (C-8”, C-9”), 
26.5 (C-3), 25.3 (C-3’), 25.0 (C-4’), 23.1 (C-5’), 21.4 (C-5’); HRMS (ES): m/z 777.2668 [M 
+ H]+, Calculated for C37H39F6N6O4S, 777.2657 [M + H] +. 
5.5  α–Substituted Catalysts  
4,8-Dihydroxyquinoline (168) 156 
 
 
A solution of Xanthurenic acid (5.00 g, 24.4 mmol) in diphenyl ether was heated to reflux 
temperature. After 3 hrs the reaction mixture was cooled to r.t., and the crude product was 
filtered and washed with hexane to give 168 as a brown solid (3.60 g, 92%), which was used 
in the next step without further purification, 1H NMR (400 MHz, DMSO- d6) δ 11.21 (br. s, 
1H, OH), 10.61 (br. s, 1H, OH), 7.73 (d, 1H, J = 7.2 Hz, H-2), 7.52 (dd, 1H, J = 7.8, 1.5 Hz, 










4-Hydroxy-8-tosyloxyquinoline (169)  
 
 
To a stirred solution of 168 in 1M NaOH (3.9 mL) at r.t was added (p-toluenesulfonyl 
chloride (710 mg, 3.73 mmol) dropwise in acetone (1.5 mL). After 18 hrs a further aliquot of 
p-toluenesulfonyl chloride (140 mg 0.75 mmol) in acetone (1 mL) was added. The mixture 
was stirred for an additional 2 hrs after which water (5 mL) was added to the solution 
resulting in the formation of a precipitate that was filtered and washed with water (10 mL) 
followed by acetone (10 mL) to afford 169 as a grey precipitate (1.12 g, 96%) that was used 
directly in the next step without further purification, 1H NMR (400 MHz, DMSO) δ 11.43 (s, 
1H, OH), 7.98 (d, J = 7.8 Hz, 1H, H-2), 7.78 (d, J = 8.3 Hz, 2H, Ar-H), 7.69 (m, 1H, Ar-H), 




A solution of 169 (500 mg, 1.59 mmol) in phosphoryl chloride (4 mL) was heated to reflux 
temperature. After 3 hrs the resulting solution was cooled and carefully added to a beaker 
containing a small portion of ethyl acetate and ice slurry. The mixture was then slowly added 
to a large separatory funnel containing (sat.) NaHCO3 and ethyl acetate, and extracted with 
ethyl acetate (3 x 200 mL). The combined organic extracts were washed with (sat.) NaHCO3 
and dried over anhydrous MgSO4. The solvent was removed under reduced pressure to afford 
the crude chloride that was purified using column chromatography using ethyl acetate and 
hexane (25/75) to give 170 as a pale-yellow solid (390 mg, 74 %), mp 140–141°C (lit.156 
value 141–142 °C); 1H NMR (400 MHz, CDCl3) δ 8.67 (d, J = 4.6 Hz, 1H, H-2), 8.16 (dd, J 
= 8.4, 1.5 Hz, 1H, H-8), 7.87 (m, 2H, Ar-H), 7.70–7.55 (m, 2H, H-6, H-7), 7.47 (d, J = 4.6 






To a solution of 170 (200 mg, 0.60 mmol), in toluene (4 mL), at 100 °C, were added 
pyrrolidine (0.25 mL, 3.0 mmol) and K2CO3 (83 mg, 0.6 mmol). After 18 hrs the solution 
was cooled to r.t., filtered through Celite®, and washed with MeOH (20 mL). The filtrate was 
concentrated under reduced pressure to give a crude residue that was purified by column 
chromatography using ethyl acetate to afford 171 as colourless solid (150 mg, 67 % ), mp 
159–161°C; 1H NMR (400 MHz, DMSO) δ 8.22 (d, J = 6.8 Hz, 1H, H-2), 7.94 (d, J = 8.5 
Hz, 1H, H-8), 7.49 (d, J = 7.9 Hz, 2H, Ar-H), 7.41 (t, J = 8.5 Hz, 1H, H-7), 7.30 (d, J = 7.6 
Hz, 1H, H-6), 7.11 (d, J = 7.9 Hz, 2H, Ar-H), 6.71 (d, J = 6.8 Hz, 1H, H-3), 3.90 (m, 4H, H-
1’, H-4’), 2.28 (s, 3H, CH3), 2.01 (m, 4H, H-2’, H-3’). 
4-(Pyrrolidin-1-yl)-8-hydroxyquinoline tosylate (172) 
 
A solution of 171 (200 mg, 0.54 mmol) in ethanol (2 mL) and 2M NaOH (1.4 mL, 2.7 mmol) 
was heated to reflux temperature. After 3 hrs the mixture was cooled to r.t. followed by the 
addition of deionized water (1 mL). The pH was adjusted to 7 with 1M HCl, and the solvent 
removed to give a crude product that was purified by column chromatography using 
MeOH/DCM (10/90) to afford the purified tosylate salt 172 as a dark-green solid (193 mg, 97 
%), mp decomposes > 285 °C; 1H NMR (400 MHz, DMSO) δ 8.22 (d, J = 6.8 Hz, 1H, H-2), 
7.94 (d, J = 8.5 Hz, 1H, H-8), 7.49 (d, J = 7.9 Hz, 2H, Ar-H), 7.41 (t, J = 8.5 Hz, 1H, H-7), 
7.30 (d, J = 7.6 Hz, 2H, H-6), 7.11 (d, J = 7.9 Hz, 1H Ar-H), 6.71 (d, J = 6.8 Hz, 1H, H-3), 





Methyl (2-chloroacetyl)-L-leu-L-tryp (173) 
 
To a solution of the 104 (100 mg, 0.3 mmol) in dry DCM (5 mL) at 0 °C, was added 
chloroacetic acid (19 mg, 0.2 mmol), HOBt (27 mg, 0.20 mmol), and DCC (54 mg, 0.26 
mmol). After 18 hrs, the mixture was filtered through Celite ® and washed with DCM (50 
mL). The filtrate was concentrated under reduced pressure to give a crude residue that was 
purified by column chromatography using ethyl acetate/hexane (30/70) to give 173 as a 
colourless solid (75 mg, 92%), mp 73–75 °C; [α]20D   + 26.5 (c 1.0, DCM); IR (DCM) 3407, 
3055, 1743 (CO2Me), 1661(CO)amide, 1266 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.31 (br. s, 
1H, N-Hindole), 7.50 (m, 1H, H-7), 7.34 (m, 1H, H-10), 7.17 (m, 1H, H-9), 7.10 (m, 1H, H-8), 
6.98 (s, 1H, H-5), 6.91 (d, J = 8.4 Hz, 1H, N-HLeu), 6.86 (d, J = 7.7 Hz, 1H, N-HTrp), 4.90 (m, 
1H, H-2), 4.52 (m, 1H, H-2’), 3.87 (d, J = 15.0 Hz, 1H, H-2”), 3.65 (d, J = 15.0 Hz, 1H, H-
2”), 3.68 (s, 3H, OMe), 3.31 (d, J = 5.3 Hz, 2H, H-3), 1.70–1.57 (m, 3H, H-3’, H-4’), 0.90 (d, 
J = 80 Hz, 3H, H-5’), 0.86 (d, J = 80 Hz, 3H, H-5’). 13C NMR (101 MHz, CDCl3) δ 171.9 
(CO), 171.3 (CO), 166.2 (CO), 136.1 (q), 127.4 (q), 123.2 (C-5), 122.2 (C-9), 119.7 (C-8), 
118.3 (C-7), 111.4 (C-10), 109.3 (q), 52.9 (C-2), 52.4 (OCH3), 51.9 (C-2’), 42.3 (C-2”), 41.1 
(C-3’), 27.4 (C-3), 24.7 (C-4’) 22.8 (C-5’), 22.0 (C-5’); HRMS (ES): m/z 408.1691 [M + H]+, 
Calculated for C20H27ClN3O4, 408.1690 [M + H]+; Chiralpak AD 30% isopropyl 










Methyl (2-((4-(pyrrolidin-1-yl)quinolin-8-yl)oxy)acetyl)-L-leucyl-L-tryptophanate (165) 
 
To a solution of 172 (200 mg, 0.54 mmol) in dry acetonitrile (10 mL) at r.t., were added 173 
(329 mg, 0.81 mmol) and cesium carbonate (352 mg, 1.08 mmol). The temperature was 
increased to 60 °C, and after 7 hrs the reaction mixture was cooled, filtered through Celite®, 
rinsed with MeOH, and the solvent removed to afford a crude residue that was purified by 
column chromatography using MeOH/DCM (3/97) to afford 165 as a pale-green (180 mg, 
60%), mp 106–109 °C; [α]20D   + 13.1 (c 0.75, DCM); IR (DCM) 3055, 2309, 1742 (CO2Me), 
1670 (CO)amide, 1266 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.22 (s, 1H, N-HLeu), 9.20 (s, 1H, 
N-Hindole), 8.33 (d, J = 6.6 Hz, 1H, H-2”’), 7.85 (d, J = 8.8 Hz, 1H, H-8”’), 7.50 (d, J = 7.7 
Hz, 1H, N-HTrp), 7.47–7.41 (m, 1H, H-7), 7.31 (t, J = 8.3 Hz, 1H, H-7”’), 7.17 (br. s, 1H, H-
5), 7.16–7.09 (m, 2H, H-10, H-6”’), 6.96–6.84 (m, 1H, H-8, H-9), 6.42 (d, J = 6.6 Hz, 1H, H-
3”’), 4.80 (m, 1H, H-2), 4.70–4.60 (m, 2H, H-2’, H-2”), 4.53 (d, J = 14.6 Hz, 1H, H-2”), 
3.75 (m, 4H, H-1””, H-4”’), 3.58 (s, 3H, OMe), 3.30–3.17 (m, 2H, H-3), 2.11–2.05 (m, 4H, 
H-2””, H-3””), 1.90 (m, 1H, H-3’), 1.75 (m, 1H, H-3’), 1.64–1.53 (m, 1H, H-4’), 0.87 (d, J 
= 6.6 Hz, 6H, H-5’), 0.83 (d, J = 6.6 Hz, 6H, H-5’); 13C NMR (101 MHz, CDCl3) δ 172.4 
(CO), 172.1 (CO), 167.8 (CO), 154.9 (q), 149.2 (q), 142.3 (C-3”’), 136.1 (q), 133.7 (q), 127.4 
(q), 124.5 (C-7”’), 124.0 (C-5), 121.2 (C-8 or C-9), 119.7 (q), 118.8 (C-8 or C-9), 118.6 (C-
8”’), 118.2 (C-7), 112.8 (C-6”’), 111.2 (C-10), 109.5 (q), 102.4 (C-2”’), 69.0 (C-2”), 53.2 (C-
1””, C-4””), 52.8 (C-2), 52.5 (C-2’), 52.1 (OCH3), 39.5 (C-3’), 27.4 (C-3), 25.7 (C-2””, C-
3””), 24.8 (C-4’), 22.9 (C-5’), 21.7 (C-5’); HRMS (ES): m/z 586.3038 [M + H]+, Calculated 
for C33H40N5O5, 586.3029 [M + H] +; Chiralpak AD 30% isopropyl alcohol/hexane, 1.0 









To a solution of (S)-(-)-α,α-diphenyl-2-pyrrolidinemethanol (300 mg, 1.18 mmol) in dry 
DCM at 0 °C, were added chloroacetyl chloride (267 mg, 2.36 mmol) and triethylamine (0.16 
mL, 1.18 mml). After 1hr (sat.) NaHCO3 was added followed by DCM (3 x 20 mL). The 
combined organic layers were dried over MgSO4 and solvent removed at reduced pressure to 
give a crude residue that was purified by column chromatography using ethyl acetate/hexane 
mixtures (30/70) to afford 175 as a colourless solid (350 mg, 90%), [α]20D   − 129.7 (c 1, DCM); 
1H NMR (300 MHz, CDCl3) δ 7.44–7.36 (m, 4H, Ar-H), 7.35–7.28 (m, 6H, Ar-H), 6.13 (s, 
1H, OH), 5.21 (m, 1H, H-2), 3.99 (s, 2H, H-2’), 3.45 (m, 1H, H-5), 3.05 (m, 1H, H-5), 2.14 
(m, 1H, H-3), 2.00 (m, 1H, H-3), 1.62 (m, 1H, H-4), 1.09 (m, 1H, H-4); 13C NMR (75 MHz, 
CDCl3) δ 168.6 (CO), 145.8 (q), 143.0 (q), 128.0, 127.4, 81.9 (q), 67.3 (C-2), 48.5 (C-5), 42.1 
(C-2’), 29.2 (C-3), 23.3 (C-4). 
(S)-1-(2-(hydroxydiphenylmethyl)pyrrolidin-1-yl)-2-iodoethanone (176) 
 
To a solution of 175 (300 mg, 0.91 mmol) in dry acetonitrile (20 mL) at 80 °C was added KI 
(755 mg, 4.55 mmol). After 18 hrs (sat.) NaHCO3 was added followed by extraction with 
DCM(3 x 20 mL). The combined organic layers were dried over MgSO4 and the solvent 
removed at reduced pressure to give a crude residue that was purified by column 
chromatography using ethyl acetate/hexane mixtures (30/70) to afford 176 as a light-brown 
oil(320 mg, 83%), [α]20D   − 146.1 (c 1.0, DCM); IR (DCM) 1619 (CO)amide, 1215 (C–O) cm
−1; 
1H NMR (400 MHz, CDCl3) δ 7.46–7.37 (m, 4H, Ar-H), 7.35–7.27 (s, 6H, Ar-H), 6.34 (s, 
1H, OH), 5.18 (dd, J = 8.8, 4.2 Hz, 1H, H-2), 3.75 (d, J = 9.6 Hz, 1H, H-2’), 3.63 (d, J = 9.6 
Hz, 1H, H-2’), 3.38 (m, 1H, H-5), 2.98 (m, 1H, H-5), 2.13 (m, 1H, H-3), 2.00 (m, 1H, H-3), 
1.60 (m, 1H, H-4), 0.92 (m, 1H, H-4); 13C NMR (101 MHz, CDCl3) δ 170.5 (CO), 146.1 (q), 
143.2 (q), 128.2–127.2 (Ar), 82.1 (C-6), 67.2 (C-2), 49.3 (C-5), 29.8 (C-3), 23.1 (C-4), −2.1 







To a solution of 172 (120 mg, 0.33 mmol) in dry actonitrile (4 mL) at r.t., were added 158 
(208 mg, 0.5 mmol) and cesium carbonate (215 mg, 0.66 mmol) and the temperature 
increased to 120 °C. Every 24 hrs iodide 167 (30 mg, 0.07 mmol) was added, and after seven 
days, the mixture was cooled and filtered through Celite®, rinsed with MeOH and the solvent 
removed to give a crude residue that was purified by column chromatography using 
MeOH/dihloromethane (7/93) to afford 166 as a colourless solid (73 mg, 44%), mp 139–142 
°C; [α]20D   − 76.5 (c 1, DCM); IR (DCM) 1638, 1347, 1265 cm
−1; 1H NMR (400 MHz, CDCl3) 
δ 8.10 (d, J = 8.0 Hz, 1H, H-2”), 7.92 (d, J = 8.0 Hz, 1H, H-8”), 7.20–7.50 (m, 11H, H-7”, 
Ar-H), 6.91 (d, J = 8.0 Hz, 1H, H-6”), 6.53 (d, J = 8.0 Hz, 1H, H-3”), 6.34 (s, 1H, OH), 5.34 
(d, J = 15.3 Hz, 1H, H-2’), 5.14 (dd, J = 8.0, 4.0 Hz, 1H, H-2), 4.88 (d, J = 15.3 Hz, 1H, H-
2’), 3.95 (m, 5H, H-5, H-1”’, H-4”’), 3.24 (m, 1H, H-5), 2.15 (m, 4H, H-2”’, H-3”’), 2.06 
(m, 1H, H-3), 1.93 (m, 1H, H-3), 1.77 (m, 1H, H-4), 1.25(m, 1H, H-4); 13C NMR (100.6 
MHz, CDCl3) δ 169.3 (CO), 155.1 (q), 147.5 (q), 145.9 (q), 143.4 (q), 139.3 (C-2”), 130.7 
(q), 127.9, 127.6, 127.4, 127.3, 127.2, 125.6 (C-7”), 118.7, 118.6 (C-8”), 113.7 (C-6”), 102.2 
(C-3”), 81.3 (q), 68.3 (C-2, C-2’), 54.1 (C-1”’, C-4”’), 48.5 (C-5). 29.6 (C-3), 25.6 (C-2”’, C-
3”’), 23.5 (C-4); HRMS (ES): m/z 508.2607 [M + H]+, Calculated for C32H34N3O3, 508.2600 










5.6 Synthesis of Alcohols 
9-(1-Hydroxyethyl)anthracene (154)163 
 
To a stirred solution of 9-anthraldehyde (1.014 g, 4.917 mmol) in diethyl ether (30 mL) at 0 
°C was added CH3Li (1.6 M in toluene, 4 mL, 6.4 mmol). After 4 hrs, sat. NH4Cl (5 mL) was 
added and the layers separated. The aqueous layer was extracted with diethyl ether (1 x 10 
mL) and the combined organic layer was dried over anhydrous MgSO4 and the solvent 
removed under reduced pressure to give 154 as a yellow solid (1.033 g, 94%) that used in the 
next step without further purification, 1H NMR (400 MHz, CDCl3) δ 8.62 (d, J = 8.6 Hz, 1H), 
8.23 (d, J = 81.5 Hz, 1H), 7.94 (d, J = 8.0 Hz, 1H), 7.41 (m, 1H), 6.42 (dd, J = 13.5, 6.8 Hz, 
1H), 1.87 (d, J = 6.8 Hz, 1H); CHIRALPACK AD (4.6 mm x 25 cm), isopropyl 
alcohol/hexane (2.5/97.5), 1.0 mL/min, 254 nm, 11.479 min, 16.462 min. 
(1S,2R)-2-hydroxycyclohexyl 4-(dimethylamino)benzoate (134) 
 
To a stirred solution of 1,2-cyclohexenediol (316.4 mg, 2.724 mmol) in pyridine (4 mL), at 0 
°C, was added 4-(dimethylamino)benzoyl chloride (201.2 mg, 1.096 mmol) and the 
temperature increased to r.t. After 18 hrs, 1M HCl (15 mL) was added, followed by 
extraction with ethyl acetate (3 x 15 mL). The combined organic layer was washed with 1M 
HCl (3 x 45 mL), dried over anhydrous MgSO4, and the solvent removed in vauo to give a 
crude residue that was purified by column chromatography using ethyl acetate/hexane 
(40/60) to afford 134 as a colourless solid (172.9 mg, 60%), 1H NMR (300 MHz, CDCl3) δ 
7.94 (d, J = 8.0 Hz, 2H, Ar-H), 6.65 (d, J = 8.0 Hz, 2H, Ar-H), 5.16 (m, 1H, H-2), 3.92 (m, 




H-5), 1.40 (m, 2H, H-4 or H-5), Chiralpak AD (4.6 mm x 25 cm), isopropyl alcohol/hexane 
(10/90), 1.0 mL/min, 254 nm, 25.373 min, 31.684 min.	  
General Procedure for the reduction of ketones: To a stirred solution of ketone in (3.0 
mmol) in MeOH (5 mL), at 0 °C was added NaBH4 (3.6 mmol). After 3 hrs, (sat). NH4Cl (10 
mL) was added and the layers separated. The aqueous layer was washed with ethyl acetate (3 
x 30 mL). The combined organic extracts were dried over anhydrous MgSO4 and the solvent 
removed under reduced pressure to afford the crude product that was purified by column 
chromatography using ethyl acetate/hexane to give the pure product. 
1-(4-Methoxyphenyl)ethanol (130) 
 
(colourless oil, 76%), 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 2H, Ar-H), 6.88 (m, 2H, Ar-H), 
4.85 (q, J = 6.5 Hz, 1H, C-H), 3.80 (s, 3H, OMe), 1.81 (s, 1H, OH), 1.48 (d, J = 6.4 Hz, 3H, 
CH3); Chiralpak AD (4.6 mm x 25 cm), isopropyl alcohol/hexane (10/90), 1.0 mL/min, 254 
nm, 8.136 min, 8.587 min. 
1-(4-Nitrophenyl)ethanol (131) 
 
(orange oil, 80%) 1H NMR (300 MHz, CDCl3) δ 8.03–7.98 (d, J = 8.4 Hz, 2H, Ar-H), 7.40 
(d, J = 8.4 Hz, 2H, d, J = 8.4 Hz, 2H), 4.87 (q, J = 6.5 Hz, 1H, C-H), 1.37 (d, J = 6.5 Hz, 3H, 
CH3); Chiralpak IC (4.6 mm x 25 cm), isopropyl alcohol/hexane (7/93), 0.8 mL/min, 254 nm, 












(oil, 79%), 1H NMR (400 MHz, CDCl3) δ 7.36 (m, 2H, Ar-H), 7.13 (m, 2H, Ar-H), 4.74 (q, J 
= 6.5 Hz, 1H, C-H), 1.93 (s, 1H, OH), 1.36 (d, J = 6.5 Hz, 3H, CH3); Chiralcel OD (4.6 mm x 
25 cm), isopropyl alcohol/hexane (10/90), 1.0 mL/min, 254 nm, 5.877 min, 6.301 min. 
1-(2,4,6-trimethylphenyl)ethan-1-ol (133) 
 
(colourless solid, 88%), 1H NMR (400 MHz, CDCl3) δ 6.80 (s, 2H, Ar-H), 5.37 (q, J = 6.8 
Hz, 1H, C-H), 2.42 (s, 3H, CH3), 2.26 (s, 3H, CH3), 1.68 (s, 1H, OH), 1.53 (m, 3H, CH3); 
Chiralpak AD (4.6 mm x 25 cm), isopropyl alcohol/hexane (9.5/90.5), 1.0 mL/min, 254 nm, 
4.453 min, 4.854 min. 
2-Methyl-1-phenyl-1-propanol (129) 
 
(clear oil, 85%), 1H NMR (300 MHz, CDCl3) δ 7.23 (m, 5H, Ar-H), 4.29 (d, J = 6.8 Hz, 1H, 
C-H), 1.90 (m, 1H, C-H), 1.78 (s, 1H, OH), 0.94 (d, J = 6.7 Hz, 2H, CH3), 0.73 (d, J = 6.7 
Hz, 2H, CH3); Chiralpak AD (4.6 mm x 25 cm), isopropyl alcohol/hexane (2.5/97.5), 2.5 







5.7 Kinetic Resolution Experiments 
General procedure for the catalytic kinetic resolution of sec-alcohols: To a stirred 
solution of the sec-alcohol (0.5 mmol), catalyst (0.025 mmol), and triethylamine (0.45 mmol) 
in DCM (2 mL) at −78 °C, was added iso-butyic anhydride (0.35 mmol). After 3 hrs, the 
reaction was quenched with MeOH (1 mL), followed by the addition of sat. NaHCO3 (5 mL). 
The organic layer was separated and the aqueous layer was washed with DCM (2 x 5 mL). 
The combined organic layer was dried over anhydrous MgSO4 and the solvent removed in 
vacuo. The alcohol and ester mixture was purified by column chromatography using ethyl 
acetate/hexane (20/80). The isolated ester was hydrolysed using 1M NaOH in MeOH (2 mL). 
After 6 hrs, the solvent was removed in vacuo and the residue purified by column 
chromatography using ethyl acetate/hexane (50/50).  
Determination of enantiomeric excesses, conversion and selectivities: All unreacted 
alcohols recovered from kinetic resolutions using catalyst were found to be enriched in the 
(R)-enantiomer, as determined by the sign of the optical rotation, while esters were enriched 
in the (S)-enantiomer (also determined by measuring optical rotation). The enantiomeric 
excess of the unreacted alcohol and the ester (after hydrolysis) were determined by analytical 
chiral HPLC (Chiracel OD, Chiralpak AD, or Chiralpak IC). 
Selectivity164 was calculated according to: 
S = ln 1- CHPLC 1 - eeA
ln 1 - CHPLC 1 + eeA
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